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Abstract
Class A macrophage scavenger receptors (SR-As) have been implicated in a
variety of macrophage associated processes, including adhesion,
atherogenesis, and host defense. There are two alternatively spliced forms of
the Class A receptor, type I and type II. Based on the primary sequence, the
receptors were predicted to have 6 domains: an N-terminal cytoplasmic domain,
a single transmembrane domain, a spacer domain, an a-helical coiled-coil
domain, and a collagenous region. The type II receptor has a short C-terminal
domain, and the type I receptor has a 110 amino acid domain which contains a
102 residue cysteine rich (SRCR) domain. Structural and functional studies
with transmembrane proteins can be hindered by the difficulties inherent in
working with these water insoluble molecules. Accordingly, stable cell lines
expressing secreted forms of the type I and II SR-As which had ligand binding
activity were generated. Using a solid-phase assay, two new ligands for the
SR-A were identified: crocidolite asbestos, a silicate responsible for asbestosis,
and lipoteichoic acid, a cell surface lipid that is a Gram-positive analog of
endotoxin. Ligand binding was pH dependent, and was shown to be mediated
by the collagenous domain. Biophysical and biochemical studies revealed that
the secreted receptor is trimeric, with 6 N-linked oligosaccharides per
polypeptide. Both receptor isotypes contain significant amounts of
hydroxylysine and hydroxyproline, modified amino acids characteristic of
proteins containing collagenous triple helices. Circular dichroism studies
revealed that both isoforms of the receptor contain amounts of a-helix
consistent with the presence of an a-helical coiled-coil, and also that gross pH
disruption of structure does not occur, suggesting that pH dependent ligand
release does not require major structural change. The pattern of the three
intramolecular disulfide bonds in the SRCR domain of SR-AI (Cys2-Cys7 , Cys3-
Cys8 , Cyss-Cys 6), which was determined using proteolytic analysis, is probably
shared by these domains found in other members of the SRCR superfamily.
Negative stain and rotary shadowed electron microscopy of the SR-As revealed
that they are highly extended molecules, with a flexible hinge between the
collagenous and coiled-coil domains. These studies have helped validate and
extend the structural model of the scavenger receptor.
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Chapter 1
Introduction: The Scavenger Receptors
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Scavenger receptors: introduction and general properties
Scavenger receptors are defined as molecules which bind to modified
lipoproteins. They were initially discovered by Brown and Goldstein and co-
workers in their efforts to resolve a quandary. Patients with familial
hypercholesteremia were found to lack the receptor for low density lipoprotein(LDL), the major carrier of cholesterol in the blood (Goldstein et al., 1995).
Despite this, these patients still manage to accumulate massive amounts of
cholesterol in macrophages in the arterial wall in atherosclerotic plaques(Goldstein et al., 1995). Obviously these cells were accumulating cholesterol in
a LDL-receptor independent fashion. Additionally, when macrophages are
exposed to high doses of LDL in culture for extended periods of time, they do
not become the cholesterol-laden macrophage-derived foam cells which are
observed in vivo (Goldstein et al., 1979; Brown et al., 1979). The breakthrough
in this area came with the observation that macrophages have a large capacity
for the receptor mediated uptake of modified forms of LDL, in particular
acetylated LDL (AcLDL), leading to massive accumulation of cholesterol in the
cell (Goldstein et al., 1979).
The receptor activity they had identified was soon found to have highly
unusual ligand binding properties. The uptake and degradation of AcLDL by
macrophages could be competed for by a diverse array of macromolecules,
breaking the general paradigm of one receptor - one ligand. The scavenger
receptor competitors are summarized in table 1.1 (adapted from Krieger and
Hertz, 1994). These include some modified proteins (AcLDL and oxidized
LDL), nucleic acids (poly(G) and poly(l)), polysaccharides (dextran sulfate and
fucoidin), and other molecules, including polyvinyl sulfate and, notably,
endotoxin. The common theme to this array of ligands it that all ligands are
polyanionic macromolecules or macromolecular complexes. However, not all
polyanions are ligands. Molecules such as poly (D-glutamate), poly(C), and
heparin have similar (or even greater) negative charge density and fairly similar
structures and properties to molecules which are ligands. The exact features
which make a molecule a ligand remain unclear; however in the case of the
polynucleotides studies have begun clarify this issue. In order to act as ligands,
nucleic acids must form four-stranded structures (Pearson et al., 1992). Poly(G)
and (I) can form such structures, while many other polynucletides can not.
Furthermore, if the four stranded conformation is disrupted by removal of
necessary cations, the ability of poly(l) to function as a ligand is lost.
Apparently, the four stranded structures have phosphate groups arranged in a
manner which enables these nucleotides to bind to the scavenger receptors. In
order to try to understand the function of these unusual receptors, as well as to
investigate other issues such as the basis for this broad ligand binding activity,
the receptors were purified and cloned as described below.
Purification of scavenger receptors
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A number of groups interested in the potential role of the scavenger
receptor in atherosclerosis and other macrophage associated properties set out
to purify it. Ligand blotting experiments revealed that a 200-260 kDa AcLDL
binding protein was expressed in several tissues and cultured cell lines (Wong
et al., 1983; Via et al., 1985; Dresel et al., 1987). Kodama, Krieger, and co-
workers succeeded in obtaining a purified glycoprotein of 220 kDa (Kodama et
al., 1988). Upon reduction, the protein exhibited an electrophoretic mobility of
77 kDa, indicating that the protein was presumably trimeric in its native state.
Ligand blotting experiments demonstrated that only the trimeric form of the
receptor was capable of binding AcLDL. A filter binding assay was used to
show that '21-AcLDL could bind to the purified protein with high affinity, and that
this binding could be blocked by the known scavenger receptor inhibitors
fucoidin, maleylated BSA, polyvinyl sulfate, and poly (I:C), but not by LDL.
Using a monoclonal antibody raised against the purified receptor to examine
expression in the liver, it was found that the receptor was localized in only those
cells which had been shown to have AcLDL binding activity. These data
strongly suggested that the purified protein was the macrophage receptor for
AcLDL initially identified by Brown, Goldstein and co-workers.
Cloning and molecular structure of the macrophage scavenger receptor
Using DNA probes based on the sequences of peptides derived from
these purified receptors, two closely related cDNAs were isolated from a bovine
lung cDNA library (Kodama et al., 1990; Rohrer et al., 1990). The cDNAs were
shown to encode scavenger receptors by a number of criteria. Using Northern-
blot analysis, it was found that the receptor was expressed in alveolar
macrophages and bovine lungs, but not in brain and muscle. In the human
monocyte cell line THP-1, expression of receptor was only detectable after
treatment with phorbol esters to differentiate the cells into macrophages. This
correlates with scavenger receptor activity, which is essentially absent in the
uninduced cells (Hara et al., 1987). Transient transfection of the cloned cDNAs
in COS M6 cells conferred the ability to bind AcLDL with high affinity (Kodama
et al., 1990; Rohrer et al., 1990). This binding was competible by the classic
scavenger receptor ligands, but not by control molecules. Thus, the
macrophage scavenger receptor had been cloned.
Sequence analysis of the cloned bovine scavenger receptor cDNAs
revealed that they encode modular proteins with some highly unusual features.
Based on the primary sequence, the receptors were divided into 6 domains(Kodama et al., 1990; Rohrer et al., 1990; Ashkenas et al., 1993) (Figure 1.1).
The receptor has a 50 residue N-terminal cytoplasmic domain which contains
several possible phosphorylation sites. This is followed by a hydrophobic
stretch of 26 amino acids predicted to form the single transmembrane domain
and a 75 amino acid spacer domain whose only notable features are a cysteine
and 2 of the 7 potential N-linked glycosylation sites on the receptor.
Immediately to the C-terminus of the spacer domain is a 121 amino acid region
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containing 2 segments of heptad repeats, with hydrophobic (often aliphatic)
residues in the "a" and "d" positions of the repeat. This sequence motif is
characteristic of the left handed a-helical coiled-coil (Cohen and Parry, 1990).
There is a "skip" in the middle of the domain, interrupting the pattem of heptad
repeats. The domain also includes the remaining 5 potential N-linked sites.
Following the putative coiled-coil region is a domain containing 24 repeats of a
different sort: Gly-X-Y, where X and Y are frequently proline. This sequence
characteristically forms a right handed three stranded collagenous structure,
and was the first report of such a domain in a transmembrane protein.
Following the collagenous domain is an isotype specific C-terminal region. The
two different receptor isotypes are the products of alternative splicing of
transcripts from a single gene (Freeman et al., 1990; Emi et al., 1993). In the
type II receptor, this domain is a 6 residue region. In the type I receptor, it is a
110 amino acid domain containing 6 cysteines. This domain helped reveal an
ancient, highly conserved sequence module termed the "scavenger receptor
cysteine rich" or SRCR domain (Freeman et al., 1990). The other members of
the superfamily of proteins containing the SRCR domain and the characteristic
features of this domain are discussed in chapter 5 and appendix B of this thesis.
Following the cloning of murine, human, and rabbit homologs of the type I and II
scavenger receptors and determination of intron/exon junctions (Ashkenas et
al., 1993; Matsumoto et al., 1990; Bickel and Freeman, 1992), the boundaries of
these domains were adjusted somewhat to take the additional information into
account (Ashkenas et al., 1993). The receptors from different species are highly
similar to each other. Notable differences include a loss of one Gly-X-Y repeat
from the human receptor and an almost complete lack of homology between the
different type II C-terminal domains.
It is rather unusual that a cloned sequence allowed a fairly detailed
prediction of the receptors' quaternary structure to be made in the absence of
any additional studies (Kodama et al., 1990; Rohrer et al., 1990). A model of the
receptor is shown in Figure 1.1. Extended collagenous sequences in proteins
invariably form trimers (Miller and Gay, 1987). a-helical coiled-coil regions can
be two, three, or four stranded structures (Cohen and Parry, 1994). The model
shown in figure 1.1 is most consistent with the ligand blotting data (Kodama et
al., 1988), which indicated that the receptor is trimeric and thus probably
contains a 3 stranded a-helical coiled-coil. It was predicted that the cysteine
rich C-terminal SRCR domain contains some intramolecular or intermolecular
disulfide bonds (Kodama et al., 1990). Furthermore, knowledge of the nature of
the ligands (polyanionic) and the observation that the collagenous sequence
contains significant positive charge led to the hypothesis that the collagenous
domain could mediate ligand binding (Rohrer et al., 1990). A major emphasis
of this thesis has been to evaluate and expand upon these predictions, yielding
a better understanding of receptor structure and function.
Tissue distribution and regulation
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The type I and II receptors are primarily expressed in macrophages. Use
of non-isotype specific monoclonal antibodies to screen multiple tissues from
many different organs for scavenger receptor expression revealed that
essentially all monocytes and tissues macrophages express this receptor (Naito
et al., 1991; Hughes et al., 1995). The receptors are also expressed by
endothelial cells in high-endothelial venules (HEV) (Geng and Hansson, 1995)
and under certain conditions by smooth muscle cells (Inaba et al., 1992; Bickel
and Freeman, 1992; Li et al., 1995). Differential expression of the type I and II
receptors has for the most part not been examined. Metabolic labeling and
immunoprecipitation with antibodies that recognize both forms of the receptor
demonstrated that the type II receptor is the predominantly expressed form in
the macrophage-like P388D1 and RAW264 cell lines (Ashkenas et al., 1993;
Fraser et al., 1993). Use of isotype specific antibodies and RT-PCR showed
that the type I receptor is expressed at higher levels in HEV cells (Geng and
Hansson, 1995). Studies with peripheral blood monocytes revealed that the
type I expression levels are increased marked upon differentiation into
macrophages, while type II levels remain constant (Geng et al., 1994). As the
receptor isotypes have virtually identical ligand binding properties (Ashkenas et
al., 1993), the significance of differential expression is presently unclear.
Presumably differences in localization of type I and II receptors are based on
the requirement of certain cells express the SRCR domain and thus to bind the
as yet unknown SRCR domain ligands.
A large number of cytokines and other small molecules can influence the
expression levels of the scavenger receptor. These include phorbol esters,
endotoxin, poly[l:C], macrophage colony stimulating factor (M-CSF), and TGF-j3
(reviewed in Krieger and Herz, 1994). Scavenger receptor expression in
microglial cells is also observed in response to optic nerve crush (Bell et al.,
1994) . Promoter elements which control the macrophage specific expression
of these receptors are under investigation (Aftring and Freeman, 1995; Horvai et
al., 1995). Horvai and colleagues have shown that PU.1, AP-1, and ets-domain
binding sites located in the scavenger receptor's 291 bp promoter can, in
concert with a 400 bp upstream enhancer site, direct expression of human
growth hormone (hGH) to at least some macrophages in a transgenic animal
model.
Physiological and pathophysiological roles for the scavenger receptor
The vast number of molecules which act as scavenger receptor ligands
in in vitro competition assays has complicated the question of the in vivo
function of the type I and II receptors. Macrophage associated physiological
and pathophysiological functions include roles in host defense, apoptosis,
clearance, atherogenesis, and adhesion. Scavenger receptor ligands and
binding properties have led to suggestions that these versatile receptors could
play a role in some or all of these processes.
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The evidence for the involvement of the scavenger receptor in the
development of atherosclerotic lesions by causing the massive uptake of
OxLDL into resident and recruited macrophages is indirect but compelling
(Krieger and Herz, 1994). Evidence for involvement of OxLDL is twofold: 1)
antibodies against OxLDL have been used to demonstrated that OxLDL is
present in plaques (Haberland et al., 1988; Palinski et al., 1989); 2)in vivo
studies have shown that probucol, an anti-oxidant, helps defend against
atherogenesis in an animal model (Carew et al., 1987). Two different lines of
evidence argue for the involvement of type I and II receptors: 1) expression of
type I or type II scavenger receptors in CHO cells confers on these cells the
ability to take up massive quantities of modified low density lipoprotein,
converting them into lipid droplet filled cells reminiscent of the macrophage
foam cells observed in plaques (Freeman et al., 1991) and 2) anti-peptide
antibodies against an epitope found in both receptor isotypes revealed that
macrophage foam cells in atherosclerotic plaques have SR on their surface
(Matsumoto et al., 1990), and in situ hybridization showed that the mRNA for
these receptors is present (Yla-Herttuala et al., 1991). These data are highly
consistent with the SRs playing a role in the development of atherogenesis by
causing massive accumulation of OxLDL derived cholesterol in macrophages in
the developing plaque.
In addition to their putative role in atherosclerosis, SRs may play a role in
macrophage adhesion. In the process of trying to identify cation-independent
macrophage adhesion receptors by using monoclonal antibodies against
surface components, an antibody which recognized both the type I and II
scavenger receptors was isolated (Fraser et al., 1993). This monoclonal
antibody, 2F8, completely blocked adhesion of macrophages to tissue culture
plastic in the presence of serum and EDTA. It is thus possible that the SR plays
a role in macrophage recruitment in atherosclerotic plaques and at other sites.
These observations were extended with the finding that the divalent cation
independent adhesion of macrophages to frozen spleen, lymph node, lung,
medulla, and gut tissue sections could be completely blocked by 2F8 (Hughes
et al., 1995). Macrophage adhesion to other tissue sections could only be
partially blocked with the antibody. This binding interaction occurred in the
absence of serum, suggesting that the SRs are directly recognizing surface
molecules expressed in these tissues. It is unclear which portion of the receptor
is mediating this interaction -- the 2F8 antibody recognizes an epitope in the
coiled-coil region, so presumably this domain or an adjacent one is involved (S.
Gordon, unpublished). The SRCR domain could also potentially play a role in
adhesion. An SRCR domain in another member of the SRCR superfamily, CD6,
has been shown to influence the interaction of thymocytes with thymic epithelial
cells (Bowen et al., 1995). This raises that possibility that the SRCR domain of
the type I scavenger receptor could have a similar function in mediating cell-cell
interactions.
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The notion that the SRs could play a role in host defense is an attractive
one. Their specific localization on the surface of macrophages makes them
ideally situated for such a role. Janeway has proposed that an important role in
immunity is played by "pattern recognition receptors" (Janeway, 1992). These
evolutionarily ancient molecules are non-clonally distributed receptors whose
role is to broadly distinguish between "self" and "non-self". Given their ability to
recognize a broad array of molecules, it seems possible that the SRs could act
as such pattern recognition receptors (Krieger and Herz, 1994). The findings
that endotoxin could compete for binding of 1251-AcLDL to CHO cells expressing
SRs, and that in vivo scavenger receptor ligands could inhibit the clearance of
Lipid IVa (an endotoxin core-lipid precursor) provide some support for the
notion. (Hampton et al., 1991). Thus, the scavenger receptor could play a role
in preventing shock by clearing endotoxin, and could presumably recognize
and phagocytose bacteria by this mechanism as well.
An additional role of the macrophage is clearance - that is the removal of
foreign materials as well as debris such as apoptotic cells. Scavenger
receptors have been suggested to be involved in the clearance of particulates
from the lung (Kobzik, 1995). In in vitro and in vivo experiments, scavenger
receptor ligands (Poly(I) and dextran sulfate, but not chondroitin sulfate) have
been shown to block the clearance of environmental particulates such as
quartz, titanium oxide, and iron oxide. Scavenger receptors have also been
implicated in the clearance of type I and III procollagen peptides (Melkko et al.,
1994). In in vivo experiments, it was found that these peptides are largely
cleared by Kupfer cells in the liver. In tissue culture, binding of these
propeptides to Kupfer cells was inhibited by SR-A ligands (formaldehyde
treated BSA, AcLDL, poly(l), but not heparin or LDL). Studies with SR-II
transfected CHO cells revealed that advanced glycation endproducts (AGE) are
ligands, suggesting that scavenger receptors could play a role in the
recognition and clearance of these molecule (Araki et al., 1995). Studies with
microglial cells revealed that SR-A competitors could block uptake of
aggregated 13-amyloid protein (Paresce et al., 1995). Studies with CHO cells
transfected with murine SR-Al revealed that this receptor confers upon these
cells the ability to take up these aggregates, suggesting that it is SR-A in the
microglial cells that is responsible for the uptake. These studies have shown
that the scavenger receptor could play a role in the clearance of proteinaceous
and other substances from the body.
Recent studies also indicate that the type I and II receptors could be
involved in the recognition of apoptotic cells. Clearance of apoptotic
thymocytes by macrophages is specifically inhibited 50% by addition of the anti-
SR monoclonal 2F8, arguing strongly that this receptor could be involved in this
process (Platt and Gordon, 1995). This clearance is inhibited 90% by the SR
ligand poly(l), but is not affected by poly(C). The recognition of these
thymocytes is presumably due to the apoptosis induced exposure on their
surfaces of some SR ligand.
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Other scavenger receptors
Numerous studies have indicated the type I and II receptors described
above are not the only "scavenger receptors", i.e. proteins that bind modified
low density lipoproteins (Krieger and Herz, 1994). The actual number of such
receptors remains unclear. Part of the confusion in the field is undoubtedly
attributable to the fact that the type I and II receptors exhibit non-reciprocal cross
competition (Freeman et al., 1991). In experiments with CHO cells transfected
with these receptors, unlabelled AcLDL and OxLDL compete efficiently for the
uptake and degradation of their iodinated counterparts. However while AcLDL
competes efficiently for OxLDL, the reverse is not true. This made it appear that
there were more receptors than is actually the case. Interestingly, the reverse is
seen in macrophages, where OxLDL can efficiently block AcLDL and OxLDL
binding, but AcLDL can only partially inhibit OxLDL binding (Sparrow et al.,
1989). More recently, the cloning of multiple additional receptors has begun to
clarify these issues. The scavenger receptors have been divided into families
based on sequence (Acton et al., 1994). The class A receptors, including the
type I and II receptors described above, contain a collagenous region. The
class B receptors are in the CD36 family of proteins. The class C group
currently contains a single multi-domain Drosophila protein. The following is a
brief description of these SR families and their members.
In addition to SR-Al and SR-All (on which this introduction and thesis are
primarily focused), a third member of the Class A scavenger receptor family has
recently been identified. MARCO, or SR-AIII, was isolated in an attempt to use
hybridization to clone human type XIII collagen (Elomaa et al., 1995). MARCO
is strikingly similar to SR-AI. In addition to an elongated collagenous region
which contains positively charged triplets near its C-terminus, it contains an
SRCR domain. MARCO is specifically expressed in the spleen's marginal zone
macrophages as well as peritoneal macrophages, and binds AcLDL as well as
fluorescently labeled Gram-negative bacteria.
The class B receptor family contain proteins homologous to CD36. This
family was initially identified as having scavenger receptor activity when human
CD36 was isolated in an expression cloning search for additional proteins
capable of binding oxidized LDL (Endemann et al., 1993). They found that
OKM5, a blocking antibody, inhibited binding of OxLDL to phorbol ester induced
macrophage-like THP-1 cells by approximately 50%, suggesting that CD36 may
play a significant role in OxLDL recognition by macrophages. Recent studies
have demonstrated that CD36 derived from several species has a broad
polyanion binding specificity similar to that seen in SR-A (X. Huang, S. Acton,
and M. Krieger, unpublished), although human CD36 apparently does not have
this property (Acton et al., 1994). In addition to being expressed in
macrophages, CD36 is found in some endothelial cells, platelets, and
adipocytes (Greenwalt et al., 1992).
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Attempts to expression clone the receptor responsible for a CHO cell
line's unusual scavenger receptor-like activity resulted in the identification of a
new CD36 family member, SR-BI (Acton et al., 1994). SR-BI, which is
approximately 32% identical to CD36, has rather different ligand binding
properties to those found in the other SRs. In addition to binding AcLDL and
OxLDL, it binds unmodified lipoproteins, namely LDL and HDL (Acton et al.,
1994; Acton et al., 1996). SR-BI also binds maleylated BSA and negatively
charged phospholipids (Rigotti et al., 1995), but does not recognize the myriad
polyanions characteristic of the SR-As. Studies with anti-peptide antibodies
have revealed that SR-BI is primarily expressed in liver, ovaries, and adrenal
glands (Acton et al., 1996). It seems likely that the principle role of SR-BI is in
lipid trafficking.
Injection of fluorescently labeled AcLDL into Drosophila embryos
revealed that hemocytes (macrophage-like cells) could recognize and
internalize this ligand (Abrams et al., 1992). Accordingly, an expression cloning
strategy was employed to attempt to isolate the receptor responsible for this
activity (Pearson et al., 1995). The receptor obtained (SR-CI) had no sequence
resemblance to the class A or B receptors, nor, taken as a whole, to any other
protein. It contains a single transmembrane domain and domains with
homology to complement control proteins (CCP) as well as somatomedin B,
MAM, and mucin like domains. Localization of expression by in situ
hybridization revealed that it was found in hemocytes early in development.
Studies with transfected CHO cells revealed that SR-CI has a broad ligand
binding specificity similar to that of SR-A.
Additional classes of scavenger receptors could well remain to be
discovered. The identification of macrosialin and Fcy-RII as OxLDL binding
proteins has perhaps added two other classes of scavenger receptors.
Macrosialin was initially observed as a 94-97 kDa protein which binds OxLDL
and phosphatidylserine (Sambrano and Steinberg, 1995), and subsequently
purified and identified based on partial amino acid sequencing (Ramprasad et
al., 1995). As this protein is predominantly expressed in the lysosome and
endosome, it is unclear whether this receptor plays a role in any way similar to
the other scavenger receptors. Fcy-RII, a macrophage expressed
immunoglubulin receptor, has also been shown to bind OxLDL in an antibody
independent manner when transfected into 293 cells (Stanton et al., 1992).
However as antibodies which block binding of OxLDL to transfected 293 cells
fail to have any effect on macrophage uptake of OxLDL, the significance of this
is questionable.
The increasing number and diverse properties of the scavenger
receptors renders it difficult to make blanket statements about this group of
receptors. All bind modified (oxidized and/or acetylated) lipoproteins, although
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this is probably not be of functional significance in some cases. Many have
fairly similar broad polyanionic ligand binding properties. Most, but not all,
appear to be predominantly expressed in macrophages or macrophage-like
cells. Studies in progress on all of these scavenger receptors should begin to
help us understand the structural and functional properties of these unusual
molecules. Described here are studies on the properties of the Class A type I
and II macrophage scavenger receptors. The primary focus of this thesis has
been to use recombinant secreted forms of the receptors to experimentally
evaluate and expand upon the structural model of these scavenger receptors
and also to identify new ligands to better understand receptor function.
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Table 1.1. Ligand binding properties macrophage scavenger receptors
Effective competitors Ineffective competitors
Modified proteins
AcLDL, OxLDL, M-BSA,
M-HDL
Nucleic acids
Polyinosinic acid (poly(l)),
poly(G), telomere models
(d(G4T4)), poly(lIC)
Polysaccharides
Dextran sulfate, fucoidin
carragheenan
Other molecules
Polyvinyl sulfate, bovine
sulfatides, endotoxin
Native and modified proteins
LDL, HDL, BSA, poly (D-glutamate),
Ac-HDL, Ac-BSA, fetuin
Nucleic acids
Poly(A), poly(C), poly(U), single and
double stranded DNA
Polysaccharides
Heparin, chondroitin sulfate,
polysialic acid, mannan
Other molecules
Polyphosphate
The molecules listed here have been assayed for their ability to block the
binding, uptake, and degradation of AcLDL by either cultured macrophages or
transfected cell lines. Some of these molecules have also been shown to
directly bind the scavenger receptor. Adapted from Krieger and Herz, 1994.
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Figure 1.1. Domain structure of the type I and II class A scavenger receptors
The receptor has been divided into 6 domains: I) N-terminal cytoplasmic
domain; 2) transmembrane (TM) domain; 3) spacer domain; 4) a-helical coiled-
coil domain; 5) collagenous domain; 6) variable C-terminal domain. In the type
I receptor, the C-terminal region is a scavenger receptor cysteine rich (SRCR)
domain, while the type II receptor has a 6 residue C-terminal domain (not
labeled in the figure). The number of amino acids in each domain in the bovine
receptors is indicated in parenthesis.
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Chapter 2
Secreted extracellular domains of
macrophage scavenger receptors form
elongated trimers which specifically bind
crocidolite asbestos
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The overall goal of my thesis was to carry out structural and functional
studies of the class A macrophage scavenger receptors. Structural studies in
particular can be quite difficult to perform using proteins with transmembrane
domains. These proteins are generally insoluble, expressed at low levels, and
can be difficult to purify in quantity. Since the domains which we were
interested in studying were extracellular, making secreted forms of the receptors
was a reasonable way to address these issues. This chapter contains a series
of experiments describing the production of secreted forms of the type I and II
class A bovine scavenger receptors and the use of metabolically labeled
secreted receptors for a variety of structural and functional studies. The
questions addressed were as follows: 1) are the secreted receptors functional(i.e. do they have the same ligand binding specificity as the transmembrane
forms); 2) is ligand binding pH dependent; 3) what is the extent of glycosylation
of the receptor; 4) what is the receptor's degree of oligomerization; and 5) is
crocidolite asbestos a SR ligand. This work was published in its entirety in
1993 in The Journal of Biological Chemistry 268, 3538-3545. The only
modifications which have been made are that figures have been re-numbered
with the prefix "2" and the references have been merged with those of other
chapters in the "references" section of this thesis.
The experiments in this chapter were for the most part performed by me,
with the exception of the pH dependence of ligand binding (Fig 2.7), which was
carried out by Shangzhe Xu. In the early stages of this work, I worked with Dr.
Neil Freedman, who initiated the secreted receptor project and generated and
sequenced the secretion constructs. Dr. Monty Krieger suggested testing
asbestos as a potential ligand, and assisted with the first binding experiment. I
wrote the initial draft of the paper, which was subsequently revised and edited
with the assistance of Dr. Krieger. Dr. Freedman also provided useful input on
the paper.
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Summary
Macrophage scavenger receptors, which have been implicated in the
development of atherosclerosis and other macrophage-mediated events, are
trimeric integral membrane glycoproteins whose extracellular domains have
been predicted to include a-helical coiled-coil, collagenous and globular
structures. To elucidate further the structural and functional properties of these
receptors, we generated transfected Chinese hamster ovary (CHO) cells which
express secreted extracellular domains of the type I and type II bovine
scavenger receptors and developed a solid-phase bead-binding assay to
assess their ligand binding properties. The secreted receptors exhibited the
distinctive, high-affinity, broad polyanionic ligand-binding specificity and the pH
dependence of binding which characterize the membrane-anchored, cell-
surface forms of the receptors. Both the type I and type II secreted receptors
were trimeric glycoproteins comprising disulfide-linked dimers and
noncovalently associated monomers. Gel filtration and glycerol-gradient
centrifugation established that the type II trimers were highly elongated and did
not associate into higher order oligomers at the low concentrations used in
these experiments. Crocidolite asbestos, which is phagocytosed by alveolar
macrophages and can cause asbestosis and mesothelioma, bound efficiently to
secreted type I receptors and less well to the type II receptors. This binding was
specific in that it was competed by a variety of well-established scavenger
receptor ligands but not by negative controls. These studies have identified a
new type of insoluble scavenger receptor ligand, and have raised the possibility
that scavenger receptors may play a role in mediating the physiological and
pathological interactions of inspired particles with alveolar macrophages.
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Introduction
Macrophage scavenger receptors are trimeric integral membrane
proteins which exhibit unusual ligand-binding characteristics (Goldstein et al.,
1979; Brown and Goldstein, 1983; Kodama et al., 1988; Kodama et al., 1990;
Rohrer et al., 1990; Penman et al., 1991). They bind a broad array of
polyanionic macromolecules or macromolecular complexes, including modified
LDL, acidic phospholipids, endotoxin (Raetz et al., 1988; Nishikawa et al., 1990;
Hampton et al., 1991), some polysaccharides (fucoidan and dextran sulfate, but
not heparin or chondroitin sulfate), and certain polyribonucleotides (poly I and
poly G, but not poly C) and polydeoxyribonucleotides (Brown and Goldstein,
1983; Pearson et al., 1992). A number of studies have suggested that the
scavenger receptors may be involved in the accumulation of cholesterol by
macrophages in arterial walls during atherogenesis (Brown and Goldstein,
1983; Jurgens et al., 1987; Steinberg et al., 1989; Steinbrecher et al., 1990).
These receptors may also participate in other physiologic and pathophysiologic
processes, such as macrophage-associated immune responses and
inflammation (Freeman et al., 1990; Kodama et al., 1990; Krieger, 1992).
The cDNAs for two forms (type I and type II) of bovine, murine, rabbit, and
human macrophage scavenger receptors have been cloned and sequenced(Kodama et al., 1990; Matsumoto et al., 1990; Rohrer et al., 1990; Freeman et al
1990, Ashkenas et al., 1992; Bickel et al., 1992). The predicted amino acid
sequences define 6 structural domains in each polypeptide chain (Kodama et
al., 1990; Ashkenas et al., 1992): 1. an N-terminal cytoplasmic domain, II. a
single transmembrane domain, II. a spacer domain, IV. an a-helical coiled-coil
domain, V. a collagenous domain, and VI. a variable length C-terminal domain.
Domains I-V are identical in the type I and type II receptors. In the type II
receptor, domain VI is a short domain (6-17 amino acids) that is poorly
conserved (Ashkenas et al., 1992). In the type I receptor, domain VI is 110
residues long and includes a 102 amino acid region designated the scavenger
receptor cysteine-rich (SRCR) domain. This domain helped to define an
ancient, highly conserved family of cysteine-rich protein domains (Freeman et
al., 1990, Aruffo et al., 1991; Krieger, 1992). Both type I and type II receptors
exhibit the distinctive, high affinity, broad-specificity ligand binding which is
characteristic of scavenger receptors. The functions of the SRCR domain have
not yet been established; however, recent studies have suggested that the
presence of this domain in the type I receptor can modulate its binding
properties relative to those of the type II receptor (Ashkenas et al., 1993).
Detailed analyses of the structures and properties of integral membrane
receptors are often complicated by difficulties inherent in working with these
water-insoluble proteins, whose natural levels of expression are frequently low.
In several cases, these technical problems have been overcome by
constructing expression vectors encoding secreted forms of these receptors andby expressing high levels of these soluble proteins in transfected cultured cells
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(Watson et al., 1990; Duan et al.,.1991; Lax et al., 1991; De Vos et al., 1992). In
some cases, the secreted forms are simply truncated versions of the full-length
receptors. In others, fusion proteins have been generated (Watson et al., 1990)
to facilitate secretion or subsequent characterization of the secreted molecule.
In the current study, we have generated Chinese hamster ovary (CHO) cells
which express secreted forms of the bovine type I and type II scavenger
receptors. We have developed a solid-phase binding assay to characterize the
ligand-binding properties and oligomerization state of these secreted receptors.
We have also used the secreted receptors to show that crocidolite asbestos can
bind to scavenger receptors. This finding potentially defines both a new class of
ligands and additional physiologic and pathophysiologic functions of scavenger
receptors.
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Materials and Methods
Materials - Reagents (and sources) were: pcDNA1 and pRc/CMV
(Invitrogen), Poly G, Poly I, and Poly C covalently attached to Sepharose beads(Pharmacia), N-glycanase (Genzyme), and E. coli ribonuclease inhibitor
(Calbiochem). Rabbit anti-bovine spacer domain IgG, low density lipoprotein
(LDL), acetylated LDL (AcLDL) and maleylated bovine serum albumin (M-BSA)
were prepared as previously described (Penman et al., 1991; Krieger, 1983;
Goldstein et al., 1979). M-BSA and BSA were coupled to CNBr-activated
Sepharose (Pharmacia) according to the manufacturers instructions. There
were approximately 2.7 mg of M-BSA or 2.85 mg of BSA crosslinked per ml of
packed gel. Crocolidite asbestos was a gift from Dr. Joseph Brain (Harvard
School of Public Health).
Construction of pRc/CMV-s-bSR-l and s-bSR-ll Expression Vectors -To
express the secreted extracellular region of the bovine type I and type II
scavenger receptors (s-bSR-1 and s-bSR-II), we constructed vectors in several
steps. First, a segment of DNA including the myelin-associated glycoprotein
(MAG) leader sequence (Arquint et al., 1987) was excised from a fibronectin
expression vector (P. Johnson and Richard Hynes, manuscript in preparation)
with the enzymes BamH I and Xba I, and then inserted into the cloning site of
pcDNA1. Next, a segment of DNA encoding the scavenger receptor spacer
domain and a portion of the coiled-coil domain, which are common to the type I
and type II bovine scavenger receptors, was inserted into the MAG leader-
containing vector. This segment (codons 78-227) was generated by PCR(primer 1: 5'-CGCGGGCCCGGGTGGGAAACGAAGAATTGCAC-3'; primer 2:
5'-TTTTTCACCTGGAGGTCCA-3') using pXSR7 -- a plasmid encoding the type
I bovine scavenger receptor (Kodama et al., 1990) -- as a template (Sambrook
et al., 1989), and subsequent digestion with Sma I and Xba I. The digested
PCR product was ligated into the pcDNA1/MAG vector, which was prepared by
Xho I treatment, Klenow blunting, and digestion with Xba I. This construct
resulted in the substitution of Arg-Gly for Lys77 at the amino terminus of the
spacer domain. The sequence of this MAG/scavenger receptor "common
domain" fusion was determined in its entirety by the dideoxy method
(Sequenase, United States Biochemical). This construct was then digested
with Xba I, and the remaining 3' portions of the extracellular domains of bSR-I or
bSR-II were added by ligation of Xba I-Xba I fragments from either pXSR7 or
pXSR3 (Rohrer et al., 1990), respectively. The inserts were subsequently
excised with Hind III and subcloned into pRc/CMV.
Cell Culture and Transfections - All incubations with intact cells were
performed at 370C in a humidified 5% CO2 incubator. As previously described(Krieger, 1983), stock cultures of wild-type CHO cells were grown in medium A
(Ham's F-12 supplemented with 100 units/mi penicillin, 100 gg/ml streptomycin,
and 2 mM glutamine) containing 5% (v/v) fetal bovine serum (medium B).
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Transfectants expressing the type I (CHO[s-bSR-I]) and type II (CHO[s-bSR-II])
secreted bovine scavenger receptors were generated using the polybrene
method (Sambrook et al., 1989). On day 0, wild-type CHO cells were plated at
5x1 05 cells/100 mm dish in medium B. On day 1, cells were refed with 3 ml of
medium B containing 10 Igg/ml polybrene (Aldrich), and either 0.5 jig pSV2dhfr*
(Stuhlmann et al., 1989) and 10 gg of pRc/CMV[s-bSR-l] per dish or 0.5 jIg of
pSV2dhfr (Subramani et al., 1981) and 10 gig of pRc/CMV[s-bSR-II] per dish.
After a 6 hr incubation, the polybrene-containing media were removed, and the
cells were incubated with medium B containing 30% (v/v) dimethylsulfoxide for
4 min at room temperature. The monolayers were then washed with medium A
and refed with medium B. On day 3, cells were harvested with trypsin and
plated at 105 cells/1i 00 mm dish in medium C (medium B supplemented with 0.5
mg/mi Geneticin(Gibco)). On days 10-12, 48 colonies were picked, and
subsequently grown into mass cultures and screened for receptor synthesis as
follows. Cells transfected with the s-bSR-l expression vector were pulse-
labeled for 30 min. with [35S]methionine (135 pCi per well) and newly
synthesized receptors were detected using an anti-spacer domain antibody and
an immunoprecipitation-gel electrophoresis-autoradiography assay as
previously described (Penman et al., 1991). One positive colony was
subsequently cloned, to yield the cell line CHO[s-bSR-I]-A2, which was used for
all experiments involving s-bSR-l. Cells transfected with the s-bSR-II
expression vector were screened by immunoprecipitation of media from
radiolabeled cells as described below. One positive colony, designated CHO[s-
bSR-ll]-2C3, was used for all experiments involving s-bSR-II.
Preparation of [35S]Methionine-Labeled Conditioned Media - Cells were
plated on day 0 in 3 ml of medium B (untransfected CHO cells ) or medium C
(transfected cell lines) in six-well dishes (1.5x105 cells/well). On day 2, cells
were washed two times with Dulbecco's phosphate buffered saline (PBS,
Gibco) and refed with 0.75 ml of labeling medium (methionine-free medium A
containing 80 pCi/ml of either [35S]methionine or [35S]Protein labeling mix
(New England Nuclear)). After incubation for 5 hours, the media were
harvested and pooled if multiple, identical wells were labeled.
Phenylmethylsulfonylfluoride and leupeptin were then added to final
concentrations of 1 mM and 0.1 mM, respectively, and the media were clarified
by centrifugation at 1500xg for 15 minutes.
Bead-Binding Assay and Electrophoresis - Metabolically labeled medium
produced as described above (500-750 p•) was added to 250 p• of buffer A (20
mM Tris HCI pH 8.0, 150 mM NaCI, 1 mM CaCI2) containing 2 mg/ml bovine
serum albumin and 0.01% (w/v) NaN3 (Buffer B). We then added 25 jil of a
suspension of buffer A containing 50% (v/v) of Sepharose beads coupled to the
indicated ligands, and enough additional buffer A to bring the final volume to 1
ml. The mixture was placed on a rotator overnight at 40C. The beads were then
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washed twice with buffer A, and adsorbed proteins were eluted by boiling for 5
minutes in 25 p.l of electrophoresis sample buffer (50 mM Tris, 2% (w/v) SDS,
0.1% (w/v) bromophenol blue, 10% (v/v) glycerol, 100 mM dithiothreitol, pH 6.8).
The eluate was subjected to 10% SDS-polyacrylamide gel electrophoresis.
Fixation, staining, and autoradiography were carried out as previously
described (Kozarsky et al., 1986). In some experiments, the beads were
replaced with 50 pg/sample of crocidolite asbestos. Quantitation of the intensity
of the 35S-labeled protein bands in dried gels was carried out using a
Molecular Dynamics Phorphorlmager according to the manufacturers
instructions.
During the course of these studies, we observed that ribonuclease
activity in the metabolically labeled conditioned media could partially degrade
single-stranded soluble poly C. It seems possible that the poly C covalently
linked to Sepharose beads was also susceptible to ribonuclease-mediated
degradation. We did not, however, detect degradation of poly G, presumably
because of its quadruplex structure (Pearson et al 1992). In all cases,
experiments with soluble or bead-bound poly C were repeated in the presence
of 40 units/ml of E. coli ribonuclease inhibitor, which effectively prevented the
degradation but did not interfere with the assay (data not shown). All results
with and without the inhibitor were essentially identical.
Immunoprecipitation of Secreted Receptors -A solution composed of 90
pI1 of buffer A, 100 p.l of 10x detergents (5% (w/v) SDS, 2.5% (w/v) sodium
deoxycholate, 10% Triton X-100 (v/v) in water), 50 pCl of BSA (10 mg/mi in
water), and 10 p.l of rabbit anti-bovine spacer domain antibody was added to
750 p• of metabolically labeled sample. After a preincubation at 370C for 1
hour, 25 p.l of a 1:1 suspension of protein A-Sepharose (Pharmacia) in PBS
were added. This mixture was placed on a rotator overnight at 40C. The
samples were then washed twice with buffer C (100 mM Tris pH 8.0, 0.5% (v/v)
Triton X-100, 0.5% (w/v) sodium deoxycholate, 0.25% (w/v) SDS), and proteins
were eluted by boiling for 5 minutes in 25 .I1 of electrophoresis sample buffer(with or without 100 mM dithiothreitol as indicated). N-glycanase treatment was
performed as previously described (Penman et al., 1991) using the indicated
digestion times and quantities of enzyme. Samples were analyzed by
electrophoresis in 3-10% gradient gels as described above. The estimated
apparent masses of the unreduced and N-glycanase-treated receptors are from
a single experiment and are based on a calibration curve defined by a set of
14C-methylated protein standards (Penman et al., 1991). Masses for the
reduced receptor subunits are based on averages from multiple experiments.
Stokes Radius Determination by Gel Filtration -A 200 p.l aliquot of conditioned
medium from [35S]methionine-labeled CHO[s-bSR-II] cells was loaded onto a
Pharmacia FPLC-Superose 6 HR 10/30 column (pre-equilibrated in Buffer A),
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which was eluted with Buffer A at a flow rate of 0.25 ml/min. Fractions (250 Il)
were diluted to 750 1l with buffer A, and subjected to the bead binding assay
using Poly G beads as described above. The calibration of the column, which
was monitored by absorbance at 280 nm, was determined with the standards of
known Stokes radii (Axelsson, 1978; Peterson et al., 1986) listed in the legend
to Figure 8. The value for IgM (11.62 nm) was calculated using equation 1 and
previously reported values for b , s20,w, and Mr (Fasman, 1976). The column
volume, Vt, was measured with 5'dGMP, and the excluded volume, Vo, was
measured using a 12,358 bp supercoiled plasmid, both of which were
monitored by absorbance at 254 nm.
Sedimentation Coefficient Determination by Glycerol Gradient
Centrifugation -A 200 gI1 aliquot of conditioned medium from [35S]methionine-
labeled CHO[s-bSR-II] cells to which 10 pI of bromophenol blue (4 mg/ml) were
added was layered on the top of an 11 ml linear glycerol gradient (5-20% (v/v)
in Buffer A containing 1 mg/mi of BSA). Calibration was performed in a
separate gradient prepared with buffer A without the BSA using the standards(Peterson et al., 1986; Kumar et al., 1991) listed in the legend to Figure 8. After
centrifugation in a Beckman SW41 rotor for 18 hr at 134,000xg, fractions of 500
pCl were collected with an Isco Density Gradient Fractionator, model 183, and the
s-bSR-ll was detected by immunoprecipitation, electrophoresis (8% gels) and
autoradiography as described above. Fractions from the calibration gradient
were precipitated with trichloroacetic acid (8% (w/v) final concentration). The
precipitated proteins were dissolved in electrophoresis sample buffer, and the
samples were neutralized by the addition of 1 M Tris HCI, pH 9.5. The samples
were then boiled, subjected to 13% polyacrylamide gel electrophoresis and the
proteins were detected by Coomassie brilliant blue staining as previously
described (Kozarsky et al., 1986).
Calculations - The molecular weight and frictional ratio of the receptor
were calculated using the following equations (Siegel and Monty, 1966).
67NijEquation 1: Mr = rss20,w
f r4,xN )1Equation 2: -- =rs 1 3
o3Mri)
where N is Avogadro's number (6.022x1 023 mol-1), 11 is the viscosity of water at
200C (1.0 x 10-3 kg/m/s), b is the partial specific volume, p is the density of H20
at 200 C (0.998 g/ml), rs is the Stokes radius determined by gel filtration
chromatography, and s20,w is the sedimentation coefficient determined by
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glycerol gradient centrifugation. The ratio (P) of the length to width (or
semimajor axis to semiminor axis) of the receptor was calculated using
successive approximations from the frictional ratio, with the receptor modeled
as a cylinder (equation 3) or a prolate ellipsoid (equation 4) (van Holde, 1985).
Equation 3:
Equation 4:
S2f 2 P3
fo 3 0.30+ln[2P]
1 1
f P"(p2-1)2
fo n(P+(p2-1)In P(P-2
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Results
Stable CHO cell lines expressing secreted forms of the type I (CHO[s-
bSR-I]) and type II (CHO[s-bSR-II]) bovine scavenger receptors were isolated as
described in Materials and Methods. The predicted domain structures of the
wild-type, integral membrane receptors and the secreted forms are shown in
Figure 2.1. To generate secreted forms, we replaced the cytoplasmic and
transmembrane domains of the wild-type receptors with the myelin-associated
glycoprotein ("MAG") leader sequence. This leader sequence was presumably
removed by a signal peptidase when the proteins were translated and inserted
into the lumen of the endoplasmic reticulum. In addition, this construction
resulted in the substitution of an arginine-glycine dipeptide for the first amino
acid of the spacer domain (Lys77 , indicated by a dot in Figure 2.1). The
molecular weight of the predicted, type I secreted scavenger receptor (s-bSR-1),
calculated from its amino acid composition is 41.7 kD (378 amino acids) and
that of the type II secreted receptor (s-bSR-II) is 30.1 kD (274 amino acids).
Metabolically labeled receptors secreted into the media by transfectants
were initially characterized by immunoprecipitation with polyclonal rabbit anti-
spacer domain antibodies (Figure 2.2). After reduction, s-bSR-I (left) and s-
bSR-II (right) migrated as broad bands with apparent masses of 78 kDa and
68.7 kDa (lanes I and 4). The unreduced samples (lanes 2 and 5) were
resolved into monomeric ("10") and dimeric ("20") forms. The unreduced type I
monomeric form exhibited an electrophoretic mobility which was slightly greater
than that of the reduced form. We have reported similar result for the full-length
type I receptor (Penman et al., 1991). Initial estimates of the apparent masses
of the dimeric forms are 135 kDa for s-bSR-I and 125 kD for s-bSR-ll. These
results are consistent with our previous studies which showed that the full-
length, membrane-anchored bovine scavenger receptors are synthesized as
trimers comprising Cys83 disulfide-linked dimers, each of which is
noncovalently associated with a receptor monomer (Penman et al., 1991). We
presume that the reduction-sensitive dimers seen in the unreduced samples
were also crosslinked by disulfide bonds at Cys83. Treatment with N-glycanase(lanes 3 and 6) sharpened the bands and reduced the apparent masses of s-
bSR-I and s-bSR-II to approximately 46 and 35 kDa, respectively. The rather
faint 40 kDa band in lane 6 was presumably due to incomplete deglycosylation
of s-bSR-II (see below). These N-glycanase-mediated shifts in mass were
similar to those previously observed for the full-length membrane-anchored
receptors (Penman et al., 1991). Thus, conversion of the receptors to secreted
forms did not significantly alter the extent of their N-glycosylation.
To determine how many of the 7 potential N-glycosylation sites on the
receptors (Kodama et al., 1990, Rohrer et al., 1990) were occupied with
oligosaccharides, we examined the time course of type II secreted receptor
digestion by N-glycanase. Figure 2.3 shows that the electrophoretic mobility of
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the receptor increased in discrete steps as a function of time of digestion with N-
glycanase. There were 5 intermediate forms detected as the apparent mass of
the mature form of the receptor decreased from 68.7 kD (lane 1) to 35 kD (lane
15). While there are several possible interpretations of this result, the simplest
is that 6 of the 7 potential N-glycosylation sites were occupied (Green et al.,
1985).
The ligand binding activities of the secreted receptors were examined
using a solid-phase bead-binding assay. Sepharose beads crosslinked to
either scavenger receptor ligands (poly G, poly I, or M-BSA) or to control
molecules (poly C or native BSA) were incubated at 40 C overnight with
[35S]methionine-labeled conditioned media from either transfected or
untransfected cells. Proteins tightly associated with the beads were eluted and
reduced by boiling in electrophoresis sample buffer and visualized after
electrophoresis by autoradiography. Figure 2.4 shows the results of this assay
for conditioned media from CHO[s-bSR-I] (left), CHO[s-bSR-II] (center), and
untransfected CHO (right) cells. The conditioned media contained a large
number of [35S]methionine-labeled, secreted proteins (not shown). The
secreted type I scavenger receptor, which represented only a small fraction of
the all of the labeled and secreted proteins (not shown), bound efficiently to
beads bearing the ligands poly G ("pG", lane 1), poly I ("pl", lane 3), and M-BSA
(lane 5). Under the conditions of these experiments, the poly G and poly I
beads bound virtually all of the labeled receptor, whereas the M-BSA beads
bound most, but not all of the active receptor molecules (not shown). In
contrast, there was little or no receptor binding to the control poly C and BSA
beads (lanes 2 and 4). Analogous results were observed for the bead binding
of s-bSR-II (lanes 6-10, center). Thus, the secreted forms of the scavenger
receptors exhibited the distinctive ligand-binding specificity which characterizes
the membrane-anchored, full-length forms.
Unexpectedly, the conditioned media from the transfected cells
contained two additional species -- pA and pB -- which bound to the beads
bearing scavenger receptor ligands, but not to beads linked to the control
molecules. The pA and pB molecules, but not the secreted scavenger
receptors, were also found in the media from untransfected CHO cells (lanes
11-15, right). We have observed clonal variations in the amounts of pA and pB
in the conditioned media from CHO cells. The binding properties of pB, which
often resolved into 2 major bands, were similar, but not identical, to those of the
scavenger receptors (see below and unpublished data). Additional
experiments will be required to characterize these molecules in greater detail.
To examine further the ligand-binding specificity of the secreted
scavenger receptors, we determined the capacity of a variety of water-soluble
scavenger receptor ligands and their negative controls to compete with M-BSA
beads for receptor binding. Figure 2.5 shows that relatively high concentrations
of poly G (100 Igg/ml), M-BSA (400 I±g/ml), and AcLDL (400 pgg/ml) prevented
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both type I and type II secreted receptors from binding to M-BSA beads, while
poly C, BSA, and LDL at corresponding concentrations did not block binding.
Secreted scavenger receptors were not detected in the medium from
untransfected cells (lane 1). Again, the ligand-binding specificity observed was
entirely consistent with that previously reported for the full-length, cell-surface
forms of the receptors. In other experiments (not shown), we observed that the
scavenger receptor ligands fucoidin and dextran sulfate could fully block, and
lipid IVA could less effectively block secreted receptor binding in this assay.
Heparin and chondroitin sulfate, two control polysaccharides which are not
scavenger receptor ligands, did not inhibit this bead binding (data not shown).
Figure 2.6 shows the concentration dependence of binding inhibition by
soluble poly I. These quantitative binding values were determined using a
Molecular Dynamics Phosphorlmager. The ID50 for poly I was less than 1 gg/ml
for s-bSR-1, and between 1 and 2.5 gg/ml for s-bSR-II. These values are similar
to those determined for the inhibition by poly I of receptor-mediated 1251-AcLDL
degradation by CHO cells expressing full-length type I or type II bovine
scavenger receptors (Pearson et al., 1992 and A. Pearson, Y. Ekkel and M.
Krieger, unpublished data). Similar quantitative results were obtained using M-
BSA and AcLDL as soluble competitors (data not shown).
Figure 2.7 shows that s-bSR-I binding to poly G beads was pH
dependent. Binding decreased to background levels as the pH was lowered
from 7.5 to 5.0. This loss in activity was reversible; after an overnight incubation
at pH 5.5, binding activity was restored to control values when the pH was
increased to 7.5 (not shown). Similar pH dependence was observed for
secreted receptor binding to.M-BSA beads (not shown), suggesting that the pH
dependence was an intrinsic property of the receptor and not the ligands.
Ligand binding to scavenger receptors expressed by bovine alveolar
macrophages has previously been reported to be pH-sensitive (Naito et al.,
1991). Taken together, these bead-binding assays established that the soluble
scavenger receptors exhibited quantitative as well as qualitative ligand-binding
properties which are similar, if not identical, to those of the full-length,
membrane-anchored forms.
The preparation of soluble scavenger receptors provided an opportunity
to examine in greater detail the structure of the receptor. For example, the
oligomerization state of s-bSR-II was assessed using gel filtration and
sedimentation analysis to compare the molecular weight of the intact receptor,
Mr, to that of the receptor monomers. The estimated Stokes radius, derived from
Superose 6 chromatography (Figure 2.8A), was 10.2 nm . The receptor eluted
from the column between thyroglobulin (8.58 nm, standard #3) and fibrinogen(10.7 nm, standard #2). As can be seen in Figure 2.8B, the receptor eluted as a
rather broad peak, suggesting that there was heterogeneity in the preparation.
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Figure 2.8C shows that the sedimentation coefficient determined by
centrifugation through a glycerol gradient was 4.65 S, with the receptor running
near the BSA standard ( 4.31 S, standard #a). The bulk of the receptor was
detected in two fractions of the gradient (not shown), In order to calculate a
molecular weight (Mr) from the Stokes radius and the sedimentation coefficient,
it is necessary to measure or to estimate the partial specific volume of the
protein (see equation 1). The partial specific volume of the polypeptide
component of the receptor can be calculated (Hinz, 1986) from its sequence to
be 0.717 mVg. This value, however, does not include contributions of the
hydroxyl groups on the proline and lysine side chains of the scavenger
receptors' collagenous domains (Penman et al., 1991), and, more importantly,
does not include the substantial contribution of the N-linked oligosaccharides.
The addition of the contributions from these components reduces the calculated
value for the partial specific volume. For example, the partial specific volume of
a typical N-linked oligosaccharide, GIcNAc5Man 3Gal2Sia2, in CHO cells is
0.629 ml/g (Hinz, 1986). Assuming that there are 6 such chains (see above),
the partial specific volume of the receptor would be 0.689 ml/g. Substituting this
and the experimentally determined values of rs and s20,w into equation 1 (see
Materials and Methods), we find that Mr is 173 kD.
The oligomerization state of the receptors can be determined by dividing
Mr by the mass of a single subunit. The apparent mass of the s-bSR-ll
monomers determined by gel electrophoresis was 68.7 kD. However,
glycoproteins run with anomalously high apparent molecular weights on SDS
gels compared to unglycosylated standards because of their reduced binding of
SDS (Segrest et al., 1972). To calculate the oligomerization state, we
estimated the molecular weight of the monomeric form to be 49.2 kD, the sum of
the molecular weight of the N-glycanase-digested form (35 kD) determined by
gel electrophoresis and the estimated weight of 6 typical N-linked
oligosaccharide chains (14.2 kD). The calculated oligomerization state is 3.5
(173/49.2). Although there is some uncertainty in this value because of the
assumptions used to account for the receptor's oligosaccharide groups, these
results suggest that the soluble receptor was trimeric. This conclusion is
consistent with our previous results, which show that the membrane-anchored,
full-length bovine scavenger receptors are trimeric (Kodama et al., 1988;
Penman et al., 1991). It also indicates that, under the conditions of these
experiments, the receptor formed very little, if any, higher-order oligomers.
Preliminary crosslinking experiments with ethylene glyco bis(succinimidyl-
succinate) also suggested that s-bSR-ll and s-bSR-I were trimeric (data not
shown).
Information about the shape of the receptor can also be derived from
these data. Based on the molecular weight of the receptor (173 kD), its Stokes
radius (10.2 nm), and an assumed partial specific volume of 0.689 ml/g, the
frictional ratio (f/fo) for s-bSR-ll was calculated to be 2.82 (see equation 2). This
indicates that s-bSR-II is an elongated molecule. If the receptor is assumed to
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be cylindrical in shape, its length would be 53 times its diameter; whereas if it
were a prolate ellipsoid, its semimajor axis would be 45 times as long as its
semiminor axis (see equations 3 and 4). These values are indicative of a highly
elongated molecule and are consistent with our previously proposed models of
scavenger receptors (Kodama et al., 1990, Rohrer et al., 1990, Krieger, 1992).
Unfortunately, we were unable to determine the Stokes radius and
sedimentation coefficient for s-bSR-l. Recovery of the type I molecule from both
the chromatographic column and the glycerol gradients was extremely low and
reliable values could not be obtained. The reasons for the low recoveries are
not clear at this time.
The metabolically labeled, secreted scavenger receptors and the solid-
phase bead-binding assay provide convenient tools to search for additional
scavenger receptor ligands. In an initial application of this approach, we
examined secreted scavenger receptor binding to asbestos fibers. We
performed a solid-phase binding assay in which the Sepharose-ligand beads
were replaced with insoluble crocidolite asbestos fibers. Figure 2.9 shows that
the incubation of metabolically labeled conditioned medium from CHO[s-bSR-I]
cells with asbestos resulted in the binding of s-bSR-I and pB to the fibers (lane
1). Furthermore, the scavenger receptor ligands poly G, poly I, fucoidin, dextran
sulfate, AcLDL, and M-BSA all inhibited receptor binding (lanes 2, 3, 5, 6, 9, 10,
and 11), while the control molecules poly C, LDL, heparin, and chondroitin
sulfate did not (lanes 4, 7, 8, and 12). The ability of scavenger receptor ligands
to block specifically receptor binding to asbestos and the intrinsic negative
charge on asbestos suggest that asbestos binding may have occurred at the
site(s) in the collagenous domain of the receptor responsible for binding other
receptor-ligands (Kodama et al., 1991; Acton et al., 1992; Doi, T., Higashino,
K., Kurihara, Wada, Y., Uesugi, S., Imanishi, T., Kawabe, Y., Matsumoto, A.,
Itakura, H., Yazaki, Y., Nakamura, H., and Kodama, T., manuscript submitted for
publication). Asbestos-binding experiments with s-bSR-II gave qualitatively
similar results; however, we observed significantly less s-bSR-II binding to the
asbestos than s-bSR-I binding (not shown). Additional studies with
macrophages in vitro and in vivo will be required to determine the physiological
relevance of this binding.
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Discussion
In the current studies, we have examined the structures and binding
properties of secreted forms of the type I and type II bovine scavenger receptors.
Expression vectors for these proteins were constructed by substituting
sequences encoding the myelin-associated glycoprotein leader sequence for
those encoding the cytoplasmic and transmembrane domains of the full-length
receptors (see Figure 2.1). Stable CHO cell transfectants expressing either the
type I or type II secreted receptors were isolated and metabolically labeled
conditioned media from these transfectants were used as sources of these
soluble receptors.
Both the type I and type II secreted bovine scavenger receptors retained
the distinctive, high-affinity, broad-specificity ligand binding which characterizes
their full-length, membrane anchored counterparts (Goldstein et al., 1979;
Brown and Goldstein, 1983; Kodama et al., 1990; Rohrer et al., 1990; Freeman
et al., 1991; Krieger, 1992). Ligand binding to the type I secreted receptor was
sensitive to low pH (5.5) as has been observed for scavenger receptor activity in
bovine macrophages (Naito et al., 1991). The mass of the intact type II secreted
receptor estimated from hydrodynamic data was 173 kD. The mass of the
individual monomeric subunits calculated from the experimentally determined
mass of the N-glycanase-deglycosylated receptor and an estimate of the
masses of the receptor's 6 N-linked oligosaccharides was 49.2 kD. Thus, the
ratio of the oligomer to subunit masses was 3.5. In conjunction with
electrophoretic analysis of unreduced and chemically crosslinked receptors,
this ratio suggests that, as is the case with the membrane anchored receptor
(Penman et al., 1991), the secreted type II receptors are trimers comprising
disulfide-crosslinked dimers noncovalently associated with monomers. The
type I receptors were also composed of monomers and dimers. Thus, the
cytoplasmic and transmembrane domains in the full-length receptors apparently
do not play an essential role in establishing the ligand-binding properties of
these receptors and are not required for the assembly of the receptors into
trimers.
At the very low concentrations of receptor used in the gel filtration and
gradient centrifugation experiments reported here, there was no evidence of the
formation of higher-order oligomers of trimers. This finding was somewhat
surprising because scavenger receptors, even though they are normally
integral membrane proteins, bear a striking resemblance to the members of a
group of secreted oligomeric mammalian proteins which all appear to
participate in host defense. Members of this group include lung surfactant
apoprotein A and the serum proteins complement factor Clq, mannose binding
protein, and conglutinin. All of these proteins have relatively short collagenous
domains, are elongated, and form higher-order oligomers in which multiple
trimeric collagenous stalks support globular head groups (Thiel and Reid,
1989). The similarities between the scavenger receptor and Clq extend to
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their ligand-binding properties. Clq has previously been reported to bind
polyanions (Loos, 1983) and we show in the accompanying paper (Acton et al.,
1992) that the collagenous domain of Clq exhibits broad ligand binding
specificity which is remarkably similar, but not identical, to that of scavenger
receptors. Additional studies will be required to determine if, at higher receptor
concentrations, the secreted or full-length scavenger receptors form higher-
order oligomers of trimers or if ligand binding affects the oligomerization state of
the receptors.
The frictional ratio (f/fo) of the type II secreted scavenger receptor was
2.82. This value indicates that the receptor is highly elongated (f/fo=1 for a
sphere). If it were cylindrical or ellipsoidal, it would be approximately 45-53
times as long as it is wide. By comparison, the frictional ratio of the extended
fibrinogen molecule is 2.37. We previously suggested that the scavenger
receptors would be elongated, because approximately 49% of the extracellular
residues of the type I receptor and 68% of the type II receptor are predicted to
fold into fibrous a-helical coiled-coil and collagenous domains (Kodama et al.,
1990; Rohrer et al., 1990; Ashkenas et al., 1992; Krieger, 1992). The
preparation of substantial amounts of secreted scavenger receptors should
permit additional biochemical and biophysical analyses of the receptors'
binding properties and structures, including electron microscopic and X-ray
diffraction studies.
The metabolically labeled, secreted scavenger receptors and the solid-
phase bead-binding assay provide convenient tools to search for additional,
potentially physiologically or pathophysiologically relevant ligands. This is
especially true for water-insoluble ligands because the insoluble ligands can be
used in place of beads in the binding assay. In an initial application of this
approach, we investigated the ability of secreted scavenger receptors to bind to
fibers of crocidolite asbestos. After inhalation, the majority of the asbestos
which is deposited in the lungs is initially accumulated by alveolar
macrophages (Rom et al., 1991). Exposure to asbestos can result in
asbestosis, malignant mesothelioma, and lung cancer (Mossman and Gee,
1989). Holian and Scheule initially raised the possibility that scavenger
receptors might play a role in macrophage recognition of negatively charged,
silicate-based asbestos fibers and other particulates in the lung (Holian and
Scheule, 1990). We found that crocolidite asbestos, a particularly pathogenic
form of asbestos, bound specifically to secreted scavenger receptors and that
this binding was inhibited by scavenger receptor ligands, but not their negative
controls. This finding raises the possibility that scavenger receptors play a role
in the recognition and uptake of asbestos by alveolar macrophages. Additional
in vitro and in vivo studies will be required to test this hypothesis. Similar solid-
phase binding assays using soluble scavenger receptors should prove useful in
helping to identify other scavenger receptor ligands. Also, the use of secreted
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forms of the scavenger receptors in other in vitro and in vivo experiments may
help further define their physiological functions.
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Figure 2.1. Domain structures of full-length and secreted scavenger receptors
The domain structures of the full-length type I (bSR-1) and type II (bSR-II)
bovine scavenger receptors were deduced from their cDNA sequences(Kodama et al., 1990; Rohrer et al., 1990; Ashkenas et al., 1992). These
domains include a short cytoplasmic domain (Cyto.), a single transmembrane
segment (TM), a spacer domain, a region predicted to form an a-helical coiled-
coil, and a collagenous domain with 24 Gly-X-Y repeats. The type I receptor
has a 110 residue long C-terminal cysteine rich domain (SRCR), while the type
II receptor has a 6 amino acid C-terminus (solid boxes). Secreted forms of
these receptors (s-bSR-1, s-bSR-II) differ from the full-length forms in that the
cytoplasmic and transmembrane domains were replaced with the myelin-
associated glycoprotein (MAG) leader sequence (shaded boxes), and Lys77
was converted to an Arg-Gly dipeptide (dot at the N-terminus of the spacer
domains).
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Figure 2.2. Immunoprecipitation of secreted bovine scavenger receptors
expressed by transfected CHO cells
The type I (CHO[s-bSR-I]) and type II (CHOI[s-bSR-II]) secreted bovine
scavenger receptor-expressing cells were plated on day 0 in 3 ml of medium C
into 6 well dishes (150,000 cells/well). On day 2, the cells were labelled for 5 hr
with 80 IgCi/ml of [35S]methionine and then the radiolabelled media were
subjected to immunoprecipitation using a rabbit anti-spacer domain anti-
peptide antibody and protein A sepharose. The samples were dissolved in
either reducing (lanes 1 and 4) or non-reducing (lanes 2 and 5) sample buffer,
or were subjected to treatment with N-glycanase (18 hr, .375 units) prior to
addition of reducing sample buffer (lanes 3 and 6) as described in "Materials
and Methods". Samples were then subjected to 3-10% polyacrylamide gel
electrophoresis and autoradiography as described in "Materials and Methods".
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Figure 2.3. Kinetics of s-bSR-II digestion by N-glycanase.
Immunoprecipitates of [35S]methionine-labelled s-bSR-II were prepared as
described in the legend of Figure 2. The samples were digested at 370 with the
indicated amounts of N-glycanase for the indicated times and subsequently
analyzed by reducing 10% polyacrylamide gel electrophoresis and
autoradiography as described in Materials and Methods.
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Figure 2.4. Binding of secreted bovine scavenger receptors to ligands coupled
to Sepharose beads.
Type I (CHO[s-bSR-I], left) and type II (CHO[s-bSR-II], center) secreted
bovine scavenger receptor-expressing cells, as well as untransfected CHO cells(right), were plated on day 0 in 3 ml of either medium B (untransfected cells) or
medium C (transfected cells) into 6 well dishes (150,000 cells/well). On day 2,
the cells were labelled for 5 hr with [35S]methionine (80 .Ci/ml) as described in
Materials and Methods. Aliquots of the radiolabelled media were incubated
overnight at 40C with buffer B and sepharose beads coupled to poly G (pG),
poly C (pC), poly I (pl), bovine serum albumin (BSA), or maleylated-BSA (M-
BSA) as indicated. The beads were then washed, and the bound components
were eluted by boiling with reducing electrophoresis sample buffer and then
subjected to 10% polyacrylamide gel electrophoresis and autoradiography as
described in Materials and Methods.
-- page 47 --
al v
O (0 It OI 1" I0I I ,0.
, u
)N
oTJLr-a)
I II
i0o 0)
OL 
Tri
rY
Figure 2.5. Inhibition of secreted bovine scavenger receptor binding to M-BSA
sepharose beads by soluble competitors.
[35S]Methionine-labelled conditioned media from CHO[s-bSR-I], CHO[s-
bSR-II] and CHO cells were prepared as described in the legend of Figure 4
and were incubated overnight at 40C with M-BSA sepharose beads and the
following additions: none (-), poly G (pG, 100 Igg/ml), poly C (pC, 100 Igg/ml),
bovine serum albumin (BSA, 400 gig/ml), maleylated BSA (M-BSA, 400 gig/ml),
low density lipoprotein (LDL, 400 jig protein/mi), or acetylated LDL (AcLDL, 400
gig protein/ml). The beads were then washed, and the bound components were
eluted by boiling with reducing electrophoresis sample buffer and then
subjected to 10% polyacrylamide gel electrophoresis and autoradiography as
described in Materials and Methods.
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Figure 2.6 Concentration-dependence of the inhibition by poly I of secreted
bovine scavenger receptor binding to M-BSA sepharose beads.
[35S]Methionine-labelled conditioned media from CHO[s-bSR-I] and CHO[s-
bSR-II] cells were prepared as described in the legend of Figure 4 and
incubated overnight at 40C with M-BSA sepharose beads, buffer B, and the
indicated concentrations of poly I. The beads were then washed, and the
bound components were eluted by boiling with reducing electrophoresis
sample buffer and then subjected to 10% polyacrylamide gel electrophoresis as
described in Materials and Methods. The intensities of the secreted receptor
bands were quantified with a Molecular Dynamics Phosphorlmager.
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Figure 2.7. Effects of pH on s-bSR-1 binding to poly G sepharose beads.
Aliquots of [35S]methionine-labelled conditioned medium from CHO[s-bSR-I]
cells were prepared as described in the legend of Figure 4 and the pH of each
was adjusted to the indicated values by adding buffer (50 mM 2-[N-
morpholino]ethanesulfonic acid, 50 mM Tris, 50 mM sodium acetate, 1 mM
CaCI2, 150 mM NaCI) of the appropriate pH. After addition of BSA (final
concentration: 0.5 mg/mi), the samples were incubated overnight at 40C with
poly G beads and binding of the secreted receptor to the beads was evaluated
by electrophoresis and autoradiography as described in Materials and
Methods.
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Figure 2.8. Determination of the Stokes radius (rs) and sedimentation coefficient
of s-bSR-II by gel filtration and glycerol gradient sedimentation.
[35S]Methionine-labelled conditioned medium from CHO[s-bSR-II] cells was
prepared as described in the legend of Figure 4 and 200 il aliquots were
subjected to either superose 6 gel filtration chromatography (panels A and B) or
glycerol gradient centrifugation (panel C) as described in Materials and
Methods. Panel A: For chromatography, the calibration standards and their
Stokes radii were: 1, IgM, 11.62 nm; 2, fibrinogen, 10.7 nm; 3, thyroglobulin,
8.58 nm; 4, apoferritin, 6.73 nm; 5, catalase, 5.12 nm; 6, alcohol
dehydrogenase, 4.6 nm; 7, transferrin, 3.55 nm; and 8, bovine serum albumin,
3.48 nm. The Stokes radii of the calibration standards are plotted against their
distribution coefficients, Kd, where Kd = (Ve - Vo)/(Vt - Vo) and Ve = elution
position of the sample, Vo = void volume of column, and Vt = total volume of the
column. The Kd of s-bSR-II is indicated by the solid circle. Panel B shows a
portion of the elution profile measured by poly G sepharose bead binding,
electrophoresis and autoradiography as described in Materials and Methods.
Panel C: For glycerol gradient centrifugation, the calibration standards and
their sedimentation coefficients (s20,w) were: a, BSA, 4.31; b, catalase, 11.35;
c, 03-galactosidase, 15.93; and d, apoferritin, 17.6. The location of s-bSR-II in
the gradient (solid circle) was determined by immunoprecipitation,
electrophoresis, and autoradiography as described in Materials and Methods.
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Figure 2.9. Binding of s-bSR-1 to crocolidite asbestos.
[35S]Methionine-labelled conditioned medium from CHO[s-bSR-I] cells was
prepared as described in the legend of Figure 4 and incubated overnight at 40C
with crocolidite asbestos (50 ig/tube) and the following soluble competitors:
none (-), poly G (pG, 25 pg/ml), poly I (pl, 25 gg/ml), poly C (pC, 25 pg/ml),
fucoidin (Fuc, 300 gig/ml), dextran sulfate (Dex SO04, 300 gg/ml), heparin (Hep,
300 pg/ml), chondroitin sulfate (Ch S04, 300 gIg/ml), maleylated BSA (M-BSA,
300 gg/ml), low density lipoprotein (LDL, 300 gig protein/mi), or acetylated LDL
(AcLDL, 300 gig protein/mi). Ribonuclease inhibitor (40 U/ml) was added to the
poly C incubations to prevent hydrolysis during the incubation. The asbestos
fibers were then washed, and the bound components were eluted by boiling
with reducing electrophoresis sample buffer and then subjected to 10%
polyacrylamide gel electrophoresis and autoradiography as described in
Materials and Methods. The autoradiograms shown in lanes 1-10 and 11-12
were from two separate experiments.
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Chapter 3
The type I macrophage scavenger receptor
binds to Gram-positive bacteria and
recognizes lipoteichoic acid
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The physiological role of the class A scavenger receptors remains an
open question. Among the veritable plethora of scavenger receptor ligands
(see Table 1.1 in the introduction), perhaps the most intriguing is
lipopolysaccharide (LPS), the ubiquitous endotoxin located on the surface of
Gram-negative bacteria (Hampton et al., 1991). The finding that SR-A binds
LPS raised the possibility that not only could the receptors play a role in
clearance of free LPS from the serum, but they might also potentially recognize
bacteria directly by means of this or related ligands. This chapter contains a
series of experiments designed to address this question. It describes the use of
metabolically labeled secreted scavenger receptor as a probe to study receptor
binding to intact bacteria and to identify potential bacterial surface components
involved in this binding. This work was published in its entirety in 1994 in
Proceedings of the National Academy of Science USA 91, 1863-1867. The
only modifications which have been made are that figures have been re-
numbered with the prefix "3" and the references have been merged with those
of other chapters in the "references" section of this thesis.
The work in this paper was carried out in collaboration with Dr. Dana
Dunne and Dr. Jordan Greenberg, who were postdoctoral associates in Dr.
Keith Joiner's laboratory. I did some preliminary experiments evaluating
whether secreted scavenger receptors could bind Gram-negative bacteria --
perversely enough, they apparently do not bind, despite the fact that the SRs
recognize endotoxin. Perhaps the endotoxin liposomes present the LPS in a
different context than the bacterial surface. I also performed the lipoteichoic
acid binding assays shown in Figure 3.3, and provided considerable advice
and assistance in getting the bacterial binding assays to work. The initial draft of
the paper was written by Dr. Dunne, however I provided considerable input into
the final published document.
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Abstract
Macrophage scavenger receptors exhibit unusually broad binding
specificity for polyanionic ligands and have been implicated in atherosclerosis
and a variety of host defense functions. Using a radiolabelled, secreted form of
the type I bovine macrophage scavenger receptor in an in vitro binding assay,
we have found that this receptor binds to intact Gram-positive bacteria,
including Streptococcus pyogenes, Streptococcus agalactiae, Staphylococcus
aureus, Enterococcus hirae, and Listeria monocytogenes. Competition binding
studies using purified lipoteichoic acid (LTA), an anionic polymer expressed on
the surface of most Gram-positive bacteria, show that LTAs are scavenger
receptor ligands and probably mediate binding of the receptor to Gram-positive
bacteria. LTAs, for which no host cell receptors have previously been identified,
are implicated in the pathogenesis of septic shock due to Gram-positive
bacteria. Scavenger receptors may participate in host defense by clearing LTA
and/or intact bacteria from tissues and the circulation during Gram-positive
sepsis. Since scavenger receptors have been previously shown to bind to and
facilitate bloodstream clearance of Gram-negative bacterial endotoxin
(lipopolysaccharide), these receptors may provide a general mechanism for
macrophage recognition and internalization of pathogens and their cell surface
components.
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Introduction
Macrophage scavenger receptors exhibit unusual broad ligand binding
specificities (reviewed in Brown and Goldstein, 1983; Krieger et al., 1993). Their
diverse, high affinity, polyanionic ligands include 1) chemically modified
proteins, such as acetylated and oxidized low density lipoprotein (LDL) and
maleylated bovine serum albumin (M-BSA), but not their unmodified
counterparts, 2) certain polysaccharides, such as dextran sulfate, but not
chondroitin sulfate, 3) four-stranded, but not one- or two-stranded,
polynucleotides, including poly G and poly I, 4) and others, such as anionic
phospholipids and crocidolite asbestos. The broad ligand binding specificity of
scavenger receptors is mediated by a short positively charged collagenous
domain in the extracellular region of the receptor (Doi et al., 1993; Acton et al.,
1993). The two isoforms of the macrophage scavenger receptor exhibit similar
binding properties, despite the presence of a cysteine rich C-terminal domain of
unknown function on the type I isoform which is not present on the type II
molecule (Kodama et al., 1990; Rohrer et al., 1990).
The physiologic and pathophysiologic functions of macrophage
scavenger receptors have not yet been established with certainty. Scavenger
receptor-mediated uptake of modified lipoproteins into macrophages has been
suggested to play a key role in the deposition of lipoprotein cholesterol in artery
walls during the formation of atherosclerotic plaques (reviewed in Brown and
Goldstein, 1983; Steinberg et al., 1989; Krieger, 1992). Because of their broad
binding specificity, macrophage scavenger receptors may also participate in
host defense activities by recognizing and mediating the endocytosis of a wide
variety of pathogenic substances (Krieger et al., 1993; Krieger, 1992). The
recent demonstration that scavenger receptors can bind a precursor of Gram-
negative bacterial lipid A provided the first support for this proposal (Hampton et
al., 1991). These findings suggest that scavenger receptors help define a set of
proteins which all contain short collagenous domains and participate in host
defense by binding a variety of pathogens (Acton et al., 1993; Sastry and
Ezekowitz, 1993). Other members of this family include complement
component Clq, mannose binding protein, pulmonary surfactant apoproteins A
and D, and conglutinin.
To further investigate the potential role of scavenger receptors in
recognizing pathogens, we developed a method for measuring the binding of
scavenger receptors to intact bacteria. We report here that a soluble form of the
type I bovine scavenger receptor binds to an wide array of Gram-positive
bacteria. We also show that lipoteichoic acid (LTA), a virtually ubiquitous Gram-
positive bacterial cell surface component, is a scavenger receptor ligand and
probably mediates receptor binding to intact bacteria. Thus, scavenger
receptors may participate in host defense by clearing LTA and/or Gram-positive
bacteria from both tissues and the bloodstream.
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Materials and Methods
Buffers and reagents - Buffers used the experiments were as follows: Buffer A -
20 mM Tris base pH 8.0/150 mM NaCI/1 mM CaCI2; Buffer A + BSA - Buffer A
containing 2 mg/mi BSA and 0.05% NaN3; Buffer B - 20 mM Tris base pH
8.0/150 mM NaCI/.05% NaN3; Buffer C - 0.1 M sodium acetate pH 4.7.
Phenylmethylsulfonylfluoride (PMSF), leupeptin, pepstatin, L-methionine,
polyGuanosine, salicylic acid and geneticin disulfate were purchased from
Sigma (St. Louis, MO). Ham's F-12 media, L-glutamine, and
penicillin/streptomycin were purchased from Gibco BRL (Gaithersburg, MD).
[35S]methionine (Trans 35S-label with.70% methionine) was from ICN
Biomedicals, (Irvine, CA). Maleylated BSA (M-BSA) coupled to CNBr-activated
Sepharose (Pharmacia) (approximately 3 mg M-BSA/ml hydrated resin) was
prepared as described previously (Resnick et al., 1993) .
Purified LTA from S. pyogenes, isolated as previously described(Simpson et al., 1980), was generously provided by James Dale and Harry
Courtney, Memphis, TN. Purified LTA was suspended in LTA buffer (0.25%
deoxycholate, 0.2 M NaCI, 1 mM EDTA, 0.02% NaN3, 10 mM Tris HCI, pH 8.0)
prior to use.
Bacterial strains - Streptococcus pyogenes strains T1/195/2, S43/192/4,
J17E/165/3, T2/44/RB4/119, and T22/76/2 in addition to a spontaneous M-
protein negative mutant (T28/51/4-4) with a large deletion in the mry/emm
operon (Scott et al., 1984) and its parent wild type (T28/150A/5) were from
Vincent Fischetti (Rockefeller University, New York City, NY). A Tn916 mutant(JRS75) of S. pyogenes which lacks both M protein and carboxypeptidase
(Caparon et al., 1991), and its type 6 parent strain (JRS4) were donated by
June Scott, Atlanta, GA. S. pyogenes wild- type strain 87-282 and its acapsular
Tn916 mutant, TX-4, were kindly provided by Mike Wessels (Channing
Laboratory, Boston, MA) (Wessels et al., 1991). Streptococcus agalactiae
strains A909 (type la), and COH-31-15 (unencapsulated Tn 918 mutant of type II
strain COH 15) were also from M. Wessels (Rubens et al., 1987). S. agalactiae
strains 110 and 181 were from Steve Mattingly, San Antonio. Staphylococcus
aureus capsular type 5 strain Reynolds and its transconjugate mutants, strains
JL 236 (Tn-918-induced capsule deficient mutant) and JL 240 (EMS-derived
capsule negative mutant) in addition to type 8 strain Becker and its mutant, JL
252 (Tn-551-induced capsule negative mutant) were generously donated by
Jean Lee (Channing Laboratory, Boston, MA)(Albus et al., 1991).
Streptococcus mutans (ATCC 25175), Enterococcus hirae (ATCC 9790),
Listeria monocytogenes (ATCC 43251), and Bacillus subtilis (ATCC 6633) were
obtained from the American Type Tissue Collection (Rockville, MD). Strains of
Streptococcus pneumoniae (rough, type 6, type 8) were from our laboratory.
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Growth of Bacteria - Gram-positive bacteria were grown overnight either on LB
agar plates (L. monocytogenes, B. subtilis) or 5% sheep blood agar plates (for
all remaining organisms). Fresh colonies were inoculated into Todd Hewitt
Broth (DIFCO) and were grown to stationary phase (16-18 hours; 1x109 CFU/1
ml) at 370C without shaking. Initial experiments indicated greater binding of
scavenger receptor to organisms grown to stationary phase compared to
organisms used at log phase. Thus stationary phase organisms were used in all
experiments presented here, although results were similar for log phase
organisms. Bacterial strains were harvested by centrifugation at 3500 x g for 10
minutes and washed twice in cold Buffer B before resuspending to a final
density of approximately I x 109 bacteria/ml (O.D.600 = 2.0).
FITC-labelled S. pyogenes - Stationary phase organisms were suspended in
PBS to O.D.600= 1.0. To 5cc of organisms, 5±l of fluorescein isothiocyanate
(100mg/ml in DMSO) was added, and the mixture was incubated at 37"C for 60
minutes with periodic vortexing. Organisms were washed twice in PBS, then
suspended in Ham's F12 containing 10% fetal calf serum.
Preparation of metabolically labeled soluble bovine scavenger receptor, type I(s-bSR-1) - Untransfected Chinese hamster ovary (CHO) cells and transfected
CHO cells (CHO[s-bSRI]-A2) expressing a truncated, secreted form of the type I
bovine scavenger receptor (s-bSR-1) were described previously (Resnick et al.,
1993). The trimeric s-bSR-I receptor comprises all four extracellular domains of
the intact receptor and exhibits the same broad binding specificity as the full
length integral membrane form of the receptor. CHO cells were grown in
medium A (Ham's F-12 medium supplemented with 100 units/mi penicillin, 100
pg/ml streptomycin, and 2 mM glutamine) containing 5% (vol/vol) fetal calf
serum (Medium B). Transfected cells were grown in Medium B containing 0.5
mg/ml G418. [35S] methionine- labelled conditioned medium was prepared
from transfected CHO[s-bSRI]-A2 cells and untransfected CHO cells as
previously described (Resnick et al., 1993), and designated [35S]s-bSR-I
medium and [35S]control medium, respectively. Protease inhibitors added to
conditioned media were 1 mM PMSF, 1 IM leupeptin, and 1 •M pepstatin.
Microbial binding assay - Thirty minutes prior to binding assays, unlabelled L-
methionine (10 mM final concentration) was added to suspensions of
microorganisms grown as described above to minimize incorporation of free
[35S]methionine into microbial proteins during the assays. One ml assay
mixtures comprising 200 p.l of bacterial suspension (approximately 2 x 108
bacteria), 50 pl of Buffer A and 750 p• of either [35S]s-bSR-I or [35S]control
media were prepared in microcentrifuge tubes and incubated overnight on a
rotator at 40C. Suspensions of maleylated BSA-coupled Sepharose beads (M-
BSA beads) (25 p•) were used in place of microorganism suspensions as
positive controls. In the experiment shown in Figure 3, the total assay volume
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was 0.25 ml instead of 1.0 ml and each assay contained 50 gIl of LTA buffer with
the indicated amounts of LTA and 10 gI of M-BSA beads. The amounts of
scavenger receptor binding shown in Figure 3 were measured with a Molecular
Dynamics Phosphorlmager.
After the overnight incubation, the bacteria or beads were pelleted by
centrifugation in a microcentrifuge at 12,500 x g for 5 minutes at 40C and
washed twice with cold buffer A. In experiments examining the ability of LTA to
inhibit the binding of the s-bSR-I to M-BSA beads, the beads were allowed to
settle by gravity before each washing step, to prevent pelleting of LTA micelles.
The washed pellets were then resuspended in SDS-PAGE sample buffer
containing 2% 8-mercaptoethanol, boiled for 5 min., and insoluble material was
removed by centrifugation at 12,500 x g for 2 minutes. The reduced samples
were fractionated by electrophoresis through 10% polyacrylamide gels (Resnick
et al., 1993) and the labeled proteins were visualized by autoradiography with
Kodak X-AR film. Prior to autoradiography, the gels were impregnated with
either 0.125 M sodium salicylate in 30% (v/v) methanol or autofluor (National
Diagnostics).
Cell Binding Assay - P388D1 cells were maintained in dishes in Ham's F12 with
10% fetal calf serum, 100units/ml penicillin and 100pg/ml streptomycin. For
experiments, approximately 12,500 cells were plated on 1 cm glass cover slips,
in media lacking antibiotics. Cells were allowed to adhere for at least 24-36
hours, then washed in Ham's F12 containing 10% fetal calf serum. S.
pyogenes, either unlabelled or FITC-labelled, was added (final dilution of 1:250
from a stock solution of O.D.600= 1.0) in the presence or absence of varying
concentrations of poly G. Mixtures were incubated for 30 minutes at 370C in
5%CO2, then washed three times in PBS, and fixed with 100% cold methanol.
Samples containing non-FITC labelled organisms were Gram-stained, then
cover slips were mounted with Moviol and DAPCO. Slides were viewed in
blinded fashion by two observers using fluorescence and phase contrast
microscopy and a Nikon Microphot FXA epifluorescence microscope. The
results presented below (bacteria bound per 100 P388D1 cells) represent the
means +/- standard deviations determined from three experiments in which at
least 100 P388D1 cells were counted for each condition.
-- page 66 --
Results
The type I bovine scavenger receptor (s-bSR-1) binds to S.
pyogenes. To determine if a secreted form of the type I bovine scavenger
receptor (s-bSR-l) could directly bind to the surface of whole bacteria, we
incubated bacteria at 40C overnight with [35S]methionine-labeled conditioned
medium either from transfected CHO cells expressing the secreted receptor
([35S]s-bSR-I medium) or from control untransfected CHO cells ([35S]control
medium). The bacteria and any bound protein were then solubilized with
detergents and the bound metabolically labeled proteins were visualized after
gel electrophoresis by autoradiography. Figure 3.1A shows that when
Streptococcus pyogenes strain T1/195/2 was incubated with [35S]s-bSR-1
medium, the most prominent of the labeled proteins bound to the bacteria was
-78 kD (lane 1), the mass of s-bSR-I (Resnick et al., 1993). This protein was
absent from S. pyogenes incubated with [35S]control medium (see figure 3.1B
below) and these binding data were similar to data for the binding of [35S]s-
bSR-I to sepharose beads covalently derivatized with the scavenger receptor
ligand maleylated BSA (M-BSA beads, not shown). Therefore, we conclude
that the 78 kD binding protein was [35S]s-bSR-I. Because the labeled
scavenger receptor in [35S]s-bSR-1 medium represented only a small fraction of
the total labeled protein (not shown), yet it was the major component of the
bound proteins (lane 1), [35S]s-bSR-I binding to S. pyogenes appears to have
been specific. In preliminary studies we also observed the binding of a soluble
form of the type II bovine scavenger receptor as well as soluble forms of human
type I and II scavenger receptor to Gram-positive bacteria (not shown).
The polynucleotide ligand poly G is an efficient competitive inhibitor of
the binding of other polyanionic ligands (Brown and Goldstein, 1993; Resnick et
al., 1993) to the cationic collagenous binding domain on the type I and type II
scavenger receptors. Figure 3.1A (lane 2) shows that the binding of S.
pyogenes to s-bSR-I resembled binding of other ligands in that poly G was an
effective competitor (compare to lane 1). This binding was not restricted to the
T1i/195/2 strain of S. pyogenes. Figures 3.1 and 3.2 and Table 3.1 show that a
total of 11 S. pyogenes strains representing 7 different M protein types bound
[35S]s-bSR-I. Thus, [35S]s-bSR-1 binding is a general characteristic of S.
pyogenes which is not strain specific.
The ability of poly G to inhibit S. pyogenes binding was used in
experiments to examine the interaction of FITC-labelled S. pyogenes (strain
T1/195/2) with a cultured murine macrophage-like cell line, P388D1, shown
previously to express macrophage scavenger receptors (Ashkenas et al., 1993).
After a 30 minute incubation at 370C, we observed binding of 72 +/- 8
bacteria/1i 00 P388D1 cells. When poly G at concentrations of 2, 20, or 200
pg/ml was included in the incubation medium, the number of cell associated
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bacteria/100 P388D1 cells was reduced to 43 +/- 4, 28 +/- 9, and 22 +/- 5,
respectively. Similar results were obtained when binding of unlabelled bacteria
was assessed by Gram staining (See Methods). These results raise the
possibility that association of S. pyogenes with intact cultured murine
macrophages may be mediated in part by their full length, cell surface
scavenger receptors. Additional studies will be necessary to determine the role
of scavenger receptors in the intemalization and processing of bacteria by
macrophages in culture and in Wvo.
s-bSR-1 binds to S. pyogenes strains lacking M protein or
hyaluronic acid capsules. To determine which cell surface component(s)
on S. pyogenes might be responsible for scavenger receptor binding, we used
mutant strains of S. pyogenes to assess the role in receptor binding of two well
characterized virulence determinants, M protein and the hyaluronic acid
capsule (Wessels et al., 1991; Phillips et al., 1981; Lancefield, 1962; Beachey
et al., 1980; Kendall et al., 1937; Whitnack et al., 1981; Hosein et al., 1979).
Figure 3.2 (lanes 1 and 2) shows that a type 28 S. pyogenes strain and its
spontaneous M protein-negative mutant bound s-bSR-l equivalently. Similar
results were obtained when assays were performed using a type 6 M protein-
negative transposon mutant of S. pyogenes and its wild type parent strain
(Table I, strains JRS75 and JRS4). Thus, the M protein is not necessary for
binding. Figure 3.2 (lanes 3 and 4) also shows that the wild type S. pyogenes
strain 87-282 and its acapsular, hyaluronic acid-negative, transposon mutant
TX4, bound [35S]s-bSR-I equally well. Therefore, it is unlikely that the
hyaluronic acid capsule played a significant role in binding to s-bSR-I.
S. pyogenes lipoteichoic acid (LTA) is a ligand for s-bSR-I.
These results show that some other surface component must mediate binding of
[35S]s-bSR-I to S. pyogenes. Another major surface component of S.
pyogenes is the polyanionic polymer lipoteichoic acid (LTA) (Ofek et al., 1975;
Kessler et al., 1979). A direct, genetics based, test of the role of LTA in binding
is not possible because no naturally occurring or genetically engineered strains
of S. pyogenes lacking LTA are available. However, because binding of
[35S]s-bSR-I to S. pyogenes apparently occurs via interaction with the
receptor's cationic collagenous ligand binding domain (see above), it is
possible to examine the potential role of LTA in mediating binding. This can be
done by determining if LTA can function as a competitive inhibitor of [35S]s-
bSR-I binding to other ligands, e.g., M-BSA beads (Resnick et al., 1993).
Figure 3.3 shows the results of an experiment in which increasing amounts of S.
pyogenes LTA were added to mixtures of [35S]s-bSR-I medium and M-BSA
beads and the amount of [35S]s-bSR-1 binding was quantitated as described in
Methods. S. pyogenes LTA was an effective inhibitor of binding (IC50 = -4
ig/ml). LTA also inhibited binding of [35S]s-bSR-1 to poly G beads, with a
similar IC50 (not shown). These data suggest that LTA may be the major
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scavenger receptor binding determinant on S. pyogenes.
s-bSR-I binds to an array of Gram-positive bacteria.The finding
that LTA probably mediates binding of scavenger receptors to S. pyogenes
raised the possibility that many, if not all, Gram-positive bacteria might bind to
scavenger receptors because LTA or analogous molecules are ubiquitous cell
surface components on these microorganisms (Reviewed in Wicken and Knox,
1975; Fischer, 1988). Figure 3.4 shows that [35S]s-bSR-1 bound to
Enterococcus hirae and S. agalactiae. Binding was competible by poly G. In
binding studies using a wide variety of Gram-positive bacteria, we observed that
all species and strains of bacteria tested bound [35S]s-bSR-I (Table 3.1).
Binding was competible with poly G although the extent of competition varied
slightly between organisms. In addition to the species shown in Figure 3.4,
[35S]s-bSR-1 bound to Staphylococcus aureus, Streptococcus mutans, Listeria
monocytogenes and Bacillus subtilis. Isogenic capsule-minus transposon
mutants of S. agalactiae and S. aureus also bound [35S]s-bSR-l equivalently or
better than the parent strains, again suggesting that the capsule plays little, if
any, role in [35S]s-bSR-I binding. In contrast to the results with all other Gram-
positive organisms examined, only minimal binding was observed to two
encapusulated and one rough strain of S. pneumoniae, organisms with atypical
LTAs (Behr et al., 1992).
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Discussion
In a series of in vitro binding studies using a truncated, secreted form of
the type I bovine macrophage scavenger receptor, we have shown that the
scavenger receptor can bind to the surface of S. pyogenes and to a wide variety
of other Gram-positive bacteria. The binding to S. pyogenes was inhibited by
poly G, a classic scavenger receptor ligand (Brown and Goldstein, 1983). Thus,
the binding was probably mediated by interactions of negatively charged sites
on the bacterial surface with the positively charged collagenous ligand binding
domain of the receptor. Experiments using S. pyogenes mutants showed that
the binding was independent of the hyaluronic acid capsule and the M protein,
two major surface virulence determinants specific for S. pyogenes (Wessels et
al., 1991; Phillips et al., 1981; Lancefield, 1962; Beachey et al., 1980; Kendall
et al., 1937; Whitnack et al., 1981; Hosein et al., 1979). Lipoteichoic acid(LTA), a polyanionic surface component found on most Gram-positive bacteria,
was shown by competition assays to be a scavenger receptor ligand. It seems
likely that LTA is at least one of the major determinants of scavenger receptor
binding to S. pyogenes.
LTAs are amphipathic molecules typically consisting of a 1-3
phosphodiester-linked polymer of glycerophosphate linked covalently to either
a glycolipid or a phosphatidyl glycolipid (reviewed in Wicken and Knox, 1975;
Fischer, 1988; Fischer et al., 1990). The resulting structures possess a
backbone of repeating negative charges, a common feature of other scavenger
receptor ligands, such as poly G and lipopolysaccharide micelles. Although
there is immunological evidence that LTAs are absent from some Gram-positive
bacteria, the presence of alternative polymers (atypical LTA's) in most of these
organisms indicates that this class of molecules is a nearly invariant component
in the Gram-positive cell wall (reviewed in Fischer, 1988; Sutcliffe and Shaw,
1991). The inability to isolate LTA-negative strains of Gram-positive bacteria
further suggests that this surface component is critical for these organisms. It is
likely that some atypical LTA's might not tightly bind to scavenger receptors, as
suggested by the weak interaction with S. pneumoniae, which expresses an
unusual LTA containing choline and ribitolphosphate (Briles and Tomasz, 1973;
McCarty, 1959).
Bacteremia with Gram-positive organisms can result in septic shock
which is often indistinguishable from that caused by Gram-negative bacteria(reviewed in Danner et al., 1989). It is generally accepted that
lipopolysaccharide (endotoxin)-mediated release of cytokines, including IL-1
and TNF, is responsible for the syndrome of septic shock with Gram-negative
organisms. It is likely that LTA serves a similar role in Gram-positive sepsis.(reviewed in Danner et al., 1989). We have shown previously that the rapid
scavenger receptor-mediated hepatic uptake of endotoxin in vivo can play a
quantitatively significant role in endotoxin clearance and probably does not play
a role in endotoxin induced activation of macrophages (Hampton et al., 1991).
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These results suggested that scavenger receptors presumably help in
protection from endotoxic shock during Gram-negative bacterial sepsis. The
current study raises the possibility that scavenger receptors might play a similar
role during Gram-positive sepsis in recognizing and removing from tissues and
the bloodstream both intact Gram-positive organisms and LTA released from
their surfaces.
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Figure 3.1. Binding of secreted bovine scavenger receptor type I (s-bSR-l) to S.
pyogenes.
[35S]Methionine labeled media from transfected CHO cells expressing
the truncated, secreted bovine type I scavenger receptor (s-bSR-I) or from
untransfected controls (Cont.) were prepared and incubated overnight at 40C
with S. pyogenes T1/195/2 (panel A) or the indicated S. pyogenes strains
(panel B) as described in Methods. In lane 2 of panel A, the mixture was
supplemented with 400 gg/ml of the scavenger receptor ligand poly G. After the
incubation, the bacteria were washed, dissolved by boiling in reducing sample
buffer, and bound [35S]labeled components were resolved by 10%
polyacrylamide gel electrophoresis and visualized by autoradiography.
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Figure 3.2. Role of the M-protein and the hyaluronic acid capsule in [35S]s-
bSR-I binding to S. pyogenes.
The indicated bacteria and [35S]methionine labeled medium from cells
expressing the truncated, secreted bovine type I scavenger receptor (s-bSR-1)
were incubated together and bound receptor was visualized by electrophoresis
and autoradiography as described in Methods. The bacteria used were S.
pyogenes M-protein positive (T28/150A/5) and negative (T28/51/4-4) strains(left, lanes 1 and 2), and the hyaluronic acid capsule positive (wild type 87-282)
and negative (TX-4) strains (right, lanes 3 and 4).
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Figure 3.3. Inhibition of [35S]s-bSR-I binding to M-BSA beads by LTA from S.
pyogenes.
Binding of [35S]s-bSR-1 to M-BSA beads in the presence of the indicated
amounts of LTA was performed as described in Methods. After an overnight
incubation at 40C, the adherent proteins were eluted from the beads by boiling
in reducing sample buffer, bound [3 5S]s-bSR-I was resolved by 10%
polyacrylamide gel electrophoresis and the relative amounts of bound [35S]s-
bSR-I were determined using a Molecular Dynamics Phosphorimager. All of
the values shown were corrected for "nonspecific" background binding by
subtracting the value determined in the presence of 400 gig/ml poly G.
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Figure 3.4. Binding of [35S]s-bSR-I to Enterococcus hirae and Streptococcus
agalactiae
The indicated bacteria and [35S]methionine labeled medium from cells
expressing the truncated, secreted bovine type I scavenger receptor (s-bSR-1)
were incubated in the presence or absence of 400 gg/ml of poly G and bound
receptor was visualized by electrophoresis and autoradiography as described
in Methods. The bacterial strains used were Enterococcus hirae 9790 and
Streptococcus agalactiae CHO-31-15.
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Table 3.1. Strains of Gram-positive bacteria which bound [35S]secreted type I
bovine scavenger receptor.
Streptococcus.pyogenes
T1/195/2
S43/192/4
J17E/165/3
T2/44/RB4/119
T22/76/2
T28/51/4-4
T28/1 50A/5
JRS75
JRS4
87-282
TX4
Streptococcus mutans ATCC 25175
Enterococcus hirae ATCC 9790
Listeria monocytogenes ATCC 43251
Bacillus subtilis ATCC 6633
Staphylococcus aureus
Reynolds
JL236
JL240
Becker
JL252
Streptococcus agalactiae
A909
COH 31-15
110
181
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Chapter 4
The collagenous domains of macrophage scavenger
receptors and complement component C1lq mediate
their similar, but not identical, binding specificites
for polyanionic ligands
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One of the more interesting questions pertaining to SR-A structure and
function is how a molecule predicted to form a rod can bind such a broad array
of ligands with high affinity and yet maintain specificity. After the cloning of the
receptor, attention was focused on the collagenous domain as a potential
ligand binding site. The cluster of positively charged residues at the C-terminal
end of the domain was a particularly attractive possibility (Kodama et al., 1990;
Rohrer et al., 1990), as the unifying theme of scavenger receptor ligands is that
they are all polyanionic (see Table 1.1, introduction). This work experimentally
addresses the question of the ligand binding domain by two means. It
evaluates whether the collagenous domain is necessary for ligand binding by
examining the effects of the truncation of this region on receptor activity. It
indirectly examines the issue of whether the collagenous domain may be
sufficient for ligand binding by determining whether a related collagenous
sequence (the collagenous stalks of Clq) is capable of mediating a similar
broad binding activity. This work was published in its entirety in 1993 in The
Joumal of Biological Chemistry 268, 3530-3537. The only changes which
have been made are that figures have been re-numbered with the prefix "4" and
the citations have been merged with those of other chapters in the "references"
section of this thesis.
My contribution to this work is limited to the experiments involving Clq,
namely those shown in Table 4.4 and Figure 4.6. These experiments were of
considerable importance in this work, as they allowed us to draw the conclusion
that the collagenous domain of the scavenger receptor is probably sufficient for
ligand binding. The paper was primarily written by Dr. Susan Acton and Dr.
Monty Krieger; however I provided some assistance with editing and revision of
the text.
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Summary
Macrophage scavenger receptors have been implicated in the
development of atherosclerosis and other macrophage-associated functions,
including host defense. The mechanism by which these receptors bind a wide
array of polyanions, such as acetylated LDL, with high affinity has not yet been
elucidated; however, it has been proposed that the positively charged
extracellular collagenous domain of scavenger receptors plays a key role in
ligand binding. To test this proposal, we generated truncation mutants of the
bovine and murine scavenger receptors and studied their expression in
transiently transfected COS cells. These mutants contain only 8 (bovine) or 5
(murine) of the 24 Gly-X-Y tripeptide repeats found in the collagenous domains
of the full-length receptors. Immunochemical analyses established that the
truncation of the bovine scavenger receptor did not interfere significantly with its
synthesis, trimerization, post-translational processing, intracellular transport,
surface expression, or stability. However, unlike their full-length counterparts,
the truncated bovine and murine receptors were unable to bind acetylated LDL.
Thus, the collagenous domain was necessary for normal ligand binding. In
addition, cotransfection of the expression vector for the truncated bovine
scavenger receptor with that for the full-length receptor resulted in dramatically
reduced activity of the full-length construct (dominant negative effect). A ligand-
bead binding assay was used to show that the isolated collagenous domain
from a different protein, complement component Clq, could bind a wide variety
of polyanions with a specificity which was similar, but not identical, to that of
scavenger receptors. These results suggest that the collagenous domain of the
scavenger receptor is both necessary and sufficient to determine the broad
binding specificity that characterizes this unusual receptor. Scavenger
receptors and Clq, along with the mannose binding protein, conglutinin and
lung surfactant apoprotein A, help define a set of proteins which all contain
short collagenous domains and which all appear to participate in host defense.
Their short collagenous domains may contribute significantly to their host-
defense functions.
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Introduction
The type I and type II macrophage scavenger receptors are trimeric
integral membrane glycoproteins which exhibit unusually broad ligand
specificity (Goldstein et al., 1979; Brown and Goldstein, 1983; Kodama et al.,
1988; Kodama et al., 1990; Rohrer et al., 1990; Penman et al., 1991). They bind
a wide variety of polyanions, including chemically modified proteins (e.g,
acetylated low density lipoprotein, AcLDL), acidic phospholipids, endotoxin
(Raetz et al., 1988; Nishikawa et al., 1990; Hampton et al., 1991) and certain
polyribonucleotides (poly I and poly G, but not poly C). Numerous studies have
suggested that the scavenger receptors may be critically involved in cholesterol
deposition in artery walls during atherogenesis (Brown and Goldstein, 1983;
Jurgens et al., 1987; Steinberg et al., 1989; Steinbrecher et al., 1990). The
broad binding specificity of the scavenger receptors and their expression in
macrophages (Brown and Goldstein, 1983; Nagelkerke et al., 1983; Pitas et al.,
1985; Kodama et al., 1990) suggest that they may also play a role in other
physiologic and pathophysiologic systems, such as macrophage-associated
host-defense and inflammation (Freeman et al., 1990; Kodama et al., 1990;
Krieger, 1992).
The cDNAs for the bovine, murine, human, and rabbit type I and type II
scavenger receptors have been cloned (Kodama et al., 1990; Rohrer et al.,
1990; Ashkenas et al., 1992; Matsumoto et al., 1990; Bickel and Freeman,
1992). The sequence of the type I bovine scavenger receptor cDNA predicts a
453 amino acid protein with the following domains (Kodama et al., 1990): 1. N-
terminal cytoplasmic (amino-acid residues 1-50), II. transmembrane (51-76), III.
spacer (77-108), IV. a-helical coiled-coil (109-271), V. collagenous (272-343),
and VI. C-terminal cysteine-rich (344-453), designated SRCR (scavenger
receptor cysteine-rich). The SRCR domain helped to define a previously
unrecognized family of remarkably well conserved cysteine-rich protein
domains (Freeman et al., 1990). The bovine scavenger receptor type II (bSR-II)
is identical to the type I receptor, except that the 110-amino-acid SRCR domain
is replaced by a six-amino acid C-terminus (Rohrer et al., 1990) (see Figure 1,
top). Despite its truncated C-terminus, the type II scavenger receptor mediates
the endocytosis of modified LDL with essentially the same affinity and is
inhibited by the same group of polyanions as the type I receptor (Rohrer et al.,
1990; Freeman et al., 1991). The observation that all of the 24 Gly-X-Y triplets
in the collagenous domain of the bovine scavenger receptors were either
positively charged or neutral at physiologic pH suggested that this domain
might play a critical role in establishing the broad ligand binding specificity of
scavenger receptors (Kodama et al., 1990; Rohrer et al., 1990).
In the current study, we have used two approaches to examine the role of
the collagenous domain in ligand binding. First, mutant truncated forms of the
bovine (t-bSR) and murine (t-mSR) scavenger receptors with only either 8 or 5
Gly-X-Y tripeptide repeats in the collagenous domains, respectively, were
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generated. Studies with the bovine mutant established that the intact
collagenous domain was not required for receptor synthesis, trimerization, post-
translational modification, intracellular transport, or cell surface stability. The
collagenous domains in both the bovine and the murine scavenger receptors
were, however, necessary for ligand binding. Second, analysis of ligand
binding to the isolated collagenous domain of complement component Clq
showed that a different short collagenous domain can have broad polyanionic
ligand binding specificity similar to that of scavenger receptors. Thus, the
collagenous domain of the scavenger receptor may be not only necessary, but
also sufficient to confer on this receptor its characteristic broad ligand binding
specificity for polyanions.
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Materials and Methods
Materials - Anti-N-terminal bovine scavenger receptor polyclonal antibodies
were prepared against a peptide from the amino-terminus of the bovine
scavenger receptor as previously described (Penman et al., 1991). LDL and
AcLDL were prepared and iodinated with specific activities of 100-400 cpm/ng,
and newborn calf and human lipoprotein-difficient sera were prepared as
described previously (Goldstein et al., 1983; Krieger, 1983). 1251-Clq
collagenous tails were a gift from Dr. Andrea Tenner (UC Irvine, CA) and were
prepared as previously described (Guan et al., 1991). Polyriboguanylic acid(poly G), polyriboinosinic acid (poly I), polyribocytidylic acid (poly C), fucoidin,
dextran sulfate, chondroitin sulfate, and methionine were obtained from Sigma.
Maleylated BSA (M-BSA) was prepared as described (Goldstein et al., 1979).
Poly G, poly I, and poly C covalently attached to Sepharose were purchased
from Pharmacia. M-BSA was coupled to CNBr activated Sepharose(Pharmacia) according to the manufacturers instructions yielding a final
concentration of 2.7 mg M-BSA/ml of packed gel.
Preparation of the expression vectors -The t-bSR mutant was generated using
the polymerase chain reaction (PCR) and the bovine type II scavenger receptor
in pBluescript. The primer used for the 5' end (5' CGC GGG GGA TCC ATG
GCA CAG TGG GAT GAC TTT 3') encoded the initiator methionine (underlined)
and the 3' primer (5' CGC GGG CTC GAG TTA TTG CAT GCT CCG ATC ACC
TTT AAG ACC TGG AGT ACC 3') was antisense and was intended to encode a
stop in the middle of the collagenous region. A base omission error at
nucleotide 884 (CCAGGT -> C_AGGT) generated during the PCR resulted in a
295pro .> 295GIn frameshift mutation that terminated the polypeptide after
translation of only 8 of the 24 Gly-X-Y repeats (...G-F-295Q-V-stop). The product
was excised with Barn H1 and Xho I and ligated into pcDNAI (Invitrogen, La
Jolla, CA) and sequenced using Sequenase 2.1 (USB) according to
manufacturers instructions. The mutant murine scavenger receptor cDNA was
also generated by PCR. A 1084 bp murine scavenger receptor PCR product
was synthesized from an amplified P388D1 cDNA library (Ashkenas et al.,
1992) using a sense oligonucleotide primer in the 5' leader of the cDNA (5'
CGC CGA GCG GCC GCG CTG TCT TCT TTA CCA GC 3') and an antisense
primer at the 3' end of the coding domain of the type II murine receptor (5' CGC
CGG TCT AGA TTA TAC TGA TCT TGA TCC GC3'). This product was cloned
into pRc/CMV (Invitrogen) using the Not I and Xba I restriction sites engineered
into the primers. One of the products, pJA20-1, had a base omission error at
nucleotide 888 (CTTACT -> C_TACT) causing a 287Thr ->287Leu frameshift.
This resulted in a sequence encoding a truncated murine scavenger receptor
containing only five Gly-X-Y triplets in its collagenous domain followed by a 10
residue hydrophobic tail at the mutant receptor's C-terminus (273GPP-GPQ-
GEK-GDR-GLL-DKLVHLVLQE-stop). The insert from pJA20-1 was cloned into
pcDNAI, using Not I and Xba I, to generate the truncated mutant murine
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scavenger receptor (t-mSR) expression vector, pJA27.
Cell culture and transfections - All cell culture incubations were at 370C in a
humidified 95% air, 5% CO2 incubator unless otherwise noted. COS M6 cells
were grown in Dulbecco's Modified Eagle Medium (DMEM) with 10% fetal
bovine serum (FBS), 100 units/mi penicillin, 100 Igg/ml streptomycin, and 2 mM
glutamine (medium A). For transfections, 1.5 x 106 cells/dish were set in 100
mm dishes in medium A on day 0. For each dish on day 1, plasmid DNA (2 - 10
gig in 50 Il H20) was mixed with 200 gIl of 10 mg/mi DEAE-dextran (Pharmacia)
and then added to 4 ml of medium A in which the FBS was replaced with 10%
(v/v) Nuserum (Collaborative Research) and supplemented with 100 IM
chloroquine. The entire mixture was then added to the cells. The cells were
incubated for 3.5 hrs, the medium was removed and the cells were shocked
with 2 ml of 10% (v/v) dimethylsulfoxide in phosphate buffered saline (PBS).
After 2-3 minutes the buffer was quickly removed by aspiration and replaced
with 10 ml of medium A. On day 2 the cells were harvested with trypsin and
replated in medium A at 0.5-1 x 106 cells/well in 6-well dishes. Cell labeling
and degradation assays were typically performed on day 3. For cotransfection
assays, DNAs were combined as indicated prior to preparation of the DEAE-
dextran complexes.
Biosynthetic labeling -Transfected cells in 6-well dishes were rinsed twice with
1 ml of PBS per well and incubated with methionine-free Ham's F12 medium
containing 100 units/mi penicillin, 100 •ig/ml streptomycin, 2 mM glutamine, and
3% (v/v) newborn calf lipoprotein-deficient serum and [35S]methionine or
[35S]protein labeling mix (New England Nuclear) (0.5 ml/well, 300 jiCi/ml for
pulse-chase experiments and 0.75 ml/well, 80-100 gCi/ml for 5 hr labeling). For
pulse-chase experiments, cells were labeled for the indicated times, then
washed once with warm medium A and incubated in 3 ml of chase medium
(medium A supplemented with 1 mM unlabeled methionine) as indicated. Cells
were harvested by scraping in lysis buffer (PBS with 1% (v/v) Triton X-100, 1
mM methionine, 50 pg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride
(PMSF) with or without 10 mM iodoacetamide as indicated). For pronase
digestions, labeled cells were washed once 20 min before the end of the chase
period with 1 ml/well of warm hepes buffered saline (10 mM hepes, pH 7.4, 0.15
M NaCI, 2 mM CaCI2) and incubated for 20 min at 370C in 0.75 ml of hepes-
buffered saline with or without 60 gg/ml pronase (Sigma). The cells were
chilled to 00C and 0.5 ml per well of ice-cold pronase quench were added (PBS
with 25% (v/v) human lipoprotein-deficient serum, 1 mM EDTA, and 1 mM
PMSF). The cells were scraped from the dish using a rubber policeman,
harvested by centrifugation at 2000 x g for 5 min at 40C, washed twice with PBS
at 40C, and lysed in 220 p• of lysis buffer.
Immunoprecipitation, electrophoresis, and autoradiography -
Immunoprecipitations of radiolabeled scavenger receptors were performed as
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previously described (Penman et al., 1991), except that unlabeled,
untransfected COS cells were used in place of Chinese hamster ovary (CHO)
cells to reduce non-specific background and 20 p• of a 50% (v/v) slurry of
protein A-Sepharose in PBS were used in place of the goat-anti-rabbit
antibody. For endoglycosidase H (Endo H) digestions, immunoprecipitates
were suspended in 20 g1 of Endo H buffer (30 mM sodium citrate, 0.75% (w/v)
SDS, 2% (v/v) 8-mercaptoethanol, 1 mM PMSF, 0.02% (w/v) NaN3, pH 5.5) and
boiled for 5 min. After cooling, the Sepharose was removed by centrifugation at
1000 x g for 5 min at 40C and the supernatant was transferred to 0.5 ml tubes.
Endo H (5 pI) was added to a final concentration of 50 mU/ml. After overnight
incubation at 370C, 8 •l of reducing sample buffer (0.25 M Tris pH 6.8, 8% (w/v)
SDS, 0.02% (w/v) bromophenol blue, 25% (v/v) glycerol, and 20% (v/v) B-
mercaptoethanol) were added and the samples were boiled for 5 min. SDS gel
electrophoresis (8% polyacrylamide and 3-10% polyacrylamide gradients)
followed by fixation, staining and autoradiography were carried out as
previously described (Kozarsky et al., 1986).
1251-AcLDL and 1251-LDL Degradation Assays -Scavenger receptor and LDL
receptor activities were measured by a ligand degradation assay as described
previously (Krieger, 1983; Freeman et al., 1991) using 5 jig protein/mi of either
1251-AcLDL or 1251-LDL. Assays were performed in triplicate in 6-well dishes
which were prepared as described above. Non-specific degradation was
determined by addition of 400 gg/ml of unlabeled competitor ligands (AcLDL or
polyinosinic acid for the scavenger receptor, and LDL for the LDL receptor) to
one of the three wells. Protein concentrations were determined by the method
of Lowry (Lowry et al., 1951). To improve the sensitivity of the assays of
transfected human LDL receptor activity in the presence of the endogenous
COS cell LDL receptor activity, the endogenous receptor activity was
suppressed, but not completely inhibited, by preincubating the cells with 25-
hydroxycholesterol (1 gg/ml) and cholesterol (10 pg/ml) for 24 hrs (Brown and
Goldstein, 1975). For cell-surface binding assays, cells were prechilled on ice
for 15 min, refed with 20 pg/ml 1251-AcLDL in ice-cold medium A with or without
400 gg/mi unlabeled AcLDL and incubated 2 hr at 40C on a shaker. Cells were
then washed rapidly three times with Tris wash buffer (50 mM Tris-HCI, 0.15 M
NaCI, pH 7.4) containing 2 mg/mi BSA, followed by two 5 min washes, and two
rapid washes with Tris wash buffer without BSA. The cells were solubilized in 1
ml of 0.1 N NaOH for 20 min at room temperature on a shaker, 50 ILl were
removed for protein determination, and the radioactivity in the remainder was
determined using a LKB gamma counter. Degradation activity is expressed as
ng of 1251-AcLDL or 1251-LDL protein degraded in 5 hours per mg of cell protein.
Binding assays with 1251-Clq collagenous tails -Bead binding assays were
conducted at 40C and were based on an assay for soluble scavenger receptor-
binding described by Resnick et al (1992). A mixture consisting of 498 p• Buffer
A (20 mM Tris pH 8.0, 150 mM NaCI, 1 mM CaCI2), 250 pI Buffer B (Buffer A
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supplemented with 2 mg/mi of BSA and 0.01% (w/v) NaN3), and 2 gI1 of 1251-
Clq tails was placed in a 1.5 ml tube. Soluble competitors and 25 gIl of a 50%(v/v) suspension of ligand-coupled Sepharose beads in Buffer A were then
added, along with enough buffer A to bring the total volume to 1 mi. The mixture
was incubated overnight with slow rotation. The beads were then washed twice
with buffer A, and the bead-associated radioactivity was measured. Although
potential degradation of poly C by ribonucleases was not determined in the
experiments shown in Table IV and Figure 6, we have previously found that
poly I and poly G, but not poly C, are resistant to contaminating ribonuclease
activities (A. Pearson, D. Resnick, S. Acton and M. Krieger, unpublished data).
However, when E. Coli ribonuclease inhibitor (40 U/ml, Calbiochem) was
added to the assay buffer, we found that there was no significant degradation of
soluble poly C and that the binding specificities for bead bound and soluble
molecules were the same as those shown in Table IV and Figure 6 (not shown).
The results presented here were determined using one of three independent
preparations of 1251-Clq collagenous tails. The absolute binding activities
varied for the three preparations; however, the ligand specificities remained
essentially the same.
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Results
To test the importance of the scavenger receptor's collagenous domain for
ligand binding, we generated a cDNA expression vector encoding a truncated
form of the bovine scavenger receptor, t-bSR (Fig. 4.1). This vector contains a
frame-shift mutation which converts the codon for Pro295, the 24th of 72
residues in the collagenous domain, to one for Gin295. This is followed by a
codon for the C-terminal Val296 and a stop codon. Thus, while the normal type
II bovine scavenger receptor (bSR-II) is 349 amino acids in length and its
collagenous domain comprises 24 Gly-X-Y repeats (Rohrer et al., 1990), the t-
bSR is 296 residues long and its collagenous domain contains only 8 Gly-X-Y
repeats. An analogous truncated murine mutant (t-mSR, 297 a.a.) with only 5
Gly-X-Y repeats in its collagenous domain was also constructed. Its sequence
is identical to that of the normal type II murine scavenger receptor (mSR-II, 350
a.a.) up to residue 286 (Ashkenas et al., 1992) and terminates with a divergent,
11 residue extension (L-D-K-L-V-H-L-V-L-Q-E-stop). Expression vectors
containing these mutants and their wild-type counterparts were individually
transiently transfected into COS cells. Receptor activity was measured 48 hours
after transfection using an 1251-AcLDL degradation assay (Table 4.1). While
cells transfected with the full-length type II bovine (bSR-II) or murine (mSR-II)
scavenger receptor expression vectors were able to degrade 1251-AcLDL
specifically, cells transfected with expression vectors for the truncated receptors
exhibited no specific receptor-mediated ligand degradation.
To determine if the mutants' inability to mediate 1251-AcLDL degradation was
due to defective binding, we measured the binding of 1251-AcLDL to the cell
surface of transfected cells at 40C. At this temperature, scavenger receptor
mediated endocytosis and degradation of ligands is inhibited (Goldstein et al.,
1979). Table 4.11 shows that cells transfected with vectors encoding the full-
length type II receptors exhibited substantial cell surface 1251-AcLDL binding
while those transfected with vectors for the truncated receptors exhibited only
the background levels of binding observed in control cells. Thus, truncation of
the collagenous domains of the bovine and murine scavenger receptors
abolished their binding activities.
The above result could have been caused directly by disruption or deletion
of the ligand binding sites on the receptors or indirectly as a result of abnormal
synthesis, processing, intracellular transport, cell-surface expression or stability
of the truncated receptors. To characterize the properties of the truncated
bovine receptor, we performed a series of [35S]methionine pulse-chase
metabolic labeling/immunoprecipitation experiments in which the receptors
were visualized by autoradiography after SDS polyacrylamide gel
electrophoresis. In a previous study using stably transfected Chinese hamster
ovary (CHO) cells, we found that the full-length bSR-II was initially synthesized
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as an 176 kDa trimeric precursor comprising somewhat heterogeneous 55 kDa
Endo H sensitive monomers (Penman et al., 1991). The precursors were
processed to Endo H resistant 219 kDa trimeric mature forms composed of 69
kDa monomers during their transport to the cell surface. The synthesis and
processing of [35S]methionine-labeled full-length bSR-II in transiently
transfected COS cells were similar to that seen in CHO cells. For example,
Figure 4.2 (left panel) shows that in transfected COS cells the 0.5 hour pulse-
labeled monomeric, bSR-II precursors ("p") were efficiently converted to mature
forms ("m"). The precursors were Endo H sensitive and were intracellular(resistant to extracellular pronase) while the mature forms were Endo H
resistant and mostly expressed on the cell surface (pronase sensitive) (data not
shown).
Similar results were obtained with the truncated bovine scavenger receptor,
t-bSR. The right panel in Figure 4.2 shows that the amount of synthesis of the t-
bSR precursor ("pt") was similar to that of the full-length bSR-II receptor (0.5 h
pulse, 0 h chase) and that the precursor was post-translationally processed to a
mature form ("mt"). As expected, the apparent masses of the precursor and
mature forms of the truncated mutant were smaller than those of the full-length
bSR-II. The stabilities of the mature forms of the full-length and truncated
receptors were similar up to 24 hours. Figure 4.3 shows that, as was the case
for the full-length receptor, the truncated precursor was Endo H sensitive (lanes
1 and 2) and pronase-resistant (lanes 3 and 4), while the mature form was Endo
H resistant and highly susceptible to pronase digestion. This indicates that the
precursor was intracellular and that most of the mature form was expressed on
the cell-surface. Thus, the truncated receptor followed a post-translational
processing and transport pathway which was strikingly similar to that of the full-
length receptor (Penman et al., 1991) and which is typical for normally folded
integral membrane cell surface glycoproteins. The only significant difference
between the synthesis, post-translational processing and intracellular transport
of the full-length and truncated receptors was that the rate of post-translational
processing of the truncated mutant was somewhat slower than that of the full-
length molecule (Figure 4.2). However, it seems unlikely that this modest
difference could account for the dramatic differences in the ligand-binding
activities of the receptors (Tables I and II).
We have previously shown that bovine scavenger receptors are trimeric and
have suggested that trimerization may play an important role in ligand binding(Kodama et al., 1988; Penman et al., 1991; Resnick et al., 1992; for an
alternative view, see Via et al., 1992). This raised the possibility that truncation
might prevent activity by interfering with trimerization. In stably transfected CHO
cells, the trimeric form of the full-length bSR-II comprises a CysS3-disulfide-
linked dimer noncovalently associated with one monomer (Penman et al.,
1991). When the cells were lysed in detergent for immunoprecipitations in the
absence of a sulfhydryl-trapping reagent, some artifactual interchain disulfides
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at Cys17 in the cytoplasmic domains were formed, crosslinking the receptor into
covalentlU associated trimers (Penman et al., 1991). Figure 4.4 shows
electrophoretic analysis of [35S]methionine-labeled (5 hrs) unreduced full-
length and truncated receptors immunoprecipitated from cells lysed in the
presence (left) or absence (right) of sulfhydryl-trapping reagent iodoacetamide.
The results were virtually identical to our previous findings for full-length
receptors expressed in CHO cells. In the presence of iodoacetamide (lanes 1
and 2), monomers ("10") and dimers ("20") but not trimers of the precursor and
mature forms of both truncated and full-length receptors were observed. In the
absence of iodoacetamide (lanes 3 and 4), reduction-sensitive trimeric ("30")
precursor and mature forms were also observed. In every case, the truncated
species exhibited lower apparent masses than their full-length counterparts.
Thus, for the truncated as well as the full-length receptors, disulfide-linked
dimeric precursors associated noncovalently with monomeric precursors in the
endoplasmic reticulum to form trimers. These trimers were processed normally
to mature forms in the Golgi complex and were subsequently stably expressed
on the cell surface. Taken together, these results indicate that the truncated
receptor was inactive because it does not have the membrane distal portion of
the collagenous domain which is essential for ligand binding.
The self oligomerization of the truncated receptor suggested that this
inactive form might act as a dominant-negative mutant by forming inactive
heterotrimers with full-length receptors when both types of polypeptide were
simultaneously expressed in the same cells. To test this possibility, we
transfected mixtures of the bSR-II and t-bSR expression vectors into COS cells
and measured receptor activity. In the experiment shown in Figure 4.5, the
amount of DNA in each transfection was held constant (10 pg/dish) while the
ratio of bSR-II to t-bSR DNA varied. As a control, the t-bSR DNA in the mixtures
was replaced with the vector pcDNAI lacking a cDNA insert. In the control
mixtures of bSR-II and pcDNAI (Figure 4.5, open squares), the receptor activity
increased linearly with the amount of bSR-II in the transfection mixtures. In
comparison, receptor activity was partially or completely inhibited when plasmid
encoding bSR-II was cotransfected with plasmid encoding t-bSR, even with
ratios of full-length to truncated DNAs of 3:1 (solid squares). The inhibition of
bSR-II activity by the t-bSR plasmid was seen repeatedly in independent
experiments using different amounts and ratios of the vectors. Preliminary
results suggest that cotransfection with the t-bSR expression vector resulted in a
reduction in the amount of full-length receptor precursor (data not shown). This
indicates that there was either a rapid degradation of the full-length polypeptide
chain or a substantial reduction in its rate of synthesis.
To determine if the inhibition of bSR-II activity by the t-bSR plasmid was
specific for scavenger receptors, we compared the effects of cotransfecting the t-
bSR plasmid with expression vectors for either the scavenger receptor or the
human low density lipoprotein receptor (hLDLR). Because COS cells express
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endogenous LDL receptors, it was possible to evaluate the effects of the t-bSR
plasmid on both endogenous and transfected LDL receptor activities. Table III
shows that, as before, cotransfection with the t-bSR plasmid virtually completely
inhibited bSR-II receptor activity. However, it had only a small effect on the
endogenous COS cell and transfected human LDL receptor activities. In other
experiments we observed similar reciprocal small reductions in both LDLR and
bSR-II activities (20-25%) when their expression vectors were cotransfected.
Thus, the minor inhibition of LDL receptor activity by cotransfection with t-bSR
may have been due in part to an intrinsic limitation in the capacity of COS cells
to express transfected gene products simultaneously.
Comparisons of the sequence and binding properties of the scavenger
receptor with those of other proteins containing collagen-like regions previously
led us to suggest that the collagen-like region might play a role in the broad
ligand-binding specificity of the scavenger receptor (Tall et al., 1978; Ross et al.,
1986; Rosenberg et al., 1988; Kodama et al., 1990). For example, Clq has
been shown to bind a variety of substrates including fibrinogen, heparin,
laminin and DNA (Raepple et al., 1976; Hughes-Jones and Gardner, 1978;
Bohnsack et al., 1985; Entwistle and Furcht, 1988; Rosenberg et al., 1988; Jiang
et al., 1991). To determine if the collagenous region of another protein might
exhibit ligand binding specificities similar to those of the scavenger receptor, we
examined the binding properties of the collagenous, or "tail", domain of
complement component Clq ("Clq tails") (Guan et al., 1991). The ability of Clq
tails to bind directly to several ligands of the scavenger receptor was
determined (Table 4.4). In these direct, solid-phase binding studies, Sepharose
beads covalently cross-linked to four different polyanionic molecules were
tested for their ability to bind to 1251-Clq tails. Clq tails bound efficiently to
beads carrying the polyribonucleotides poly I and poly G, and less efficiently to
maleylated BSA (M-BSA) beads, but did not bind poly C beads. We have
reported similar results for the binding of detergent solubilized bovine lung
scavenger receptors (Kodama et al., 1988) and soluble forms of the bovine
scavenger receptors (Resnick et al., 1992) to polyribonucleotide beads. Thus,
the collagenous tails of Clq appeared to have a ligand-binding specificity
similar to that of scavenger receptors (Brown and Goldstein, 1983).
To more thoroughly compare the binding specificities of Clq tails and
scavenger receptors, we determined the capacity of a larger panel of ligands to
inhibit the binding of 1251-Clq tails to M-BSA beads (Figure 4.6). A variety of
molecules previously shown to inhibit AcLDL binding to scavenger receptors(shaded bars) and some of their corresponding negative controls which do not
inhibit scavenger receptors (hatched bars) were tested. The scavenger
receptor competitors poly G, poly I, the sulfated polysaccharides fucoidin and
dextran sulfate, and M-BSA all inhibited binding of 1251-Clq tails to the M-BSA
beads. The ID50so values for poly I and poly G were determined to be in the
range of 10-25 ng/ml in this assay when approximately 34 igg of M-BSA coupled
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to the beads was used (data not shown). Poly G and poly I bound more tightly
to 1251-Clq tails (Table 4.IV) than to either membrane bound or soluble
scavenger receptors (Pearson et al., 1992, Resnick et al., 1992). Unlike the
other scavenger receptor ligands, AcLDL, the prototypical scavenger receptor
ligand, did not compete for 1251-Clq tail binding to M-BSA beads (see
discussion below). The scavenger receptor negative controls chondroitin
sulfate, native LDL and poly C did not block 1251-Clq tail binding to M-BSA
beads. A high concentration of native BSA (500 gg/ml) was maintained
throughout the binding assay to stabilize the 1251-Clq tails. Thus, native BSA,
unlike M-BSA, did not inhibit the binding detected in these experiments. These
results show that the collagenous tail domain of Clq exhibited a broad binding
specificity similar, but not identical, to that of scavenger receptors. Together
with the results using the t-bSR mutant, these experiments suggest that the
collagenous domain of the scavenger receptor is necessary, and may be
sufficient, to determine the broad binding specificity which characterizes this
unusual receptor.
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Discussion
One of the most distinctive features of scavenger receptors is their broad
ligand binding specificity (Brown and Goldstein, 1-983; Krieger, 1992). Typical
cell surface receptors, such as the LDL or EGF receptors, bind their ligands with
high affinity and great specificity. Macrophage scavenger receptors also bind
ligands with high affinity; however, they bind an extraordinarily wide variety of
ligands. Their ligands include modified proteins such as acetylated LDL
(AcLDL) and maleylated bovine serum albumin (M-BSA), but not native LDL or
native BSA, certain polyribonucleotides (poly I and poly G but not poly C), and
certain polysaccharides (dextran sulfate but not chondroitin sulfate),
phospholipids, polyvinyl sulphate, and bacterial lipopolysaccharide (Brown and
Goldstein, 1983; Nishikawa et al., 1990; Hampton et al., 1991). The only
common feature of scavenger receptor ligands recognized to date is that they
are polyanionic macromolecules or complexes; however, many polyanions fail
to act as ligands.
We have previously suggested that the receptor's collagenous domain may
play a crucial role in ligand binding and receptor function (Kodama et al., 1990;
Rohrer et al., 1990) To test this hypothesis, we generated frameshift mutations
in the cDNAs for the bovine and murine type II scavenger receptors which result
in the premature termination of the proteins within the collagenous domains.
These bovine and murine truncation mutants, which contain only the N-terminal
8 of 24 (bovine) or 5 of 24 (murine) Gly-X-Y triplet repeats, exhibited no ligand-
binding activity when they were transiently expressed in COS cells. Metabolic
labeling/immunoprecipitation experiments established that the synthesis, post-
translational processing, oligomerization, cell-surface expression, and stability
of the truncated bovine scavenger receptor were essentially identical to those of
the full-length bovine type II scavenger receptor. Since the truncation of the
bovine scavenger receptor did not prevent its assembly into trimers, this
suggests that only little (8 Gly-X-Y triplets), if any, of the collagenous domain is
required for trimerization and raises the possibility that the other domains of the
receptor, especially the alpha-helical coiled-coil domain, trimerize
independently of the collagenous domain. The rate of processing of the
truncated receptor was somewhat slower than that of the full-length type II
receptor; however, this apparently minor difference seems unlikely to be
responsible for the complete inactivity of the truncated receptor. Kodama, Doi
and colleagues have independently analyzed similar truncation mutants and
point mutants and found that positively charged residues in the 22 C-terminal
amino acids of the collagenous domain are required for ligand binding
(Kodama et al., 1991, Doi et al., 1993).
To determine indirectly if the collagenous domain might be sufficient to
account for the broad binding specificity of the receptor, we examined the
binding of scavenger receptor ligands and their negative controls to the
collagenous N-terminal tails of complement component Clq. Clq is a complex
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heterooligomeric molecule. The individual ClqA, C1qB and C1qC polypeptide
chains assemble into [AB]2C2 hexamers creating two collagenous tails. Each
collagenous tail is composed of two short segments of Gly-X-Y triplets, and
each has a globular domain at its C-terminus (Reid, 1982). Three [AB]2C2
hexamers associate into the complete Clq molecule, whose ultrastructure
resembles a bouquet of tulips with bent collagenous stems (the tails) and
globular flowers (Reid, 1982; Loos, 1983). The ClqA subunit contains a cluster
of positively charged residues at the N-terminus of the collagenous region that
has been shown to bind DNA and heparin (Jiang et al., 1992). The scavenger
receptor also has a conserved, highly positively charged region at the C-
terminus of its collagenous domain (Ashkenas et al., 1992). In a series of
binding and competition assays, we observed that Clq tails exhibited a broad
binding specificity for polyanions which was strikingly similar, but not identical,
to that of the scavenger receptors. The binding of Clq to polyanions, some of
which include known scavenger receptor ligands, has been reported previously
(Raepple et al., 1976; Hughes-Jones and Gardner, 1978; Bohnsack et al., 1985;
Entwistle and Furcht, 1988; Rosenberg et al., 1988; Jiang et al., 1991); however,
the similarity of the binding specificities of the Clq collagenous region and
scavenger receptors has not been previously considered in detail. The current
results suggest that the collagenous region of the scavenger receptor is not only
necessary, but may also be sufficient, for establishing the characteristic broad
binding specificity of the scavenger receptor.
The most notable difference between the specificities of the Clq tail and the
scavenger receptors observed in the current studies was that AcLDL, the
prototypical high-affinity ligand of the scavenger receptor, did not inhibit the
binding of Clq tails to M-BSA beads. AcLDL does inhibit the binding of soluble
scavenger receptors to M-BSA beads (Resnick et al., 1992). Thus, while a
collagen triple helix containing multiple positively charged residues can exhibit
broad polyanionic ligand binding properties similar to those of scavenger
receptors, the detailed binding characteristics will almost certainly depend on
the particular amino acid sequence of the Gly-X-Y triplets, and perhaps will also
depend on the higher order oligomeric structure of the collagenous domains. It
is also possible that other domains of the scavenger receptor, especially the
adjacent coiled-coil and SRCR domains, may either directly or indirectly
modulate the receptors' ligand specificity (e.g., see Penman and Krieger,
1992).
The importance of the full-length collagenous domain for the function, but
not the oligomerization, of scavenger receptors suggested that truncated
receptor subunits might act as dominant negative mutants by assembling into
nonfunctional heterotrimeric complexes with full-length receptor subunits. The
expression vector encoding the truncated bovine scavenger receptor mutant did
specifically abolish scavenger receptor function when it was cotransfected with
an expression vector for the full-length bovine type II receptor. It is possible that
this dominant negative effect, although receptor-specific, may be a
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consequence of cell-type specific properties of the transient COS cell
transfection system used. Further studies will be required to determine whether
this construct will be useful for stably reducing scavenger receptor levels in
macrophages in vitro and in vivo.
Collagenous domains are present in several mammalian proteins,
including scavenger receptors, complement component Clq, mannan binding
protein, lung surfactant apoprotein and conglutinin (Drickamer et al., 1986; Voss
et al., 1988; Thiel and Reid, 1989). All of these proteins are thought to be
involved in clearing the extracellular space of debris, including pathogenic
material. Organisms may have employed collagenous regions in some of their
proteins to perform rudimentary host-defense functions, possibly before the
development of the humoral immune system. The binding activities and
functions of these proteins may have been expanded and/or refined by
variations in the sequences of the collagenous domains and by the addition of
other functional domains. For example, the globular heads on the collagenous
stalks of the mannan binding protein are C-type lectin domains which bind
molecules with exposed mannose/N-acetyl-D-glucosamine residues, including
yeast mannans and virulent gram-negative bacteria (Drickamer et al., 1986;
Ezekowitz et al., 1991). The globular heads of Clq bind to antibodies engaged
by their antigens. The functions of the presumably globular SRCR domains on
the collagenous stalk of the type I scavenger receptor have not yet been
defined. Thus, analysis of the structure and function of these and other proteins
suggests that, in addition to the set of collagenous proteins which form the
extracellular matrix, there is a distinct set of proteins containing short
collagenous triple helical domains which participate in host defense.
Acknowledgements - We thank Dr. Andrea Tenner for the generous gift of 1251.
labeled Clq tails, Dr. Douglas Buechter for critical comments, and Lorna
Andersson for technical assistance. We also thank Julia Khorana for help with
preparation of the figures.
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Figure 4.1. Domain structures of the full-length (bSR-II) and truncated (t-bSR)
bovine type II scavenger receptors
The domain structure of the type II scavenger receptor (top) was deduced
from its cDNA sequence (Rohrer et al., 1990). The N-terminal cytoplasmic tail
(Cyto.) is followed by a single transmembrane domain (TM), a spacer domain(Spacer), an alpha-helical coiled-coil domain (Coiled-coil), a collagenous
domain (Collagen, shaded), and a six amino acid C-terminal domain. The
mutant t-bSR is truncated in its collagenous domain such that it contains only 8
of the 24 Gly-X-Y tripeptide repeats which are normally present.
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Figure 4.2. Biosynthesis, processing, and stability of full-length and truncated
type II bovine scavenger receptors expressed in transiently transfected COS
cells
Expression vectors containing either the full-length (bSR-II, left) or
truncated (t-bSR, right) bovine type II scavenger receptors were transiently
transfected into COS cells (10 •tg/100 mm plate) on day 1 and the cells were
replated on day 2 into 6-well dishes at 1 x 106 cells/well. On day 3, the cells
were pulse-labeled with [35S]methionine for 30 min and chased in medium A
containing 1 mM unlabeled methionine for the indicated times. After cell lysis,
scavenger receptors were immunoprecipitated, reduced, subjected to
electrophoresis in an 8% SDS-polyacrylamide gel, and visualized by
autoradiography as described in Materials and Methods ('p' and 'Pt' denote
precursors of wild-type and truncated receptors, respectively; 'm' and 'mt'
denote mature forms of wild-type and truncated receptors, respectively).
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Figure 4.3. Endoglycosidase H- and pronase-sensitivities of truncated bovine
scavenger receptors in transiently transfected COS cells
The expression vector for the truncation mutant (t-bSR) was transiently
transfected into COS cells (10 gg/100 mm plate) on day 1 and the cells were
replated on day 2 into 6-well dishes at 1 x 106 cells/well. On day 3 the cells
were pulse-labeled for 30 min with [35S]methionine and chased in medium A
containing 1 mM unlabeled methionine for 2 hrs. Some of the cells were then
incubated with or without pronase (lanes 3 and 4) as described in Materials and
Methods. All of the monolayers were lysed and the truncated scavenger
receptors were immunoprecipitated, reduced, subjected to electrophoresis in an
8% SDS-polyacrylamide gel, and visualized by autoradiography as described
in Materials and Methods. For endoglycosidase H (Endo H) treatment (lanes 1
and 2), immunoprecipitated protein was incubated with Endo H or control buffer
overnight at 370C, prior to electrophoresis and autoradiography.
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Figure 4.4. Oligomerization of full-length and truncated type II bovine
scavenger receptors in transiently transfected COS cells
COS cells were transiently transfected with 10 igg/100 mm dish of either
the bSR-II or t-bSR expression vectors on day 1, replated at 1 x 106 cells/well in
6-well dishes on day 2, and metabolically labeled for 5 hrs with 100 ACi/ml of
[35S]protein labeling mix (New England Nuclear) on day 3. Cells were lysed
either in the presence or absence of 10 mM iodoacetamide as indicated.
Lysates were then immunoprecipitated, and, without reduction, were subjected
to 3-10% gradient SDS-polyacrylamide gel electrophoresis, and the receptors
were visualized by autoradiography. ('pt' and 'mt' denote precursor and mature
forms of the truncated receptor, and '1O', '20' and '30' denote monomers, dimers,
and trimers, respectively)
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Figure 4.5. Effects of the cotransfection of control and t-bSR expression vectors
on the scavenger receptor activity of bSR-II transfected COS cells
On day 1, the indicated amounts of the expression vector for bSR-II were
cotransfected with the indicated amounts of either a control vector without a
cDNA insert (open squares) or the t-bSR expression vector (solid squares). The
cells were replated in 6-well dishes (1 x 106 cells/well) on day 2, and then
scavenger receptor activity was measured using an 1251-AcLDL degradation
assay on day 3 as described in Materials and Methods.
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Figure 4.6. Effects of soluble competitors on the binding of 1251-Clq
collagenous tails to M-BSA Sepharose beads
The average values for the binding of 1251-Clq collagenous tails to M-
BSA Sepharose beads was determined after incubating duplicate specimens
overnight at 40 C in buffers containing no additions (control, solid bar) or the
indicated scavenger receptor competitors (shaded bars) or negative controls
(hatched bars) as described in Materials and Methods. The poly G, poly I,
fucoidin, dextran sulfate, chondroitin sulfate, and poly C concentrations were 10
gg/ml while the concentrations of M-BSA, AcLDL, and LDL were 400 gg
protein/mi. The 100% of control value was 2020 cpm and represented 12% of
the total 1251-Clq collagenous tails included in the incubations.
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Table 4.1. Activities of full-length and truncated type II bovine and murine
scavenger receptors in COS cells
transfected scavenger receptor 1251-AcLDL degradation(ng/5 hr/mg protein)
bSR-II (full-length bovine type II) 275
t-bSR (truncated bovine type II) 0
mSR-II (full-length mouse type II) 268
t-mSR (truncated mouse type II) 0
none 7
COS cells in 100 mm dishes were transiently transfected on
day 1 with 10 gig of plasmid pcDNAI with one of the indicated
cDNAs inserted into the expression site. The cells were
replated on day 2 into 6-well dishes at 1 x 106 cells/well in
triplicate and receptor activity was assayed on day 3 using an
1251-AcLDL degradation assay as described in Materials and
Methods. The values represent averages of duplicate
determinations corrected for nonspecific activity (single
determinations).
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Table 4.2. Cell-surface binding of 1251-AcLDL at 40C by COS
cells transfected with expression vectors for the full-length and
truncated type II bovine and murine scavenger receptors
transfected scavenger receptor 1251-AcLDL bindin
(ng/mg protein)
bSR-II 66
t-bSR 8
mSR-II 109
t-mSR 9
none 8
COS cells in 100 mm dishes were transiently transfected on
day 1 with 8 Igg of plasmid pcDNAI with one of the indicated
cDNAs inserted into the expression site. The cells were
replated on day 2 into 6-well dishes at 1 x 106 cells/well and
assayed on day 3 for 1251-AcLDL binding activity (20 jlg
protein/mi) at 40C as described in Materials and Methods.
The values represent averages of duplicate determinations
corrected for nonspecific activity (single determinations).
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Table 4.3. Effects of expression of the truncated scavenger receptor on the
activities of the full-length bovine scavenger receptor and the endogenous and
transfected human LDL receptors
Cotransfected Receptor
bSR-II
None*
hLDLR**
Ligand
1251-AcLDL
1251-LDL1251-LDL
ligand degradation(ng/5 hr/mg)
+control vector + t-bSR
179 8
130 117
417 323
Inhibition by
t-bSR
(%)
96
10
23
*Endogenous LDL receptor activity measured
**Endogenous LDL receptor plus transfected human LDL receptor activity
measured
COS cells in each 100 mm dish were transiently transfected on day 1 with 3 jg
of the indicated cotransfected receptor vectors and 5 jig of either the control
vector without a cDNA insert or the expression vector for t-bSR. The cells were
replated at 1 x 106 cells/well in 6-well dishes on day 2, and then assayed for
1251-AcLDL or 1251-LDL degradation activity on day 3. For 1251-LDL
degradation assays, cells were preincubated with 25-hydroxycholesterol (1
•ig/ml) plus cholesterol (10 gig/ml) for 24 hours prior to the assay as described in
Materials and Methods.
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Table 4.4. Binding of 1251 -Clq
collagenous tails to ligands
coupled to Sepharose beads
1251 
-Clq
Ligand tails Bound(% of total)
Poly I 103.5%
Poly G 81.6%
M-BSA 28.2%
Poly C 3.5%
The binding at 40C of 1251-Clq
collagenous tails to the indicated
ligands coupled to Sepharose
beads was determined as
described in Materials and
Methods. Total counts of 1251-Clq
collagenous tails used in each
incubation was 14,500 cpm.
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Chapter 5
The SRCR Superfamily: A collection of host-defense
related proteins reminiscent of the immunoglobulin
superfamily
-- page 115 --
The function of the SRCR domain on the type I receptor has been a
mystery since the initial cloning of the receptor. It has little effect on the ability of
the scavenger receptor to bind its polyanionic ligands, as the type II receptor(lacking this domain) has essentially identical ligand binding properties
(Kodama et al., 1990; Rohrer et al., 1990; Ashkenas et al., 1993). In the course
of doing periodic searches of the Genbank database for proteins homologous to
the SR-A, I noticed that novel SRCR domain containing proteins were
appearing at an increasing rate. This chapter contains a review of the
scavenger receptor cysteine rich (SRCR) superfamily. This work was published
in its entirety in 1994 in Trends in Biochemical Sciences 19, 5-8. After the
publication of this work, I discovered that we had incorrectly aligned CD6
domain 1, resulting in the loss of a cysteine. Several typographical errors in the
published version were also corrected prior to inclusion in this thesis, and all
citations have been merged into the "references" section of this thesis.
There have been several significant advances in our knowledge of the
SRCR domains since the publication of this review. These include the
identification of 5 new superfamily members and the discovery of a ligand for
CD6. I have summarized many of these findings in appendix B. A map of the
disulfide bonding pattern of the SR-Al SRCR domain was determined using
proteolytic mapping and HPLC separation of fragments. This work is included
in chapter 6 of this thesis. Additional studies are presented in appendix C on
progress in efforts to determine the high resolution structure of a single SRCR
domain.
I generated the sequence alignment and wrote the initial draft of this
review. Alan Pearson noticed the internal repeat in the WC1 and M130, and
both Alan and Dr. Monty Krieger provided assistance with finalizing the
sequence alignment and the editing and revising of the manuscript.
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Analysis of the cysteine-rich domain in the type I macrophage scavenger
receptor (SRCR domain) has helped define an ancient and highly conserved
motif. Single and multiple tandem SRCR domains appear in a number of
secreted and integral membrane proteins associated with cell surface
recognition and host defense.
Many proteins are molecular mosaics composed of a wide variety of
conserved sequence motifs which encode structurally distinct domains(Doolittle, 1985). In many cases, these motifs are characterized by short,
disulfide stabilized domains present in the extracellular portions of membrane
proteins and in secreted proteins (Doolittle, 1985; Krieger, 1986). Examples
include the immunoglobulin repeat (Hunkapiller and Hood, 1989; Williams and
Barclan, 1988), kringle domains, epidermal growth factor (EGF)-like repeats,
complement C9/LDL receptor domains, Ly-6 repeats (Williams, 1991; Palfree,
1991) and the P-domain (Hoffman and Hauser, 1993). These protein domains
are well suited for a variety of biochemical tasks, including ligand binding, and
are readily combined with themselves or with other types of domains for the
construction of complex mosaic proteins. Numerous proteins containing as few
as one and as many as 36 copies of any one single type of domain have been
reported (Wharton et al., 1985; McLean et al., 1987).
One ancient and highly conserved family of cysteine-rich protein
domains was recognized during the analysis of the structure of the type I
macrophage scavenger receptor (Freeman et al., 1990; Krieger, 1992). This
class of domain, designated SRCR (1cavenger receptor cysteine-rich) domain,
was initially defined by the presence of one to four copies per polypeptide chain
of an approximately 101 amino acid long motif in the type I scavenger receptor,
the speract receptor, CD5/Lyl and complement factor I (CFI) (total of 13
sequences, including 9 independent sequences and 4 sequences of homologs
from different species). The recent cloning of genes encoding 24 additional,
independent SRCR domains, and 10 additional homologs, has allowed us to
revise our initial description of the consensus SRCR domain and to define two
distinct subgroups. The recently available sequences, which were identified
using the programs BLASTN and TBLASTN (Altschul et al., 1990), are those of
CD6 (Aruffo et al., 1991), the cyclophilin C binding protein (Friedman et al.,
1993) and its homolog the MAC2-binding protein (Koths et al., 1993)(CyCAP/MAC2-BP), the WC1 antigen (Wijngaard et al., 1992), M130 (Law et al.,
1993), a new CFI homolog (Muglia et al., 1991), and two new homologs each of
CD5/Lyl (Yu et al., 1990; Murakami and Matsuura, 1992) and the scavenger
receptor (Matsumoto et al., 1990; Bickel and Freeman, 1992). Thus, the
superfamily of SRCR domain containing proteins includes 8 different members
derived from five mammalian (human, bovine, murine, rat and rabbit), one
amphibian (Xenopus laevus) and one invertebrate (sea urchin) species (Table
5.1). The sequences of the SRCR domains are shown in Figure 5.1.
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An alignment of all 33 independent SRCR domains (total of 47
sequences) is shown in Figure 5.1. Positions at which there is greater than
50% sequence identity are shaded. We have divided the SRCR superfamily
into two groups, A and B, based primarily on the differences in the spacing
pattern between their cysteine residues (Figure 5.2). All of the group A domains
contain six cysteines, while most of those in group B have eight cysteines.
Although several members of group B contain only six (WC1-1, M130-8, CD5-2,
and bovine CD5-1) or seven (CD6-1) cysteines, the presence of cysteines at the
C1 and C4 positions and other sequence features clearly suggest that they are
members of group B.
Independent consensus sequences for groups A and B, as well as a
combined overall consensus sequence, are shown at the top of Figure 5.1. The
overall consensus sequence includes residues at 41 out of 101 possible
positions. The principle differences between the group A and B sequences are:
1) cysteines are not present at sites C1 and C4 in group A, aromatic residues
almost invariably replace the C4 cysteines, and 2) group B contains a
conserved glycine adjacent to the C4 position and a moderately well conserved
tryptophan two residues before position C6 which are not found in group A.
The sequences of the SRCR domains in CFI and CD5, particularly the
CD5-2 domains, are the least well conserved members of the superfamily, and
are responsible for much of the gapping seen in the alignment (Figure 5.1). In
the case of CD5-2, although the N-terminal half of this SRCR domain clearly
conforms to the consensus sequence, most of the residues in the C-terminal
half of the domain differ substantially from the consensus (Figure 5.1). Because
the CFI and CD5 sequences played important roles in the initial analysis of the
SRCR domain (Freeman et al., 1990), the alignment of sequences and the
definition of the SRCR consensus shown in Figure 5.1 differs from those
proposed previously.
All but one of the 33 independent SRCR domains have six or eight
cysteines. Analysis of the structure of the type I macrophage scavenger
receptor (Penman et al., 1991) suggests that some, and possibly all, of its SRCR
domain's cysteines participate in intradomain disulfide bonds. Furthermore, the
cysteines in CyCAP/MAC2-BP do not participate in intermolecular disulfide
bonds (Friedman et al., 1993; Koths et al., 1993). Based on the known
structures of other cysteine-containing domains (e.g., immunoglobulin, kringle,
Ly-6 repeat, P-domain), we assume that in most SRCR domains the conserved
cysteines participate in intradomain disulfide bonds. The pattern of cysteine
pairing into disulfides has not been established experimentally; however,
sequence analysis suggests two likely disulfide pairs. The cysteines at
positions C1 and C4 in group B domains may be disulfide bonded, because
this pair of cysteines is always present in group B but not in group A (Figure
5.2). A similar argument suggests that the cysteines at positions C2 and C7
form a disulfide bond. These cysteines are present in the human, murine, and
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rat CD5-1 domains but not in their bovine counterpart. This pair of cysteines is
also absent in WC1-1 and M130-8. On the other hand, in CFI, WC1-2, and
WC1-7, only one member of this pair is present; the other is apparently
substituted by a cysteine at a different site. If these proposed C1-C4 and C2-C7
pairs are correct, the remaining two potential disulfide pairs are either Cs-
C5/C6-C8, C3-C6/C5-C8, or C3-C8/C5-C6. It is important to note, however, that
not all of the cysteines need participate in intradomain disulfide bonds, as is
clearly the case for at least one of the seven cysteines in CD6-1.
A schematic representation of the known SRCR domain containing
proteins is shown in Figure 5.3. All of the members of this group are cell surface
or secreted polypeptides containing between 1 and 11 SRCR domains. Other
than the scavenger receptor trimer (Penman et al., 1991), the oligomeric states
of these proteins are unknown; although MAC2-BP forms a large multimer
(Koths et al., 1993). Proteins containing multiple SRCR domains in a single
polypeptide chain have short interdomain spacers whose median length is 6
residues. Our dendrigraphic (Devereux et al., 1984) and visual analysis of two
such proteins, WC1 and M130, revealed an interesting higher order repeat,
which had previously been identified as an internal repeat in WC1 at the DNA
sequence level (Wijngaard et al., 1992) and was independently identified in a
somewhat different form by Law and colleagues (Law et al., 1993). This repeat
is defined by a cassette of four SRCR domains, designated [b-c-d-e]. The N-to-
C terminal ordering of the SRCR domains in WC1 and M130 can be
represented as follows: WC1 (domains 1-11), a-[b-c-d-e]-d-[b-c-d-e]-f; and
M130 (domains 1-9), h-i-j-k-[b-c-d-e]-l. The [b-c-d-e] cassette contains an
unusually long, well conserved, 35 residue spacer between the c and d
domains and appears three times in highly conserved, but not identical, forms:
twice in WC1 and once in M130. Apparently, WC1 and M130 are derived from
a common cassette-bearing ancestor. This cassette may impart some common
function to these integral membrane proteins.
The biochemical functions of SRCR domains have not been established
with certainty; however, it seems possible that most, if not all, of these domains
are involved with binding to other cell surface or extracellular molecules. In the
case of the speract receptor, the SRCR domains compose 91% of the
extracellular portion of the molecule, and thus probably mediate the binding of
its ligand, the sperm activating peptide speract (Dangott et al., 1989). Similarly,
the SRCR domains compose most of CD5's extracellular sequence, and
probably define the binding site for CD72, the only known ligand for CD5 (Van
de Velde et al., 1991). The C-terminal SRCR domain of the type I macrophage
scavenger receptor is not required for the protein's assembly, intracellular
transport, cell surface expression or binding of its known polyanionic ligands; a
second natural isoform of the scavenger receptor, type II, is virtually identical to
the type I receptor except that it does not have the C-terminal SRCR domain
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(Krieger, 1992). Thus, in scavenger receptors, the SRCR domain may impart an
additional, but as yet undefined, binding capacity.
All of the known mammalian SRCR domain-containing proteins are
expressed on the surfaces of cells associated with the immune system and host
defense functions (T-cells, B-cells, macrophages) or are secreted and known or
suspected of being involved with host defense (CFI, CyCAP/MAC2-BP). This is
strikingly reminiscent of the immunoglobulin superfamily of cysteine containing
protein domains. Single or multiple tandem copies of immunoglobulin domains
also appear in diverse secreted and membrane associated proteins. These
domains participate in a variety of binding interactions which play critical roles
in host defense (Hunkapiller and Hood, 1989; Williams and Barclay, 1988).
Additional studies will be required to determine the detailed molecular
structures of SRCR domains and their functions.
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Table 5.1. Proteins containing SRCR domains a
Number of
SRCR
domains per
Protein (abbr.) chain Source Functions Location
Macrophage
scavenger receptor,
type I (MSR)
Cyclophilin C(CyCAP) or MAC2
binding protein(MAC2-bp)
Speract receptor(SperactR)
Complement factor I
(CFI)
Mammalian
macrophages
Murine bone marrow
stromal cell line,
murine macrophages,
and human breast
carcinoma cells
Sea urchin sperm
Mammalian and
amphibian plasma
Binding and
endocytosis of
diverse ligands
Binds cyclophilin
C and MAC2, a
lactose/galactose
specific lectin
Binds speract, a
sperm-activating
peptide
Protease,
regulation of the
complement
cascade
Cell surface
Secreted fluids, e.g.
breast milk, tears,
plasma
Cell surface
Secreted into the
plasma
11 Mammalian CD4-,
CD8-, yS T cells
Human macroDhaaes
Mammalian T cells and
some specialized B
cells
Unknown
Unknown
Unknown
Mammalian T cells and
some specialized B
cells
Binds CD72, a B-
cell surface
protein
aAdapted from Krieger, 1995
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Figure 5.1. Comparison of the sequences of 47 SRCR domains from 8 proteins.
The sequences were aligned using both the program PILEUP (24) and
manual adjustment. Only 33 of the 47 SRCR sequences listed represent
independent SRCR domains, the remaining sequences are homologs from
other species (e.g., four species of scavenger receptor, two species of CFI, etc.).
Residues are shaded when at least 17/33 independent sites are identical (when
there are four homologs, each sequence contributed .25 to the total count; for
two homologs, each sequenced contributed .5 to the total). Consensus sites
are indicated in the top row (Overall consensus) when _22.25 of the 33
positions are occupied by a single amino acid (capital letter) or a single class of
residue (a, aliphatic (A, I, L, V); x, aromatic (F, W, Y); h, hydrophobic (a, X, M); +,
positively charged (H, K, R); -, negatively charged (D, E); ±, charged (-, +); o, S
or T). Consensus sequences for Group A domains (>4.75/7 sites) and Group B
domains (217.5/26 sites) are also shown. In addition, the consensus cysteine
positions are identified by number. For multiple SRCR domains in individual
proteins, the domains are numbered from the amino terminus. Abbreviations
used are as follows: MSR, macrophage scavenger receptor ; CyCAP,
cyclophilin C associated protein; MAC2bp, MAC2 binding protein; SperactR,
speract receptor; CFI, complement factor I; and WC1, WC1 antigen. In the
cases where multiple species homologs are presented, the following
abbreviations for species designation are used: b, bovine; h, human; m, murine;
r, rat; I, rabbit (lapin); and x, Xenopus laevus.
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Figure 5.2. Consensus spacing of cysteines based on the alignment in part A
The average number of residues between the cysteines is indicated.
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Consensus Spacing of Cysteines in SRCR Domain Subtypes
Group A 25 12
Group B 9 15 12 4
i 9 9 9 1• i
25 9 9 9 -91
_ _ __ _ __ ___
lammullmmlm=
i
Figure 5.3. Models of proteins in the SRCR domain superfamily
Models illustrating the number and relative positions of SRCR domains(semicircles) in eight proteins are shown, with the names and sources of each
protein indicated. Also shown are the numbers of cysteines in each domain.
-- page 127 --
Members of the SRCR Domain Superfamily
Proteins Containing Group A Domains
I I
Proteins Containing
I
Group B Domains
NH 2
COOH
S
NH2
-' IMM
NH 2
(U01H
Scavenger CyCAP/ Speract Complement WC1 M130 CD6 CD5Receptor, Type I MAC2-BP Receptor Factor I Antigen
Mammalian T cellsMammalian Secreted Sea urchin Mammalian and Mammalian CD4", Human a alian  cells
macrophages fluids sperm amphibian plasma CD8", y8 T-cells macrophages and some types
IIof B-cells
Im
I
OV VI I
Chapter 6
Biochemical, spectroscopic and electron microscopic
analysis of the structures of the human class A
macrophage scavenger receptors
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The preceding chapters have begun to address some structural
questions about the scavenger receptor, including the determination of its
oligomeric state and generally extended shape, and the identification of its
ligand binding domain. However much of the structural model of the scavenger
receptor presented in the introduction (diagrammed in Figure 1.1) remains
unproven. This chapter contains a series of experiments aimed at testing this
model, and at further refining it. In particular, it asks the following questions: 1)
does the collagenous sequence contain modified residues associated with
collagenous structure; 2) is the gross level of a-helix in the protein consistent
with the proposed structure of the coiled-coil domain; and 3) what is the
disulfide bonding pattern in the SRCR domain. It also examines the question of
pH dependence of receptor structure, in particular with regard to a previously
proposed mechanism of pH dependent ligand release. Finally, it begins to
address the question of overall receptor structure by using two electron
microscopic imaging techniques to visualize individual type I and II receptor
molecules.
This chapter is a draft of a manuscript which, when completed, will be
submitted to The Journal of Biological Chemistry. There remains an unresolved
question with regard to the interpretation of the electron microscopic images of
the SRs. Different conformations of the receptor have been observed at low
and high pH by rotary shadowed EM. Efforts are being made to reproduce this
effect with negative stain EM, and to also see whether hydrodynamic data
supports such an alteration of structure. The basis for this observation and its
significance remain unclear.
I carried out most of the experiments presented in this chapter. The
expression constructs for the secreted receptors were generated by Dr. Karen
Schwartz, as was the amplified cell line expressing the type II receptor.
Shangzhe Xu produced the amplified type I expressing cell line, and provided
assistance with tissue culture. Drs. Henry Slater and John Chatterton
performed the electron microscopy using purified receptor that I provided. I
wrote the initial draft of the paper, and edited and revised it with input from both
Dr. Monty Krieger and Dr. Chatterton.
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Abstract
Type I and type II class A macrophage scavenger receptors (SR-AI and SR-
All) have been implicated in the development of atherosclerosis and other
macrophage-mediated processes. They are predicted to be highly elongated
trimers, containing fibrous a-helical coiled-coil and collagenous triple helical
domains. The SR-Al trimer also includes three SRCR (Scavenger Leceptor
Eysteine-bich) domains, each presumably containing three intramolecular
disulfides. Transfected Chinese hamster ovary cells expressing secreted forms
of the human receptors (s-hSR-AI and s-hSR-AII) were generated, and their
highly purified products were used for biochemical and biophysical analysis of
these receptors' structures. The pattern of the three intramolecular disulfide
bonds in the SRCR domain of SR-A (Cys2-Cys7 , Cys3-Cys", CysS-Cys6) was
determined using proteolytic analysis. Both s-hSR-Al and s-hSR-All contain
significant amounts of hydroxylated lysine and proline, modified amino acids
characteristic of proteins with collagenous triple helices. Circular dichroism
(CD) studies revealed that both isoforms of the receptor contain amounts of a-
helix consistent with the predicted model, that much of the secondary structure
is identical at pH 7.4 and 5.7, and that the stabilities of the a-helices are greater
at the lower pH (apparent Tins for both were 640C (pH 7.4) and 740C (pH 5.7)).
Thus, the dissociation of ligands from these receptors at low pH is unlikely to be
a consequence of major structural disruptions in the a-helical domain. Both
metal shadowing and negative staining techniques were used for the electron
microscopic visualization of these elongated molecules. The negative-stained
molecules ( -440 A long) are composed of two rod-like segments (collagenous
and a-helical coiled-coil domains, -200 A each) connected by a flexible hinge.
In s-hSR-AI, the SRCR domains were identified as distinct globular structures at
the end of the collagenous domains. These studies have confirmed the
previously predicted structural models for the class A scavenger receptors.
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Introduction
Three structurally distinct classes of modified lipoprotein-binding scavenger
receptors have been identified to date. These include the class A (SR-A), class
B (SR-B), and class C (SR-C) receptors (Krieger and Herz, 1994; Elomaa et al.,
1995; Endemann et al., 1993; Acton et al., 1994; Pearson et al., 1995). In
addition, macrosialin has recently been shown to be an oxidized LDL binding
protein (Ramprasad et al., 1995). Class A macrophage scavenger receptors
are trimeric integral membrane glycoproteins which exhibit unusual ligand
binding properties (Krieger and Herz, 1994). They bind a diverse array of
macromolecules or macromolecular complexes, whose only common property
is that they are polyanionic. These ligands include modified lipoproteins
(acetylated or oxidized LDL), bacterial surface lipids (endotoxin and lipoteichoic
acid), certain polynucleotides (poly(G) and poly(l), but not poly(C)), and some
sulfated polysaccharides (fucoidan and dextran sulfate, but not heparin or
chondroitin sulfate). A number of studies have suggested that class A
scavenger receptors may play a role in a wide variety of macrophage
associated physiologic and pathophysiologic processes, including cholesterol
deposition in arterial walls during atherosclerosis (Krieger and Herz, 1994;
Brown and Goldstein, 1983; Steinberg et al., 1989), adhesion (Fraser et al.,
1993), and immune responses and inflammation (Hampton et al., 1991; Dunne
et al., 1994).
The cDNAs encoding two closely related isoforms of class A macrophage
scavenger receptors have been cloned from bovine, murine, rabbit, and human
tissues (Kodama et al., 1990; Matsumoto et al., 1990; Rohrer et al., 1990;
Freeman et al., 1990; Bickel and Freedman, 1992) These isoforms, designated
class A type I (SR-AI) and type II (SR-All), are the alternative splicing products of
a single gene (Freeman et al., 1990; Emi et al., 1993). Based on the amino acid
sequence, SR-AI and SR-AII were predicted to contain six distinct structural
domains (Kodama et al., 1990; Rohrer et al. 1990; Ashkenas et al., 1993): 1, an
amino terminal cytoplasmic domain; II, a single transmembrane domain; III, a
spacer domain; IV, an a-helical coiled-coil domain; V, a collagenous domain;
and VI, an isotype specific C-terminal domain of variable length. Domains I-V
are identical in SR-Al and SR-All. In SR-AII, domain VI consists of a short (6-17
amino acid), poorly conserved sequence with no remarkable features. In SR-AI,
domain VI is 110 residues long, and includes an 8 residue hinge followed by a
102 residue region called the scavenger receptor cysteine-_ich (SRCR) domain.
This domain helped to define an ancient, highly conserved superfamily(Freeman et al., 1990) which currently includes 13 proteins containing 45
independent SRCR domains (Resnick et al., 1994; Li and Snyder, 1995;
Kitamoto et al., 1994; Elomaa et al., 1995; Mayer and Tichy, 1995; Nunes et al.,
1995). The functions of the SRCR domains in these diverse proteins are, for the
most part, undefined; however it has been proposed that SRCR domains may
participate in ligand binding interactions. Recent studies by Arrufo and
colleagues have established such a function for one of the SRCR domains in
CD6, a protein expressed by T cells and some B cells (Whitney et al., 1995b).
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The SRCR domain in SR-AI, however, does not appear to play a key role in its
distinctive broad polyanionic ligand binding (Rohrer et al., 1990; Ashkenas et
al., 1993). The SRCR domain in SR-AI presumably confers an as yet undefined
binding activity on this endocytic surface receptor. A third structurally related
member of the SR-A family has recently been cloned and characterized(Elomaa et al., 1995). This receptor, called MARCO or SR-AIII, has an extended
predicted collagenous region and a C-terminal SRCR domain, but no readily
apparent coiled-coil domain.
Detailed analysis of the structures of class A scavenger receptors has been
limited by the availability of adequate amounts of protein and by technical
difficulties inherent in working with water insoluble molecules. To circumvent
these problems, we have generated stable CHO cell lines which express
substantial amounts of truncated, secreted forms of the human class A
scavenger receptors, s-hSR-Al and s-hSR-AII. We have used purified secreted
receptors to test predictions made about the structures of the SRCR, coiled-coil,
and collagenous domains. We have also directly examined the low resolution
structure of these molecules using electron microscopy. Our findings have
confirmed the previous predictions and extended our understanding of the
structures of the class A macrophage scavenger receptors.
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Experimental Procedures
Materials - CHO[DHFR-] cells were obtained from the ATCC. Lysyl
endopeptidase from Achromobacter lyticus (Lys-C), modified trypsin, and
sequencing grade protease V8 (Glu-C) were obtained from Wako Bioproducts,
Promega, and Boehringer Mannheim Biochemica, respectively. Uranyl acetate
was obtained from Polysciences. Mica sheets (1 x 4 cm), graphite rods (for
carbon evaporation), 500-mesh copper grids, and a diffraction grating replica
with latex spheres were purchased from Ted Pella, Inc. Poly G beads and other
reagents were obtained as previously described (Resnick et al., 1993).
Construction of pRc/CMV-s-hSR-AI and pRc/CMV-s-hSR-AII Expression
vectors -- cDNAs encoding soluble forms of the human macrophage scavenger
receptor type I and type II were generated by PCR using a 5' oligonucleotide
encoding a sequence comprising the myelin-associated glycoprotein (MAG)
leader sequence (Arquint et al., 1987) as well as a FLAG epitope tag (Hopp et
al., 1988) and overlapping the SR-A cDNAs by 21 bases starting at the lysine at
base position 230 (Matsumoto et al., 1990). The 3' oligonucleotides contained
the last 21 bases of the type I or type II receptors followed by an Xba I restriction
site. The blunt/Xba I fragment was ligated to pRc/CMV (Invitrogen) at the Hind
Ill(blunt)/Xba I sites. The constructs were named pRc/CMV-s-hSR-AI or -All.
After cleavage of the signal sequence, the N-terminal sequence of the
expressed proteins is predicted to be D-Y-K-D-D-D-D-K-Kn-, where Lysn is the
first residue contributed by the scavenger receptor.
Cell culture, transfections, and DHFR amplification - All incubations with
intact cells were performed at 370C in a humidified 5% CO2 incubator. Stock
cultures of CHO [DHFR-] cells were grown in medium A (IMDM supplemented
with 100 units/mi penicillin, 100 gg/ml streptomycin, 10-4 M hypoxanthine, 10-s M
thymidine, and 2 mM glutamine) containing 10% (v/v) fetal bovine serum (FBS)
(medium B).
Transfectants expressing the secreted human SR-AI (CHO[s-hSR-AI]) were
generated using the Lipofectin method as suggested by the manufacturer
(Gibco BRL). On day 0, CHO[DHFR-] cells were plated at 106 cells/100 mm
dish in medium B. On day 1, the cells were washed twice with Dulbecco's
complete phosphate buffered saline (cPBS, Gibco) and refed with a transfection
mixture containing 5 ml medium A with 100 p• Lipofectin, 10 gg Bgl II linearized
pRc/CMV-s-hSR-I, and 200 ng Bam HI linearized pSV2-dhfr (Subramani et al.,
1981). Following a 5 hr incubation, 5 ml of medium A containing 20% (v/v) FBS
were added. On day 2, the cells were refed with medium B, and on day 3, cells
were harvested with trypsin and plated at 2x10 s - lx10 cells/100 mm dish in
medium C (IMDM supplemented with 100 units/mi penicillin, 100 mg/ml
streptomycin, 2 mM glutamine, and 0.5 mg/ml Geneticin (Gibco)) containing 7%
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(v/v) FBS which was extensively dialyzed against 150 mM NaCI (medium D).
On day 4, colonies were switched to medium C containing 10% dialyzed FBS
and 50 nM methotrexate (Sigma). Cells expressing increasingly higher levels
of s-hSR were selected by progressively increasing the concentration of
methotrexate and re-screening for expression using metabolic labeling and a
poly G solid-state bead binding assay as previously described (Resnick et al.,
1993). One positive clone, designated CHO[s-hSR-AI] (clone 38-2-19) was
resistant to 1 gM methotrexate and expressed high levels of s-hSR-AI. It was
used for all experiments involving s-hSR-AI.
Transfectants expressing s-hSR-AII (CHO[s-hSR-AII]) were generated
using a variation of the Lipofectin method. CHO[DHFR-] cells were grown in
Ham's F12 instead of IMDM. Cells were plated at a density of 5x1 06 cells/ 100
mm dish prior to transfection. Colonies were screened by Western blotting
using an anti-peptide antibody raised against a C-terminal peptide of hSR-AII.
A highly expressing cell line, CHO[s-hSR-AII]clone-201-16, resistant to 5 gM
methotrexate, was obtained by amplifying with increasing concentrations of
methotrexate and was used to generate s-hSR-All.
Expression and purification of s-hSR-Al and s-hSR-AIl - Expression: Cells
were set in 850 cm2 roller bottles in Medium E (Ham's F-12 medium containing
10% FBS, 100 units/mi penicillin, 100 jIg/ml streptomycin, and 2 mM glutamine)
at a density of 10' cells per bottle. Cells were grown to ~ 50% confluence and
were then washed twice with cPBS and refed with 200 ml Medium F (50%
Ham's F12, 50% DMEM, 100 units/mi penicillin, 100 jig/ml streptomycin, 2 mM
glutamine, 10 mM HEPES pH 7.4, and 1 mM sodium butyrate). Four days later
the cells were refed and incubated for an additional 4 days. The culture media
were then collected, and after addition of sodium azide (final concentration :
0.01% (w/v)), were clarified by centrifugation (4000xg for 15 minutes at 40C),
and stored at 40C or -200C.
Purification: All steps were carried out at 40C. Culture media were
concentrated using a spiral cartridge ultrafiltration apparatus (Amicon) fitted with
an S1Y100 membrane (approximate molecular weight cutoff of 100 kDa).
Following concentration of 4-14 liters to approximately 350 ml, the concentrate
was diafiltered against 6 liters of 50 mM ammonium bicarbonate, pH 7.5, and
further concentrated to a final volume of 125 ml, all in the same device. The
sample was then clarified by centrifugation (30 minutes, 4000xg). The
supernatant was applied at a flow rate of 0.75 ml/min to a 6 by 1.5 cm column
containing 10 ml AG-Poly G resin (Sigma) which had been equilibrated in 5%
Buffer A (1 M ammonium bicarbonate, pH 7.5)/95% H20. The column was
washed with 50 ml of 5% A and eluted at 0.5 mI/min with a 95 ml linear gradient
containing 5-100% Buffer A. The effluent was monitored at 280 nm, and those
fractions containing protein were analyzed by 10% SDS/PAGE and silver
staining (Kozarsky et al., 1986; Morrissey, 1981). Fractions containing s-hSR-A
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were pooled, diluted 1:1 with H20, and applied at 1 ml/min to a Mono Q HR5/5
column (Pharmacia) which had been pre-equilibrated in 7.5% Buffer A/92.5%
H20. The column was then washed with 30 ml 7.5% Buffer A at 2 ml/min, and
eluted at 1 ml/min with a 40 ml 7.5-100% linear gradient of Buffer A in H20. The
eluant was monitored at 280 nm and analyzed by gel electrophoresis as
described above; fractions containing s-hSR-A were pooled. Yields were
approximately 10.6 mg from 14 liters of s-hSR-AI medium and 10.8 mg from 4
liters of s-hSR-AII medium.
Disulfide mapping of the SRCR domain of s-hSR-AI - Urea (final
concentration: 6 M) was added to 200 gg of s-hSR-AI and the sample was
submerged in boiling water for 20 minutes and then cooled to room
temperature.
LysC digestion: The urea concentration was lowered to 4 M by addition of
Tris pH 9.0 (final concentration: 0.1 M) and then Lys-C was added at an enzyme
to s-hSR-AI ratio of -1:45 (w/w). Following incubation at 370 C for 4-13 h,
peptides were resolved using HPLC (Hewlett Packard 1090 system). In some
cases, the samples were reduced by boiling in the presence of 100 mM DTT for
20 minutes prior to chromatography. Samples were applied at 1 ml/min to an
analytical C-18 column (Vydac 218TP54) which was then washed for 5 minutes
with H20/0.1% trifluoroacetic acid and eluted with a linear gradient containing 0-
60% acetonitrile/0.1% trifluoroacetic acid. Peaks containing disulfides were
identified by mobility changes upon reduction and by comparison to digests of
the type II receptor, which lacks the SRCR domain. The composition of these
peaks was determined by both N-terminal sequencing and analysis of the
amino acid composition (performed by the Biopolymers Laboratory, M.I.T.
Department of Biology). Fractions containing these peptides were isolated and
further characterized. Prior to additional proteolytic digestion, the fractions were
evaporated to dryness (Speed-vac) and dissolved in 8 M urea by boiling for 20
minutes.
V8 (Glu-C) digestions: HPLC purified fragments of s-hSR-Al were diluted in
25 mM NH4HCO, pH 7.5 to reduce the urea concentration to 1 M, and digested
with 1 pgg enzyme for 10 hours at 370C. Peptides were resolved on reverse
phase HPLC as described above and analyzed by mass spectrometry using
MALDI-TOF analysis (HHMI Biopolymers Facility, Harvard Medical School) and
either amino acid analysis or N-terminal sequencing.
Trypsin digestions: HPLC purified fragments of s-hSR-Al were diluted in
50 mM Tris/1 mM CaCI2 pH 7.6 to reduce the urea concentration to 1 M, and
digested with 1 Ig enzyme for 10 hr at 370C. Products were analyzed as
described above.
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Circular Dichroism - CD spectra were recorded in a 1.0 cm pathlength cell
at a sample concentration of 1.32 IpM (s-hSR-AI) or 1.39 IgM (s-hSR-II) in Buffer
B (10 mM sodium phosphate, 150 mM sodium chloride, pH 7.4 or as indicated).
Protein concentration was determined by absorbance at 280 nm in 6 M GuHCI,
assuming extinction coefficients of 39680 and 15280 M-'cm-' for the s-hSR-Al
and s-hSR-All, respectively (Edelhoch, 1967). Thermal unfolding studies were
also performed in buffer B. An Aviv model 60 DS CD spectrophotometer with a
thermo-electric temperature controller was used for all measurements. For
calculation of percent a-helicity, O. = 37,550 degree cm2 / decimole was
assumed to correspond to 100% helicity (Chen et al., 1974). This value was
derived by assuming that the length of the a-helical region was 52 residues,
which corresponds to the length of the predicted a-helical coiled-coil region
before the "skip" in this domain (Kodama et al., 1990; Ashkenas et al., 1993).
The second portion of the a-helical coiled-coil domain following the skip may be
slightly longer, however the effect of accounting for this on the calculation would
be inconsequential. If the a-helical regions were significantly shorter, it would
result in a decrease in the value for 100% helicity, and accordingly an increase
in the % helicity calculated (Chen et al., 1974). Apparent melting temperature
was chosen as the point at which the first derivative of the melting curve was
maximal. Melting curves were not fully reversible, therefore, true
thermodynamic parameters could not be determined.
Electron Microscopy - Negative-stained samples were prepared using the
pleated sheet technique (Smith and Seegan, 1984). A thin layer of carbon was
evaporated onto freshly-cleaved mica sheets using a Model DV502A High
Vacuum Evaporator (Denton Vacuum). Samples of s-hSR-Al and s-hSR-AII
were diluted to 1 ILg/ml in PBS and adsorbed to the carbon film using the
procedure of Valentine et al. (1968). A small piece (approx. 0.5 x 1.0 cm) of
carbon-coated mica was inserted at a 450 angle (carbon-side up) into a small
vessel containing 500-600 I.1 of sample, held there for 5-10 s, and withdrawn.
The carbon film partially detaches from the mica sheet, and floats on the
aqueous sample, allowing macromolecules to adsorb to the lower surface of the
carbon film. Next, the carbon film was washed by inserting the carbon-coated
mica into deionized water for 5 s. Finally, the carbon film was floated onto
aqueous 1% (w/v) uranyl acetate (pH 4.3), and pleated to approximately 25% of
its original length by using the mica sheet to gently compress the carbon film
against the edge of the vessel. A 500-mesh copper grid was placed shiny side
down on the pleated carbon, and retrieved with a piece of Saran Wrap
stretched across the open end of a test tube. Excess stain solution was
removed from the filmed grid using pre-moistened Whatman No. 1 filter paper.
The filmed grid was removed from the Saran Wrap, and allowed to dry for > 1hr.
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Negative-stained samples were observed in a JEOL JEM 1200EX II
transmission electron microscope operating at 80 kV with a 100 gpm condenser
aperture, a "spot size" of 2 gm, and a 100 pm objective aperture. Photographs
were taken at magnifications ranging from 40,000-60,000. Microscope
magnification was calibrated using a diffraction grating replica (2160 lines/mm)
and latex spheres (0.261 pm).
Measurements of individual molecules were made by projecting the EM
negatives onto a Sigma-Scan digitizing board (Jandel Scientific, 22 X
magnification). The length of the spacer/coiled-coil domain was taken as the
distance from the thick end of the molecule to the junction of the thick fibrous
segment with the thin fibrous segment (see Results and Discussion). The
length of the collagenous domain was taken as the distance from the junction of
the two fibrous segments to the end of the thin fibrous segment. In the case of s-
hSR-AI, the end of the thin fibrous segment was taken as the junction between
the thin segment and the globular SRCR domains; however, the true end of this
segment may have been partially obscured by the SRCR domains (see below).
The widths of the two fibrous segments were estimated by measuring a
perpendicular bisector of each segment. The "length" of the globular domain
(SRCR trimer) was measured along a line which passed through the end of the
thin fibrous segment and divided the globular domain into two approximately
symmetrical halves. In the majority of the molecules, this line was collinear with
the thin fibrous segment. The "width" of the globular domain was then taken as
the maximum distance across the domain perpendicular to the "length line".
Results and Discussion
Stable amplified CHO[DHFR-] cell lines expressing high levels of secreted
forms of the human type I (CHO-[s-hSR-AI]) and type II (CHO-[s-hSR-AII]) class
A macrophage scavenger receptors were generated as described under
"Experimental Procedures". The predicted domain structures of the integral
membrane forms of the receptor are shown in Fig. 6.1. To generate the
secreted forms of the receptor, the cytoplasmic and transmembrane domains
were replaced with a myelin associated glycoprotein signal sequence, which
was linked to the SR-A protein by a FLAG epitope tag. The signal sequence
was presumably removed when the proteins were translated and secreted. The
calculated molecular weight of the predicted type I secreted receptor (s-hSR-AI)
is 42.3 kDa (383 amino acids), while that of the type II secreted receptor (s-hSR-
All) is 32.1 kDa (290 amino acids). The binding properties of the expressed s-
hSR-AI and s-hSR-AII were evaluated using a solid-state bead binding assay
previously developed to determine activity of soluble scavenger receptors(Resnick et al., 1993). The secreted receptors exhibited ligand binding activity
with the expected polyanion specificity (not shown).
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s-hSR-Al and s-hSR-AII were purified from the culture media using
ultrafiltration, poly G affinity and Mono Q ion exchange chromatography, as
described in "Experimental Procedures". The final material was purified to
greater than 95% homogeneity, as evaluated either by HPLC or by SDS/PAGE
and silver staining (not shown). Yields were approximately 0.75 mg purified s-
hSR-AI per liter of culture medium and 2.7 mg s-hSR-All per liter. These
purified proteins were then used to examine the structures of s-hSR-Al and s-
hSR-AII.
Disulfide linkages in the SRCR domain: The pattern of disulfide
bonds in the SRCR domain of s-hSR-Al was determined by sequentially
cleaving the protein with proteases (Lys-C followed by V8 or trypsin) and
determining the composition of the relevant peptide products, using amino acid
analysis, mass spectrometry and/or N-terminal sequencing, as described in
"Experimental Procedures". Digestion products were separated by HPLC and
the fractions containing disulfide-bond linked peptides were identified by both
their reduction sensitivity and by comparison to digests from s-hSR-AII (which
lacks the SRCR domain). The experimental strategy and the results are
summarized in Figure 6.2. Note' that the six cysteines in the SRCR domain of
SR-AI are numbered 2, 3, 5, 6, 7, 8, as described by Resnick et al. (1994).
SRCR domains fall into two groups, those, such as that in SR-AI, without
cysteines 1 and 4 and those with them (Resnick et al., 1994). Two products of
the Lys-C digestion, designated peptides I and II (Fig. 2), were identified by
amino acid analysis and N-terminal sequencing. Unambiguous assignment of
disulfide bonds required further proteolytic digestion. Peak I was digested with
V8 protease, subjected to reverse phase HPLC, and disulfide containing peaks
were again identified. Analysis of these peaks using either mass spectrometry
and amino acid analysis (III) or mass spectrometry and N-terminal sequencing
(IV) allowed unambiguous assignment of the disulfide bridges as Cys2-Cys7
and Cys3-CysO. Digestion of peak II with trypsin followed by reverse phase
HPLC yielded fragment V, and both amino acid analysis and mass spectrometry
established the presence of the Cyss-Cys 6 disulfide bond.
This disulfide bonding pattern is consistent with the prediction of a Cys2-
Cys7disulfide bond made based on sequence comparisons of many different
SRCR family members (Resnick et al., 1994). It seems highly likely that all
SRCR domain family members share the disulfide bond pattern established
here for the SRCR domain of SR-Al and that cysteines 1 and 4 form a disulfide
in those SRCR domains which have all eight cysteines.
Chemical modifications of s-hSR-A characteristic of triple
helical collagenous domains: In hSR-AI, the C-terminal SRCR domain(VI) is separated by an 8 amino acid linker from domain V, a 69 amino acid
domain which is also found in SR-AII. This domain was predicted to form a
collagenous structure because it is composed of 23 Gly-X-Y triplet repeats(Kodama et al., 1990; Matsumoto et al., 1991). One of the hallmarks of collagen
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is the presence in the Y position of the triplets of two post-translationally
modified amino acids, hydroxylysine and hydroxyproline (Kivirikko and Myllyla,
1985). Hydroxyproline is important for the thermal stability of collagen, while
hydroxylysine plays a role in the crosslinking of collagens and also acts as a
substrate for glycosylation. Previous electrophoretic studies of SR-A
biosynthesis using an inhibitor of hydroxylation, a,a'-dipyridyl, provided indirect
evidence for hydroxylation of bovine SR-A (Penman et al., 1991). To measure
proline and lysine hydroxylation directly, we performed amino acid analysis of
purified s-hSR-Al and -All. The relative abundances of all of the other amino
acids were essentially those predicted from the sequences, assuming that the
leader sequence was removed during biosynthesis. Table 6.1 shows that both
hydroxylysine and hydroxyproline were present in s-hSR-Al and -All. Assuming
that these modifications occurred only in the Y position of the triplet repeats,
they correspond to the hydroxylation of 86% and 107% of the prolines and
lysines in the collagenous domain of the type I receptor, and 56% and 106% in
the type II receptor. The presence of significant quantities of these modified
residues lends further support to the proposal that this domain forms a triple
helical collagenous structure (Kodama et al., 1990, Penman et al., 1991).
Circular dichrolsm analysis of the a-helical contents of s-hSR-AI
and -All: Domain IV is a 121 amino acid segment adjacent to the collagenous
domain. The presence of an array of heptad repeats in this domain led to the
prediction that it folds into a three stranded a-helical coiled-coil (Kodama et al.,
1990). Circular dichroism (CD) spectroscopy of s-hSR-Al and -All in the 202-
250 nm range revealed that these proteins have characteristically a-helical
spectra, with minima at 222 and 208 nm (Fig. 6.3 Panels A and C). The a-
helicities of s-hSR-AI and -All calculated from 0222 (Chen et al., 1974) are
approximately 41% and 40%, respectively. Because domain IV represents 32%
and 42% of s-hSR-AI and s-hSR-AII, respectively, and the collagenous domain
(V) is not expected to provide a major contribution to 0. (Piez and Sherman,
1970 ), these results are consistent with the model that domain IV forms an
extended a-helical coiled-coil. They also suggest that there is some a-helical
character in the SRCR domain. The contributions, if any, of the spacer domain
(I11) to the a-helical character of these receptors has not been established.
Like many endocytic receptors, the class A scavenger receptors release
their ligands at low pH (Naito et al., 1991; Resnick et al., 1993), presumably to
allow recycling of the receptor to the cell surface after deposition of its ligand in
an acidified endosome. We previously suggested that the presence of histidine
residues in two of the normally aliphatic "a" and "d" positions of heptad repeats
in the a-helical coiled-coil domain (IV) might be important for pH dependent
ligand binding (Kodama et al., 1990). Titration of these imidazoles might disrupt
at least portions of the coiled-coil and the adjacent ligand binding collagenous
domains. Doi, Kodama and co-workers (1994) provided support for this
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suggestion when they showed that mutation of His' to leucine abolished the
ability of the receptor to release its ligands in a pH dependent manner. To
determine if low pH dramatically altered the secondary structure of hSR-A, we
compared the CD spectra of s-hSR-Al and -All at pH 7.4 and 5.6 (Figure 6.3
panels A and C ). The CD spectra at pH 5.6 were only very slightly perturbed
relative to those at pH 7.4, suggesting that there were no substantial differences
in the secondary structures at these pHs. However, we did observe a
substantial pH-dependence in the thermal stabilities of the a-helices in s-hSR-
Al (Fig 6.3 Panel B) and -All (Panel D). At pH 7.4, s-hSR-AI and s-hSR-AII
exhibited sharp thermal transitions, "melting" at -64 OC, whereas at pH 5.6, this
transition occurred at -74 OC (Figure 6.3, Panels B and D).
The higher melting temperatures and apparently increased stability of the
coiled-coil at pH 5.6, as well as the unaltered CD spectra, suggest that
substantial unwinding of the coiled-coil is unlikely to account for decreased
ligand binding at low pH. These results, however, do not preclude the
possibility that small pH dependent perturbations in the structure of the coiled-
coil domain and associated alterations in the adjacent collagenous domain may
play a role in ligand release. Furthermore, it is not yet clear if His26o is included
within the coiled-coil as was originally predicted (Kodama et al., 1990), because
it is difficult to predict precisely where the coiled-coil segment ends based solely
on the amino acid sequence (Ashkenas et al., 1993). Additional studies will be
required to define precisely the mechanism by which Hism influences ligand
binding.
Studies by Anachi, Brodsky, and co-workers using a peptide model of the
collagenous ligand binding domain have recently demonstrated that this region
is massively destabilized at low pH (Anachi et al., 1995). As they observed this
effect only below pH 4.5, the relationship of their results to pH-dependent ligand
binding is unclear. It is possible that in the context of the whole receptor, or in a
receptor-ligand complex, this structural transition could occur at a higher pH.
Electron Microscopy of s-hSR-Al and -All: Negative-stained images
of s-hSR-AI (Fig. 6.4A and B) and s-hSR-AII (Fig. 6.4C and D) confirmed that
these molecules have elongated structures, and are not assembled into higher
order oligomers (Resnick et al., 1993). By negative staining, both SR-A
isoforms appeared to be composed of two fibrous segments which differed
noticeably in thickness (see also footnote 1). The principle difference between
the two isoforms was the presence in s-hSR-AI, but never in s-hSR-All, of a
globular domain. This globular domain, which sometimes appeared to be
resolved into two or, less frequently, three small subdomains, was observed at
the end of the thin segment but never at the end of the thick segment. This
globular domain almost certainly represents three SRCR domains. Therefore,
we propose that the thin segment is the collagenous domain and the thick
segment is the a-helical coiled-coil domain. The thick segment may also
include a contribution from the spacer domain (Figure 6.1 and see below).
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Length, width, and angle measurements of the individual s-hSR-AI/II
domains were performed on the negatively stained images as described in
"Experimental Procedures". The results are summarized in Table 6.2 and
Figure 6.5. The average length of the thin segment of the type II receptor,
which consists of 23 Gly-X-Y repeats and a 15 residue C-terminal domain, was
210 t 29 A, a value similar to the predicted length of the collagenous domain,
197 A (69 res. x 2.86 A/res., Bella et al., 1994). The average thin segment
length for the type I isoform, 170 ± 27 A, was significantly shorter, raising the
possibility that the SRCR domains may partially obscure the C-terminus of the
collagenous domain in these images. It seems unlikely that the SRCR domains
would normally block access to the C-terminus of the collagenous domain in
solution, because this portion of the collagenous domain is required for ligand
binding (Acton et al, 1993; Doi et al, 1993) and most of the binding properties of
the type I and type II isoforms are similar (Ashkenas et al, 1993). The average
lengths of the thick segments in both the type I and type II isoforms, 210 ± 32 A
and 230 + 28 A respectively, were somewhat longer than the predicted length of
the a-helical coiled-coil domain, 181 A (121 x 1.5 A, Harbury et al., 1994). The
quaternary structure of the 75-residue spacer domain at the N-terminus of the a-
helical coiled-coil domain, and its contribution to the length of the thick segment,
are unknown.
The average widths of the thick and thin segments were not as well defined
as their lengths (Table 6.2) and were almost 2-fold greater than the widths
predicted from crystal structures of a three-stranded a-helical coiled-coil (24 A,
Harbury et al., 1994) or a collagenous triple helix (10 A, Bella et al., 1994).
Absolute width measurements are particularly susceptible to small errors in
measurement caused by distortion of the molecules during EM specimen
preparation. Furthermore, it is difficult to assess the contributions of the many
N-linked oligosaccharides in the a-helical coiled-coil domains (Kodama et al,
1990, Resnick et al., 1993; Matsumoto et al., 1990) to the observed widths.
However, in both s-hSR-AI and s-hSR-AII, the thick segments were
approximately 2-fold wider than the thin segments, a ratio similar to the
predicted ratio of 2.4. Thus, the relative widths of the segments are consistent
with the proposal that the thick segment represents the a-helical coiled-coil
domain with some contribution made by the spacer domain and that the thin
segment is the collagenous domain.
The globular structure observed at the end of the thin segments in s-hSR-AI
is presumably composed of three individual SRCR domains. Its average
dimensions were 58 ±12 A x 76 ± 18 A. In a small number of the negatively
stained images, these structures could be resolved into two or three discrete
subdomains whose average dimensions were 54 10 A x 35 ± 9 A (n=23).
Many of the negatively stained molecules appeared to be bent near thejunction of the two fibrous segments. The angle between these segments varied
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from 200 to 1800, with 80% of the molecules having angles greater than 1000.
Thus, there appears to be a flexible hinge linking the a-helical coiled-coil and
collagenous domains, with some preference for molecules with a more
extended conformation. Segmental flexibility might contribute to the ability of
these receptors to bind a wide variety of ligands, e.g., relatively small molecules(Pearson et al., 1992), large macromolecules and macromolecular complexes
(Krieger and Herz, 1994) and even intact microorganisms (Dunne et al., 1994).
The extended nature of the scavenger receptors (overall length ~ 440 A)
could serve to project their collagenous ligand binding domains away from the
cell surface and thus make them more accessible to very large ligands.
Interestingly, the other member of the SR-A family, MARCO, does not have an
a-helical coiled-coil domain (Elomaa et al., 1995). However, it does contain a
much longer collagenous domain (87 Gly-X-Y repeats), resulting in a predicted
fibrous length of about 750 A. Antibody blocking experiments suggest that, as is
the case with SR-AI and SR-AII, MARCO's ligand binding domain is at the C-
terminal end of the receptor (Elomaa et al., 1995). Strikingly, the Gly-X-Y
repeats in MARCO are interrupted by a skip. Similar disruptions in short
collagenous domains have been reported to introduce a flexible hinge which
separates two fibrous segments (e.g., Clq, Schumaker et al., 1981, Thiel and
Reid, 1989). The skip in MARCO may be functionally equivalent to the flexible
hinge in SR-Al and -All. Thus, all of the class A scavenger receptors appear to
project their ligand binding domains away from the cell surface via a hinged
fibrous structure.
A somewhat different perspective on the structures of SR-A is provided by
rotary metal shadowing techniques. Rotary metal-shadowed images of s-hSR-
Al and s-hSR-All at pH 7.4 (not shown) indicated that both molecules are
elongated rods, with an average length of approximately 310 A. Both s-hSR-Al
and -All appeared relatively uniform in thickness along their length. However,
in the s-hSR-AI images, there was also an approximately 100 A diameter
globular region at one end of each rod, presumably formed by the three SRCR
domains of the trimer. This structure was absent in all of the s-hSR-AII images.
Stained images obtained after dialysis of the type I receptor into pH 4.3 buffer
looked similar to those described above. It thus appears that at neutral pH
these molecules are "snapped-back" on themselves, giving an angle of 00
between the segments.
The reason behind the different results with the different methods is
unclear. While the negative stained images were nominally obtained at pH 4.3,
the molecules were adhered to the carbon film at pH 7.4. It is not known
whether structural rearrangement would occur once the molecules are on the
carbon. The CD studies presented above suggest that if a major structural
change occurs between pH 7.4 and 5.7, it does not significantly affect
secondary structure. It may well be that the putative ligand binding region of the
collagenous interacts with acidic residues in the spacer domain, folding the
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molecule in half at neutral pH. Whatever the cause of the apparent snap-back,
it may not apply to the receptor when it is anchored in a membrane.
Hydrodynamic studies are in progress to evaluate whether this pH dependant
conformational change occurs in solution as well. If this is a real effect, it could
in some way relate to the mechanism for pH dependant ligand release.
The studies of the structures of s-hSR-Al and s-hSR-All described here
have provided significant support for the fibrous structural model originally
proposed for the class A scavenger receptors (Figure 6.1). They also have
provided a disulfide map of the SRCR domain and, by low resolution electron
microscopic imaging, have improved our understanding of the overall structure
of the extracellular portion of the receptor.. Future higher resolution studies of
these molecules will further our understanding of the structure and unusual
binding properties of these multiligand/multifunction receptors.
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Footnotes
1The majority of the negatively stained molecules (77%) had this overall
structure. We also observed a number of shorter molecules in every sample.
The average dimensions of these molecules (230 x 49 A) were similar to those
of the thick fibrous segments. Presumably, the thin fibrous segment of SR-A
was present, suggesting that the thin fibrous segment was not resolved in these
molecules.
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Figure Legends
Figure 6.1. Predicted quaternary structures of the type I and type II class A
macrophage scavenger receptors.
The domain structures of the type I and type II receptors were deduced
from their cDNA sequences. These domains include a cytoplasmic domain, a
single transmembrane domain (TM), a spacer domain, a region predicted to
form an a-helical coiled-coil, and a putatively collagenous domain containing
23 Gly-X-Y repeats. The type I receptor has an 110 amino acid COOH terminal
region comprising an 8 residue hinge and a 102 amino acid scavenger receptor
cysteine rich (SRCR) domain, while the type II receptor has a 17 amino acid C-
terminus. In the secreted forms used in this paper, the cytoplasmic and
transmembrane domains were replaced with a cleavable signal sequence
followed by a FLAG epitope tag.
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Figure 6.2. Identification of disulfide bonds in the SRCR domain.
Purified s-hSR-AI was subjected to proteolytic digestion with LysC as
described in materials and methods. Shown at the top are this enzyme's target
sites in the SRCR sequence, with amino acids numbered as in the full length
protein. Following cleavage with LysC, fragments I and II were identified as
reduction sensitive peaks by reversed phase HPLC and further characterized
using both N-terminal sequencing and amino acid analysis. Peak I was
digested with V8 protease and the resulting peptides were resolved by HPLC
yielding fragments III and IV. Peak II was digested with trypsin, yielding peak V.
The identities of peaks III, IV, and V were determined using mass spectrometry
and either amino acid analysis or N-terminal sequencing.
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Figure 6.3. Circular dichroism (CD) analysis of s-hSR-AI and s-hSR-AllI
CD spectra of s-hSR-AI and -All were recorded at concentrations of 1.32
and 1.39 pM, respectively, in 10 mM sodium phosphate, 150 mM NaCI, at the
indicated pH values. Panels A, C - spectra were recorded for 3 seconds at each
wavelength at OOC. Panels B, D - samples were equilibrated at each
temperature for 1.5 minutes prior to measuring 0, for 30 seconds.
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Figure 6.4. Negative stain images of s-hSR-Al and s-hSR-AII.
Samples of purified s-hSR-Al or s-hSR-AII were prepared as described in
"Experimental Procedures" and visualized using transmission electron
microscopy. Double-tailed arrows indicate coiled-coil/spacer domains (thick
fibrous segments), single-tailed arrows indicate collagenous domains (thin
fibrous segments), and arrow heads indicate SRCR domains. Panels A and B,
s-hSR-AI; Panels C and D, s-hSR-AII. Bars indicate 0.1 pm.
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Figure 6.5. Dimensions of s-hSR-AI and s-hSR-AII based on negative stain
electron microscopy.
Values (mean ± s.d.) are based on the measurements of >100 negatively
stained images. The angle between the two fibrous domains was variable,
ranging from 20 - 1800, with 80% of the values > 1000.
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Table 6.1. Quantitation of hydroxylated lysine and proline in s-hSR-AI and -All.
Amino Acid s-hSR-Al s-hSR-AII
Predicted Measured Predicted Measured
Lysine 22 16.5 ±1.0 19 14.9 ±0.1
Hydroxylysine - 5.35±0.13 - 5.31±0.09
Proline 18 16.4 ±1.0 16 14.0 ±0.1
Hydroxyproline - 5.16±0.25 - 3.35±0.17
Values given are the average number of residues per polypeptide± the
standard deviation based on two experiments. The average deviation of
predicted from the observed values for the other amino acids was 8% and 5.7%
for s-hSR-l and s-hSR-II.
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Table 6.2. Dimensions of negative-stained EM Images of s-hSR-AI and -All.
Domain s-hSR-Al s-hSR-AII
Length (A) Width (A) Length (A) Width (A)
Coiled- 210 ± 32 39 ± 9 230 ± 28 49 ± 10
coil/Spacer
Collagenous 170 ± 27 20 ± 4 210 ± 29 23 ± 5
SRCR (trimer) 58 ± 12 76 ± 18 NA NA
Overall Length 440 + 49 NA 440 ± 43 NA
Values given are the means of at least 100 measurements ± the standard
deviation. Overall length is defined as the sum of the measured lengths of the
coiled-coil/spacer, collagenous, and SRCR domains.
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Chapter 7
Perspective - scavenger receptors and the future
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The purification, cloning, and sequencing of the type I and type II class A
scavenger receptors by Kodama, Krieger, and co-workers (Kodama et al., 1988;
Kodama et al.,, 1990; Rohrer et al., 1990) revealed that these receptors
contained features which immediately allowed a plausible quaternary structure
to be proposed (presented in Fig. 1.1, introduction). A major goal of this thesis
has been to both evaluate these predictions and to extend them, yielding an
increasingly accurate picture of receptor structure. An additional aim has been
to try and better understand receptor function by screening some candidate SR
ligands.
Studies in this thesis have provided structural information about the
receptor as a whole as well as about all of the domains individually. These
findings are summarized in Figure 7.1. These experiments have provided
considerable support for the validity of many of the structural features predicted
based on the primary sequence (Kodama et al., 1990; Rohrer et al., 1990), and
have extended those predictions. However, there remain some unanswered
questions in the realm of receptor structure, in particular with regard to the
nature of the ligand binding interaction. Perhaps the most intriguing is the
mechanism by which a positively charged rigid rod selectively binds along its
surface some, but not all, negatively charged molecules with quite high affinity.
More typically, high affinity specific binding occurs in fairly restrictive pockets of
a protein, with selectivity enforced by steric considerations and interactions with
surrounding residues. An original suggestion that the scavenger could make
such a binding pocket by forming higher order oligomers (as is the case for
Clq) was shown to be incorrect. A related question pertains to the number of
ligand binding sites. The receptor's predicted trilateral symmetry raises the
possibility that it could have some multiple of 3 binding sites, although some of
the ligands may be large enough to sterically hinder simultaneous occupancy of
those sites. Very preliminary studies using affinity co-electrophoresis (not
shown) have suggested that there may be multiple binding sites, although the
results are not unambiguous. The receptors have been shown to exhibit pH
dependent ligand binding; however the mechanism for this remains unclear.
Studies in this thesis have demonstrated that one reasonable hypothesis,
namely that major disruption of receptor structure in response to protonation of
a key histidine in the coiled-coil domain causes ligand release, does not appear
to be the mechanism for this process.
Studies are underway to generate higher resolution structural
information about the receptor which may provide an answer to some of these
questions. Currently, efforts are focused on two different approaches. One line
of investigation involves attempts to crystallize the entire secreted type I and II
class A human receptors and to determine the receptor structure by X-ray
diffraction techniques. Small crystals of SR-AI have been grown, and further
experiments are in progress. These experiments are presented in Appendix D
of this thesis. An alternative approach for the determination of receptor
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structure involves the crystallization of receptor fragments individually. It is
possible that this would make the problem somewhat more tractable. Efforts to
independently crystallize or obtain via NMR the structure of the SRCR domain
are described in appendix C. Such a structure would be highly useful, although
it would not show how the domains interact. Similarly, structures could also
perhaps be obtained for the collagenous and coiled-coil domains, either from
proteolytic products from the full receptor, or perhaps by independent
expression of these domains.
Recently, both small collagens and three stranded a-helical coiled-coils
formed from synthetic peptides have been crystallized, and their structures have
been determined at high resolution (Harbury et al., 1994; Bella et al., 1994).
This raises the possibility that several interesting structural questions could be
addressed using peptide models of putatively important regions of the
analogous scavenger receptor domains. In the case of the coiled-coil domain,
the question of pH dependent release of ligands could be investigated by
determination of the structure of a peptide which encompasses the critical C-
terminal histidine residue (Doi et al., 1994). Perhaps more significantly,
structures of peptide models of the collagenous ligand binding domain could
help us understand how this domain recognizes ligands. Anachi, Brodsky, and
colleagues have demonstrated that maintenance of the structure of a peptide
model which includes the putative ligand binding region of the collagenous
domain is pH dependent, with significant destabilization at low pH (Anachi et
al., 1995). They do not report that their model trimer is capable of mediating
ligand binding activity; however perhaps theirs or a similar model could be used
for such structural studies. This assumes that the ligand binding activity could in
fact be reconstituted in a peptide model and does not require any of the other
structural elements present in the scavenger receptor. Given our current
understanding of SR structure, higher resolution studies such as those
presented above seem like the best way to address the many remaining
structural issues.
While structural studies have slowly revealed the physical features of the
class A scavenger receptors, the actual in vivo function of these receptors
remains shrouded in mystery. The vast majority of studies investigating SR
function have used in vitro competition and binding studies to identify plausible
ligands and have "raised the possibility" that scavenger receptors could play a
role in many (or even most?) macrophage-receptor mediated processes.
Examples of this sort of study are found in chapters 2 and 3 of this thesis, where
I show that crocidolite asbestos and lipoteichoic acid are SR-A ligands.
Asbestos and non-opsonized Gram-positive bacteria (which have lipoteichoic
acid on their surfaces) both are bound by macrophages, which of course
express SR-A on their surfaces. These are, therefore, potentially
physiologically relevant ligands. However, this type of approach is ultimately
unsatisfying, and even well conceived and designed experiments fall short of
the mark in convincinglv defining the SR-A role. The relatively few in vivo
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studies that have been carried out have been illuminating (e.g. Hampton et al.,
1991; Kobzik, 1995). However these studies take place in a complex
physiological background containing many scavenger receptors. Even if these
and similar sorts of experiments conclusively demonstrate that a scavenger
receptor is involved in the process being studied, which particular scavenger
receptor or receptors are acting often remains an open question.
Recently, Kodama and co-workers have reported the targeted disruption of
the class A scavenger receptor in mice (unpublished, Pearson, 1996). This is a
critical development for the field, as it will finally allow some definitive
experiments on SR-A function to be carried out. Preliminary results have
indicated that these mice are healthy, and accordingly that the SR-A does not
appear to be an essential gene. While there is no readily apparent phenotype,
more detailed investigations applying some of the numerous findings obtained
from in vitro studies have produced some interesting observations. Binding of
OxLDL by peritoneal macrophages is reduced by 50%, providing more support
for this receptors involvement in atherogenesis (Kodama, unpublished).
Crossing these SR-A deficient mice with strains with atherogenic propensities
such as apoE deficient mice (Breslow, 1993) will help to still better define the
pathophysiological role of this receptor in atherogenesis. Studies by Gordon
and colleagues (unpublished, Pearson, 1996) have revealed that the ability of
thymic macrophage to engulf apoptoic thymocytes is decreased by 50% in
these SR-A deficient animals, supporting their previous findings which had
been based on antibody inhibition of this process (Platt and Gordon, 1995).
This suggests that the SR-A plays a role in the clearance of apoptotic cells, at
least in this limited case. Obviously the SR is not the principle mediator of the
clearance of apoptotic cells, as the animals develop normally. Experiments
investigating the potential role of the SR-A in host defense have yet to be
carried out. Studies with these mice and macrophage cell lines derived from
them will ultimately provide the answers to this and other questions concerning
the in vivo function of the scavenger receptor.
An essentially untouched aspect of SR function lies in the SRCR domain.
Its presence for the most part has little effect on the polyanionic ligand binding
properties associated with the scavenger receptors, although in at least one
case it does modulate them somewhat (Ashkenas et al., 1993). Given its
location at the end of a long, rigid rod, and that some of the other SRCR domain
superfamily members have been shown to be involved in ligand binding, it
seems highly likely that it has an as yet unknown soluble, cell surface, or cell
matrix ligand. Use of recombinant SRCR domain to search for such ligands
using an approach similar to that used to identify a ligand for the lymphocyte
homing receptor in high endothelial venules could be successful (Watson et al.,
1990), assuming that the ligand is expressed on the surface of tissues or cells
with which macrophages interact. One such potential location would be the
vascular endothelium, given its role in recruitment of circulating monocytes into
tissues. Differential expression of SR-Al and SR-AII has not yet been well
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studied. Possibly knowledge of the differences in expression patterns would
suggest likely functions for the SRCR domain.
This thesis has answered many structural questions about the class A
scavenger receptors. As has been discussed above, many structural and
functional questions remain unanswered. With the reagents currently available,
in particular the availability of high levels of the protein for crystallization and
other structural studies as well as the SR-A deficient mice, the tools are now in
place to begin to answer these questions.
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Figure 7.1. Summary of structural findings about class A scavenger receptors.
Elements of receptor structure discovered or confirmed in the course of this
thesis are indicated in boxes adjacent to the relevant domain(s). Number of
residues in each domain in the human receptor are as indicated.
Abbreviations: SRCR, scavenger receptor cysteine-rich, TM, transmembrane.
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Appendix A
The Type I and Type II bovine scavenger receptors
expressed in Chinese hamster ovary cells are
trimeric proteins with collagenous triple helical
domains comprising noncovalently associated
monomers and Cys -disulfide linked dimers
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This appendix contains studies designed to examines in detail issues
related to the biosynthesis and processing of the class A scavenger receptors.
It addresses the following questions: 1) What are the kinetics of receptor
glycosylation, oligomerization and degradation; 2) what is the oligomeric state
of the receptor, and what role does a cysteine found in the spacer domain
(Cys3) play in this oligomerization; 3) is the receptor hydroxylated (as predicted
for the collagenous domain); 4) is the receptor expressed on the cell surface.
This work was published in 1991 in The Journal of Biological Chemistry 266,
23985-23993.
My contribution to these studies was limited to the identification and
preliminary characterization of a reagent which could successfully crosslink
scavenger receptors in intact cells both on the cell surface and internally.
Figure 10 was based on this result, though the actual experiment shown was
performed by Marsha Penman, as were most of the others in this work. The
paper was written primarily by Dr. Monty Krieger, and I and others contributed to
its editing and revision.
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The Type I and Type II Bovine Scavenger Receptors Expressed in
Chinese Hamster Ovary Cells Are Trimeric Proteins with Collagenous
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Scavenger receptors have been implicated in the de-
velopment of atherosclerosis and other macrophage-
associated functions. The structures and processing of
type I and type II bovine macrophage scavenger recep-
tors were examined using polyclonal anti-receptor an-
tibodies. Pulse/chase metabolic labeling experiments
showed that both types of scavenger receptors ex-
pressed in Chinese hamster ovary (CHO) cells behaved
as typical cell surface membrane glycoproteins. They
were synthesized as endoglycosidase H-sensitive pre-
cursors which were converted to endoglycosidase H-
resistant mature forms expressed on the cell surface.
The reduced precursor and mature forms were doub-
lets on sodium dodecyl sulfate-gel electrophoresis, pri-
marily because of heterogeneous N-glycosylation. The
approximate molecular sizes were: type I precursor,
65/63 kDa; type I mature, 82/76 kDa; type II precur-
sor, 57/53 kDa; and type II mature, 72/65 kDa. During
post-translational processing, the cysteine-rich C ter-
minus (SRCR domain) of some of the type I receptors
was proteolytically removed to form a relatively sta-
ble, approximately 69-kDa degradation product. Type
II receptors differ from type I receptors in that they
do not have SRCR domains and an analogous proteo-
lytic cleavage was not observed. Several experiments
provided strong evidence that the Gly-X-Y-repeat do-
mains in the scavenger receptors oligomerize into col-
lagenous triple helices. For example, a,a'-dipyridyl, an
inhibitor of the collagen-modifying enzymes prolyl and
lysyl hydroxylases, interfered with both the kinetics
and nature of post-translational receptor processing,
and both precursor and mature forms of the receptors
in intact cells could be cross-linked with difluorodini-
trobenzene into reduction-resistant trimers. In intact
cells, precursor receptor trimers (type I, 198 kDa; type
II, 176 kDa) were assembled in the endoplasmic retic-
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ulum by the noncovalent association of monomers and
Cys"3-disulfide-linked dimers (type I, 129 kDa; type
II, 119 kDa). When cells were lysed in the absence of
the sulfhydryl trapping agent iodoacetamide, oxidation
of the side chain of Cys"7 in the cytoplasmic domain
leads to the artifactual formation of reduction-sensi-
tive covalently linked trimers. The approximate
masses of the mature dimer and trimer forms were 162
and 237 kDa for type I receptors and 147 and 219 kDa
for type II receptors. CysS"-disulfide-linked dimer for-
mation was not required for function because mutant
receptors (Cys"3 -- Gly8 3 ) assembled into trimers of
noncovalently associated monomers and exhibited nor-
mal receptor activity. Treatment of cells with difluo-
rodinitrobenzene cross-linked some of the receptors
into complexes larger than trimers, raising the possi-
bility that the trimers may assemble into higher order
oligomers.
The macrophage scavenger receptors are integral mem-
brane glycoproteins which exhibit unusually broad ligand
specificity (Goldstein et al., 1979; Brown and Goldstein, 1983;
Kodama et al., 1988, 1990; Rohrer et al., 1990; Freeman et al.,
1990). They bind a wide variety of polyanions, including
chemically modified LDL,' acidic phospholipids, and poly(I).
Numerous studies have suggested that the scavenger receptors
may be critically involved in cholesterol deposition in artery
walls during atherogenesis (Brown and Goldstein, 1983; Stein-
berg et al., 1989; Jurgens et al., 1987, Steinbrecher et al., 1990).
The broad binding specificity of the scavenger receptors and
their expression in macrophages (Brown and Goldstein, 1983;
Pitas et al., 1985; Nagelkerke et al., 1983; Kodama et al., 1990)
suggest that they may also play a role in other physiologic
and pathophysiologic systems, such as macrophage-associated
immune responses and inflammation (Kodama et al., 1990;
Freeman et al., 1990). For example, bacterial endotoxin (li-
popolysaccharide) is a ligand for scavenger receptors, and
scavenger receptors play a quantitatively important role in
the clearance of endotoxin from the circulation by the liver
(Hampton et al., 1991; Raetz et al., 1988).
Purified bovine scavenger receptor(s) are comprised of
roughly equal amounts of reduction-sensitive trimers (220
kDa) and dimers (150 kDa) (Kodama et al., 1988). On reduc-
tion, these oligomeric forms collapse into monomers of about
'The abbreviations used are: LDL, low density lipoproteins; SRCR,
scavenger receptor cysteine-rich; PBS, phosphate-buffered saline;
Hepes, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; DFDNB,
difluorodinitrobenzene; SDS, sodium dodecyl sulfate.
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77 kDa, approximately 15-20 kDa of which are due to N-
linked glycosylation. The trimeric form, but not the dimeric
or monomeric forms, can bind the ligand acetyl-LDL
(AcLDL). We used the partial sequence of the purified bovine
receptor to clone two classes of scavenger receptor cDNA,
type I and type II, from bovine lung (Kodama et al., 1990;
Rohrer et al., 1990) and subsequently to clone their homo-
logues from cultured murine macrophages (Freeman et al.,
1990). The homologous human cDNAs have also been cloned
(Matsumoto et al., 1990). When incorporated into mammalian
expression vectors, the cloned cDNAs confer scavenger recep-
tor activity on transiently transfected COS cells (Kodama et
aL, 1990; Rohrer et al., 1990) and stably transfected CHO cells
(Freeman et al., 1991; Matsumoto et al., 1990).
The sequence of the type I bovine scavenger receptor cDNA
predicts a 453 amino acid protein with the following domains
(Kodama et al., 1990): I, N-terminal cytoplasmic (amino acid
residues 1-50); II, transmembrane (51-76); III, spacer (77-
108); IV, a-helical coiled-coil (109-271); V, collagenous (272-
343); and VI, C-terminal cysteine-rich (344-453), designated
SRCR (scavenger receptor cysteine-rich). The SRCR domain
helped to define a previously unrecognized family of remark-
ably well conserved cysteine-rich protein domains (Freeman
et al., 1990). The type I receptor has 7 potential N-linked
glycosylation sites in the spacer and a-helical coiled-coil do-
mains and 8 cysteines, 6 of which are in the SRCR domain.
The type II scavenger receptor is identical to the type I
receptor, except that the 110-amino acid SRCR domain is
replaced by a 6-amino acid C terminus (Rohrer et al., 1990).
Despite its truncated C terminus, the type II scavenger recep-
tor mediates the endocytosis of modified LDL with essentially
the same affinity and broad specificity as the type I receptor
(Rohrer et al., 1990; Freeman et aL, 1991). In the current
study, we have generated rabbit polyclonal anti-peptide anti-
bodies to the bovine scavenger receptor and used them to
examine the synthesis, post-translational processing, and
structure of bovine scavenger receptors expressed in stable
CHO cell transfectants.
MATERIALS AND METHODS
Cell Culture-All incubations with intact cells were performed at
37 'C in a humidified 5% CO2, 95% air incubator unless specified
otherwise. As described previously (Krieger, 1983), stock cultures of
wild-type CHO cells were grown in medium A (Ham's F-12 supple-
mented with 100 units/ml penicillin, 100 Ag/ml streptomycin, and 2
mM glutamine) containing 5% (v/v) fetal bovine serum (medium B),
and transfectants were grown in medium C (medium A containing
3% (v/v) newborn calf lipoprotein-deficient serum, 0.5 mg/ml ge-
neticin (G418, Gibco Laboratories), 250 jM mevalonate, 40 AM com-
pactin, and 3 Mg of protein/ml of AcLDL). The isolation of transfec-
tants expressing the type I bovine scavenger receptor (CHO[bSR-I],
clone IB2) and the type II bovine scavenger receptor (CHO[bSR-II],
colony II-5 or a subclone, IIB3) was described previously (Freeman
et aL, 1991). Transfectants expressing the Cys83 to Gly 3 mutant forms
of the type I (CHO[bSR-I(Gly")], colony 1-27) and type II
(CHO[bSR-II(Gly")], colony 3-12) receptors were generated using
the Polybrene method (Sambrook et al., 1989) as follows. On day 0,
wild-type CHO cells were plated at 5 x 105 cells/100-mm dish in
medium B. On day 1, the monolayers were refed with 3 ml of medium
B containing 10 Mg/ml Polybrene (Aldrich), 0.5 Mg/dish pSV2dhfr*
(Stuhlmann et al., 1989), 0.5 Mg/dish pRc/CMV (Invitrogen), which
contains a G418 resistance marker, and 10 ug/dish of either the
expression vector pCMV4bSRI(Gly53 ) (type I) or pCMV4bSRII(Gly")
(type II) (see below). After a 6-h incubation at 37 "C, the polybrene-
containing media were removed, and the cells were incubated with
medium B containing 30% (v/v) dimethyl sulfoxide for 4 min at room
temperature. The monolayers were then washed with medium A and
refed with medium B. On day 3, the cells were reset at 10, cells/100-
mm dish in medium E (medium B supplemented with 0.5 mg/ml
geneticin). On days 13-14, the surviving colonies were screened for
the uptake of 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine
perchlorate-labeled AcLDL (3 gg of protein/ml in medium E, over-
night incubation followed by fluorescence microscopy (Kingsley and
Krieger, 1984)), and receptor-positive colonies were isolated and
used in the indicated experiments. Native LDL and AcLDL and
1,l'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate-
labeled AcLDL were prepared as previously described (Krieger, 1983,
Kodama et al., 1988).
Preparation of Expression Vectors for Cys"3 to Gly8 Mutant
cDNAs-The expression vectors pCMV4bSRI and pCMV4bSRII
were constructed as follows: the cDNAs for the type I and type II
scavenger receptors were excised from pXSR7 (Kodama et al., 1990)
and pXSR3 (Rohrer et al., 1990) by HindIII with Klenow blunting
and then BamHI, and these cDNAs were inserted between the BglII
and SmaI sites of pCMV4 (gift of David Russell, Andersson et al.,
1989). A single-stranded phagemid was generated by M13K07 infec-
tion of CJ236 Escherichia coli cells (Bio-Rad) transformed with
pCMV4bSRI, and this phagemid served as the template for single
primer oligonucleotide-mediated mutagenesis by the Kunkel method
(Sambrook et al., 1989). The complementary mutagenic oligonucleo-
tide CCAACCGTGCCATTCTTCGT was used to create a Cys83 to
Gly" point mutation (UGC --* GGC) at nucleotides 247-249. The
sequence of the 0.7-kilobase SmaI/XbaI fragment of the mutant
cDNA was confirmed by dideoxy sequencing, and this fragment was
then subcloned into the pCMV4bSRI and pCMV4bSRII vectors to
generate the mutant expression vectors pCMV4bSRI(Gly') and
pCMV4bSRII(Gly"). The receptor activities expressed by COS M6
cells (Kodama et al., 1990; Rohrer et al., 1990) transiently transfected
with these mutant vectors were equivalent to or slightly greater than
those of cells transfected with the corresponding wild-type expression
vectors (data not shown).
Antibodies-Oligopeptides were coupled via their terminal cysteine
residues to hemocyanin as previously described (Kozarsky et al., 1986;
Beisiegel et al., 1981; Russell et al., 1984). The peptides were the: 1)
17 N-terminal residues (MAQWDDFPDQQEDTDSC), 2) 16 amino
acids from the spacer domain plus an additional cysteine not found
in the receptor (DISPSPEGKGNGSEDEC), and 3) 15 amino acids
from the scavenger receptor cysteine-rich (SRCR) domain
(CRSLGYKGVQSVHKR). Antibodies were raised in New Zealand
White rabbits (Kosarsky et al., 1986) and purified from the serum
prior to use by Protein A-Sepharose (Pharmacia LKB Biotechnology
Inc.) chromatography (Sambrook et al., 1989). The protein concen-
trations of the purified antibody preparations were: 4 mg/ml, anti-N
terminus; 7 mg/ml, anti-spacer: and 5 mg/ml, anti-SRCR.
Cell Labeling-Cells were plated on day 0 in 3 ml of medium D
(medium A containing 3% newborn calf lipoprotein deficient serum)
or medium E in six-well dishes (150,000 cells/well).
Metabolic Labeling with 5"S]Methionine-On day 2, monolayers
were washed two times with PBS and then incubated with 0.5 ml of
pulse-labeling medium F (medium D prepared with methionine-free
Ham's F-12 (Hazelton)) containing 300 MCi/ml [35S]methionine
(>800 Ci/mmol, Du Pont-New England Nuclear). After the indicated
times of pulse-labeling, cells were either washed once with Hepes-
buffered saline and harvested by lysis or washed once with medium
A, refed with 3 ml/well medium B or medium D supplemented with
1 mM unlabeled methionine (chase media), and harvested at the
indicated times. Cells were lysed. and the extracts were prepared for
immunoprecipitation as previously described (Kozarsky et al., 1986)
using lysis buffer A (calcium- and magnesium-free PBS with 1% (v/
v) Triton X-100, 1 mM methionine, 1 mM phenylmethylsulfonyl
fluoride, and 0.1 mM leupeptin) without or with 10 mM iodoacetamide
as indicated. In some experiments. 2 Ag/ml tunicamycin were included
in a 3-h pretreatment in medium D or E and in the subsequent
labeling and chase media. In others, a,a'-dipyridyl (100 AM, Sigma)
was included in a 1-h pretreatment in medium D and in the subse-
quent labeling and chase media. To chemically cross-link receptors
in intact ["S]methionine-labeled cells, the labeled cells were washed
twice with ice-cold PBS and incubated for 1 h at 4 "C in PBS with
or without 350 M 1,5-difluoro-2.4-dinitrobenzene (DFDNB, Pierce).
The cells were then washed three times with PBS containing 5 mM
glycine to inactivate unreacted cross-linker (Bischoff et al., 1988) and
harvested in lysis buffer A containing 5 mM glycine with or without
10 mM iodoacetamide.
Cell Surface Labeling with '25 1-On day 2, monolayers were placed
on ice, washed three times with ice-cold PBS, overlayed with an
Enzymobead (Bio-Rad) labeling mixture (see below) on ice for 30
min with rocking every 5 min, washed four times with ice-cold PBS
containing 20 mM Kl, and harvested with a lysis buffer as described
above. Each vial of beads was prepared by hydration with 500 Al of
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PBS overnight at 4 "C according to the manufacturer's instructions.
Immediately prior to use, 50 pl of 2% glucose (w/v) in water were
added to a vial of hydrated beads, and labeling mixtures for each well
of cells were prepared in polypropylene tubes as follows: aliquots of
beads (62.5-67 Al) were diluted to 375-500 Al with PBS containing
20 mM glucose, and 1.7-2.5 mCi of Na'25I (Amersham, 13.5 mCi/,g
of iodine) were added.
Immunoprecipitation, Electrophoresis, and Autoradiography-Im-
munoprecipitation of LDL receptors with anti-C antibody and sample
preparation for electrophoresis were performed as previously de-
scribed (Kozarsky et aL, 1986). The same protocol was used for
immunoprecipitations with anti-scavenger receptor antibodies except
that the detergent mixture was prepared without SDS and contained
1-2 million solubilized, unlabeled, wild-type CHO cells per ml. These
cells were included to reduce nonspecific background. Additionally, 5
Al of 20% (w/v) SDS in water were included in each precipitation.
The amounts of anti-peptide antibody used for precipitations varied
as indicated. SDS-polyacrylamide gel electrophoresis, for which the
specimens were boiled with or without f3-mercaptoethanol (5%), gel
fixation, staining, and autoradiography were carried out as previously
described (Kozarsky et aL, 1986) using 8%, 10%, or 3-10% gradients
of acrylamide as indicated. The following reduced 14C-methylated
standards (Amersham) were used to estimate molecular masses: my-
osin (200 kDa), phosphorylase b (97.4 kDa), bovine serum albumin
(69 kDa), ovalbumin (46 kDa), carbonic anhydrase (30 kDa), and
lysozyme (14.3 kDa). The estimated molecular mass values presented
are averages from multiple experiments. Additional unlabeled stand-
ards (Pharmacia) included a 2-macroglobulin (170 kDa), e-galactosid-
ase (116 kDa), transferrin (76 kDa), and glutamate dehydrogenase
(53 kDa).
Enzymatic Digestions-Pronase (20 Ag/ml, Sigma) treatment of
labeled monolayers to identify cell surface receptors was carried out
as previously described (Kozarsky et aL, 1986; Tolleshaug et al., 1983).
For endoglycosidase H (Endo H, Genzyme) digestions, washed im-
munoprecipitates were resuspended in 20 A1 of 50 mM sodium phos-
phate, pH 5.5, 0.5% SDS, and 1 mM phenylmethylsulfonyl fluoride,
with or without 2% (v/v) #-mercaptoethanol. The samples were boiled
for 5 min and cooled to room temperature, sodium azide was added
to a final concentration of 0.1% (w/v), and 2.5 Al of 50 mM sodium
phosphate, pH 5.5, with or without 0.3 Ag/ml Endo H were added.
Samples were incubated at 37 °C overnight prior to electrophoresis.
For N-glycanase digestions, washed immunoprecipitates were resus-
pended in 11.1 1d of 0.5% SDS with or without 0.7% 1 -mercaptoeth-
anol and boiled for 3 min. Subsequently, the following additions were
made: 15.3 l of 0.44 M sodium phosphate, pH 8.6, 2 mM phenylmeth-
ylsulfonyl fluoride, 5.6 lg of 7.5% (v/v) Nonidet P-40 in water, and
1.5-2.5 rl of N-glycanase (250 units/ml, Genzyme). Samples were
incubated at 37 °C overnight prior to electrophoresis.
Assays-Specific, high affinity scavenger receptor activity at 37 °C
was assessed as previously described (Krieger, 1983; Freeman et aL,
1991) by measuring cellular degradation of '25I-AcLDL (1-50 sg of
protein/mI) in 24-well culture dishes using 400 sg/ml poly(I) to
correct for nonspecific degradation. Protein concentrations were de-
termined by the method of Lowry et al. (1951).
RESULTS
To permit further analysis of the structures of the type I
and type II bovine scavenger receptors, we prepared three
polyclonal rabbit anti-peptide antibodies which recognize pep-
tide sequences from the cytoplasmic N terminus, the extra-
cellular spacer domain, or the extracellular SRCR (scavenger
receptor cysteine-rich) domain. Fig. 1 shows the ability of
these antibodies to immunoprecipitate bovine scavenger
receptors from CHO transfectants expressing either the type
I receptor (CHO[bSR-I] cells) or the type II receptor
(CHO[bSR-II] cells) and from control untransfected CHO
cells. The cells were pulse-labeled for 30 min with [35S]
methionine and then immediately processed (0 chase) or
incubated for an additional 3 h in medium supplemented with
1 mM unlabeled methionine prior to immunoprecipitation,
SDS-gel electrophoresis, and autoradiography. After pulse-
labeling, the anti-N-terminal peptide antibody (anti-N-term)
precipitated doublet precursor (p) forms of both types of
scavenger receptor with apparent molecular sizes of 65 kDa
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FIG. 1. Immunoprecipitation of bovine scavenger receptors
expressed in transfected CHO cells with polyclonal anti-pep-
tide antibodies. The type I (CHO[bSR-I]) and type II (CHO[bSR-
II]) scavenger receptor-expressing cells and wild-type untransfected
cells were plated on day 0 in 3 ml of medium D in 6-well dishes
(150,000 cells/well). On day 2, the cells were pulse-labeled with 300
aCi/ml [35S]methionine for 30 min, chased for 0 or 3 h, and lysed
with buffer A containing 10 mM iodoacetamide, and the extracts were
subjected to immunoprecipitation as described under "Materials and
Methods" with one of the following antibodies: anti-N-term (6 rl/
tube), anti-SRCR (10 Al/tube), or anti-spacer (7 ul/tube). Metaboli-
cally labeled proteins in the immunoprecipitates were reduced with
3-mercaptoethanol, separated by SDS-polyacrylamide (8%) gel elec-
trophoresis, and visualized by autoradiography as described under
"Materials and Methods."
and 63 kDa for the type I receptor (lane 1) and 57 kDa and
53 kDa for the type II receptor (lane 7). After the 3-h chase,
the precursors were converted into less well resolved doublet
mature (m) forms with apparent molecular masses of 82 kDa
and 76 kDa for the type I receptor (lane 2) and 72 kDa and
65 kDa for the type II receptor (lane 8). The results with the
anti-SRCR peptide antibody (anti-SRCR) were similar to
those with the anti-N-term antibody for the type I receptor
(lanes 3 and 4), although in other experiments, the anti-
SRCR antibody was not as quantitatively effective as the
anti-N-term antibody in precipitating type I receptors. As
expected, the anti-SRCR antibody did not recognize the type
II receptor (lanes 9 and 10) which does not have an SRCR
domain (Rohrer et al., 1990). The anti-spacer domain antibody
recognized the precursor forms of both types of receptor,
although not as well as did the other antibodies; however, it
did not precipitate the mature forms, suggesting that the anti-
spacer domain antibody may recognize a conformation/mat-
uration-sensitive epitope(s). The radioactive bands seen in
both the untransfected CHO lanes (13-18) as well as in the
lanes from the transfected cell (e.g. the high molecular weight
bands in lanes 3-5, 9-11, and 15-17) are presumed to be
background precipitation artifacts. Scavenger receptor bands
of the expected size were not detected in the untransfected
CHO cells using these antibodies (lanes 13-18).
The relationships between the "p" and "m" forms of the
receptors were examined in greater detail in the pulse/chase
experiment shown in Fig. 2. Cells were pulse-labeled for 10
min, and immunoprecipitates from each of the indicated chase
times were treated with or without endoglycosidase H (Endo
H). Conversion from an endoglycosidase H-sensitive to a
resistant form indicates that a protein contains N-linked
oligosaccharides which are processed from a high mannose,
Endo H-sensitive precursor form to a complex, Endo H-
resistant mature form in the medial Golgi compartment
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FIG. 2. Kinetics of scavenger receptor biosynthesis: endo-
glycosidase H sensitivity. Type I and type II scavenger receptor-
expressing cells were plated in medium D and subsequently pulse-
labeled with 300 MCi/ml [35S]methionine for 10 min, chased for the
indicated times, and lysed with buffer A; the extracts were subjected
to immunoprecipitation (anti-N-term antibody, 6 gl/tube). The pre-
cipitates were treated with endoglycosidase H (Endo H) or subjected
to control incubations without the enzyme as indicated and were
reduced with #-mercaptoethanol before 10% gel electrophoresis and
autoradiography as described under "Materials and Methods." The
precursor and mature forms of the type I and type II receptors are
indicated by pi, mr, pu, and mi, respectively. A degraded form of the
type I receptor is indicated by d. Molecular mass markers are 69 kDa
and 46 kDa.
(Kornfeld and Kornfeld, 1980). Fig. 2 shows that the precursor
forms of both types of scavenger receptor were Endo H-
sensitive while the mature forms were Endo H-resistant.
Thus, the scavenger receptors expressed in CHO cells are N-
glycosylated proteins, and the Endo H-sensitive N-linked
sugars contribute approximately 15-16 kDa to the apparent
mass of the precursor forms of the receptors. The apparent
masses of the type I and type II receptors without N-linked
sugars, 50 kDa and 41 kDa, respectively, are consistent with
those (50 kDa and 38 kDa) predicted from the primary se-
quence of the receptors derived by cDNA cloning (Kodama et
aL, 1990; Rohrer et al, 1990). There was an apparent precur-
sor/product relationship between the precursor and mature
forms, and the maturation for both types of receptor was slow:
no mature form was seen after 15 min of chase, and only a
small amount was seen after 30 min of chase. In the case of
the type I receptor, a second, Endo H-resistant form of the
receptor (d in Fig. 2) with an apparent molecular mass of
about 69 kDa was seen after 180 min of chase.
Fig. 3 shows the results of a more extended pulse/chase
experiment. Significant amounts of the mature forms of the
type I and II receptors as well as the d form of the type I
receptor remained stable for up to 8 h of chase, while virtually
no receptor protein was detectable after 24 h of chase. The
kinetics of the appearance of the d form of the type I receptor
and its reduced size relative to the mature form m, suggested
that it might be a degraded product derived from the proteo-
lytic removal of part of the extracellular C terminus from the
mature form of the type I receptor. This was confirmed using
the anti-SRCR antibody, because this antibody could not
immunoprecipitate the d form of the type I receptor (not
shown). Removal of the N-linked oligosaccharides with N-
glycanase demonstrated that the differences in the m, and d
forms cannot be attributed to alterations in the N-linked
sugars (data not shown). The estimated molecular masses of
CHO i[bSR-Il P1' M J
CHO mx--o &[bsR- JI]
-46
-974
-69
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FIG. 3. Processing and stability of scavenger receptors in
transfected CHO cells. Type I and type II scavenger receptor-
expressing cells were plated in medium E and subsequently pulse-
labeled with 300 jCi/ml [3 S]methionine for 30 min, chased for the
indicated times, and lysed with buffer A with 10 mM iodoacetamide,
and the extracts were subjected to immunoprecipitation (anti-N-term
antibody, 1 Al/tube), reduction with f-mercaptoethanol, 8% gel elec-
trophoresis, and autoradiography as described under "Materials and
Methods."
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FIG. 4. Pronase and endoglycosidase H sensitivity of scav-
enger receptors. Type I and type II scavenger receptor-expressing
cells were plated in medium D and subsequently pulse-labeled with
300 sCi/ml [35S]methionine for 30 min, chased for 2 h, and treated
with (lanes 2 and 5) or without (lanes 1, 3, 4, and 6) pronase (20 jg/
ml, 20 min, 37 'C) before harvesting with buffer A, and the extracts
were subjected to immunoprecipitation (anti-N-term antibody, 6 Al/
tube). Some of the immunoprecipitates (lanes 3 and 6) were treated
with endoglycosidase H (Endo H), and then all samples were subjected
to reduction with f-mercaptoethanol, 8% gel electrophoresis, and
autoradiography as described under "Materials and Methods."
the N-glycanase-treated type I and type II receptors were 53
kDa and 44 kDa, respectively. These values are similar to
those for the Endo H-treated precursors and suggest that
most of the differences in the electrophoretic mobilities of the
precursor and mature forms were due to post-translational
processing of N-linked oligosaccharides. We and others have
previously described a partially degraded form of the native
LDL receptor in CHO cells (Kozarsky et al., 1986) and human
fibroblasts (Lehrman et al., 1985) which is analogous to the d
form of the type I scavenger receptor. For LDL and scavenger
receptors, the degraded forms arise as a consequence of the
proteolytic removal of extracellular cysteine-rich terminal
domains.
To determine the location (surface or internal) of the var-
ious forms of the receptors in intact cells, we used extracellular
pronase sensitivity (Kosarsky et al., 1986; Tolleshaug et aL,
1983) and cell surface iodination assays. Fig. 4 shows the
effects of pronase on receptors from cells pulse-labeled with
[3"S]methionine for 0.5 h and chased for 2 h in medium
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supplemented with 1 mM unlabeled methionine. Under the
conditions of this experiment, the bulk of the labeled type I
receptor had been processed into the mature and degraded
forms, whereas there were roughly equal amounts of precursor
and mature forms of the type II receptor (compare lanes 1
and 4). Essentially all of the mature and degraded Endo H-
resistant forms were removed by extracellular pronase treat-
ment, while the low level of type I precursor and the substan-
tial level of type II precursor were pronase-resistant (lanes 2
and 5). These results were confirmed by the analysis of steady
state cell surface receptor expression using surface iodination.
Fig. 5 shows that mature, N-glycanase-sensitive forms of both
type I and type II receptors were observed after immunopre-
cipitation, electrophoresis, and autoradiography of 125I-labeled
surface receptors.
These experiments indicated that both types of scavenger
receptor expressed in CHO cells behaved as typical cell surface
membrane proteins which were co-translationally modified
with high mannose N-linked sugars in the endoplasmic retic-
ulum and transported through the Golgi apparatus, where the
N-linked chains were processed to the complex form, en route
to the cell surface. The bovine scavenger receptors differ from
other previously described integral membrane receptors in
that their primary sequences contain a domain with 24 Gly-
X-Y repeats which, we proposed, folds into a collagen-like
triple helix (Kodama et al., 1990; Rohrer et al., 1990). A
distinctive characteristic of Gly-X- Y repeat collagenous triple
helical domains is that some of the prolines and lysines are
hydroxylated by a,a'-dipyridyl-sensitive hydroxylases prior
to triple helix formation (Hurych and Chvapil, 1965; Kivi-
rikko and Myllyea, 1986; Drickamer et al., 1986; Colley and
Baenziger, 1987a, 1987b; Jimenez et al., 1973; Muller et al.,
1978; O'Reilly et al, 1988; Persson et al., 1988). Proline
hydroxylation stabilizes the triple helical structure and is
thought to occur in the endoplasmic reticulum (Kivirikko and
Myllyea, 1986).
Fig. 6 shows the independent and combined effects of a,a'-
dipyridyl and tunicamycin (an inhibitor of N-glycosylation)
on the structures of type I and type II scavenger receptors in
N-HO Cells bSR-IbSR-I+I
I -rGlvcanase -I+ I - I+
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FIG. 5. Surface iodination of transfected CHO cells. Type I
and type II scavenger receptor-expressing cells were plated in medium
D and subsequently labeled with 125I as described under "Materials
and Methods." The cells were then lysed with buffer A; the extracts
were subjected to immunoprecipitation (anti-N-term antibody, 6 Ml/
tube), treatment with (lanes 2 and 4) or without (lanes 1 and 3) N-
glycanase; and then all samples were subjected to reduction with 0-
mercaptoethanol, 10% gel electrophoresis and autoradiography as
described under "Materials and Methods."
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FIG. 6. Effects of a,a'-dipyridyl and tunicamycin on the
synthesis and processing of scavenger receptors. Type I and
type II scavenger receptor-expressing cells were plated in medium E
and subsequently treated with either 100 AM a,a'-dipyridyl, 2 /tg/ml
tunicamycin, or both as described under "Materials and Methods,"
pulse-labeled with 300 LCi/ml [35S]methionine for 2 h in the presence
or absence of the same drugs, and lysed with buffer A, and the
extracts were subjected to immunoprecipitation (anti-N-term anti-
body, 0.5 tl/tube), reduction with #-mercaptoethanol, 10% gel elec-
trophoresis, and autoradiography as described under "Materials and
Methods."
cells labeled for 2 h with ["5S]methionine. Under the condi-
tions of this experiment, both precursor and mature forms of
the receptors were observed without drug treatment (lanes 2
and 6). Treatment of the cells with a,a'-dipyridyl alone (lanes
1 and 5) led to somewhat increased electrophoretic mobilities
of the precursors which were also observed in 30-min pulse-
labeled cells (not shown) and a reduction in the amount of
precursor converted to mature form. This interference of a,a'-
dipyridyl with normal precursor-to-mature processing was
confirmed in pulse/chase experiments (not shown). Inhibition
of the post-translational processing and intracellular trans-
port of collagen domain-containing proteins by a,a'-dipyridyl
has been reported previously (Colley and Baenziger 1987b;
Jimenez et al., 1973; Muller et al., 1978; O'Reilly et al., 1988;
Persson et al., 1988). Treatment of the cells with tunicamycin
alone (Fig. 6, lanes 3 and 7) resulted in the collapse of the
doublets into more rapidly migrating singlet forms of both
type I and type II scavenger receptors with apparent molecular
masses of 49 kDa and 40 kDa, respectively. These values are
similar to those obtained after N-glycanase or Endo H treat-
ments (see above). Both forms of the receptor synthesized in
the presence of tunicamycin exhibited a,a'-dipyridyl-sensi-
tive electrophoretic mobilities (lanes 4 and 8). Thus, the
effects of a,a'-dipyridyl on scavenger receptor electrophoretic
mobility were not dependent on the addition of N-linked
sugars to the receptor. These data indicate that both forms of
the scavenger receptor were subject to prolyl and/or lysyl
hydroxylation, that the collagenous domains probably fold
into collagen triple helices, and that the hydroxylation, and
thus the folding, facilitates intracellular transport.
The presence of triple helical collagenous domains in the
scavenger receptors appears to explain, at least in part, our
previous finding that about half of the scavenger receptors
purified from bovine lung membranes was isolated as reduc-
tion-sensitive trimers (Kodama et al., 1988). However, most
of the rest of the purified receptor was isolated as reduction-
sensitive dimers. The receptors' ligand AcLDL bound only to
the trimeric form. To examine the disulfide-dependent cova-
lent structure of the bovine receptors synthesized in the CHO
cells, we determined the electrophoretic mobilities of reduced
and unreduced receptors after ["3 S]methionine labeling for
23989
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either 20 min or 2 h (Fig. 7). After a 20-min labeling, the
unreduced precursor forms of the type I and type II receptors
(lanes 2 and 6) migrated as three distinct bands, designated
p-10, p-20 , and p-30 for the monomeric, dimeric, and trimeric
forms. The apparent masses for the type I receptor were 65/
63 kDa (doublet), 129 kDa, and 198 kDa, and for the type II
receptor were 57/53, 119, and 176 kDa. On reduction (lanes 1
and 5), these bands collapsed into the precursor forms de-
scribed above. After labeling for 120 min, the unreduced
receptors migrated as sets of monomeric, dimeric, and trimeric
precursor and mature forms (lanes 4 and 8). The apparent
masses of the mature forms were 82/76, 162, and 237 kDa and
72/65, 147, and 219 kDa for the type I and type II receptors,
respectively. The monomeric unreduced precursor and mature
forms of the type I receptor (lanes 2 and 4, "1o") exhibited
slightly increased electrophoretic mobilities (smaller apparent
masses) relative to their monomeric reduced counterparts
(lanes 1 and 3). The increased mobilities of the unreduced
forms may be a consequence of intramolecular disulfide bond-
ing as has previously been observed for the LDL receptor
(Daniel et al., 1983). These results establish that both type I
and type II bovine scavenger receptors synthesized in CHO
cells can be isolated as disulfide-linked dimers and trimers,
that this oligomerization can be detected in the precursor,
Endo H-sensitive, forms, and, because the results were similar
for type I and type II receptors, that the cysteine residues in
the SRCR domain are probably not involved in the interchain
disulfide bonds.
The presence of reduction-sensitive trimers in the type II
receptor was unexpected. This form of the molecule has only
2 cysteines per chain (Cys3 and Cys"7), only 1 of which is
extracellular (Cys") and, thus, available to participate in a
disulfide bond. The reducing environment in the cytoplasm
should prevent the side chain of Cys"7 from forming disulfide
bonds in intact cells. Therefore, we tested the possibility that
the reduction-sensitive trimeric forms of the receptors seen
in Fig. 7 were experimental artifacts due to oxidation of
intracellular cysteines during or after cell lysis. Fig. 8 shows
the effects of including the sulfhydryl trapping agent iodoa-
cetamide in the cell lysis buffer. The use of 10 mM iodoacet-
amide (compare lanes 1 and 5 with lanes 2 and 6) eliminated
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FIG. 8. Effects of iodoacetamide and mutation of Cyses to
Gly ss on scavenger receptor oligomerization. Transfected cells
expressing the wild-type (Cys") forms of the type I and type II
scavenger receptors and cells expressing the GlyS mutant forms were
plated in medium E and subsequently pulse-labeled with approxi-
mately 300 ,Ci/ml [3S]methionine for 20 min, chased for 2 h, and
lysed with buffer A with or without 10 mM iodoacetamide as indicated,
and the extracts were subjected to immunoprecipitation (anti-N-term
antibody, 1 /l/tube), 8% gel electrophoresis without sample reduction,
and autoradiography as described under "Materials and Methods."
Abbreviations: bSR-I(GS ) and bSR-II(G83), cells expressing the mu-
tant type I and type II receptors.
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FIG. 7. Comparison of the electrophoresis of reduced and
unreduced scavenger receptors. Type I and type II scavenger
receptor-expressing cells were plated in medium E and subsequently
pulse-labeled with 300 uCi/ml [3"S]methionine for either 20 min or
120 min and lysed with buffer A, and the extracts were subjected to
immunoprecipitation (anti-N-term antibody, 1 Ml/tube), reduction
with #-mercaptoethanol as indicated, 3-10% gradient gel electropho-
resis, and autoradiography as described under "Materials and Meth-
ods." The monomeric, dimeric, and trimeric precursors are indicated
by p-10 , p-20, and p-30, respectively. The monomeric, dimeric, and
trimeric mature forms are indicated by m-10, m-20, and m-30.
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FIG. 9. Kinetics of processing of unreduced scavenger
receptors in transfected CHO cells. Type I and type II scavenger
receptor-expressing cells were plated in medium E and subsequently
pulse-labeled with 300 ,Ci/ml [3 5SJmethionine for 30 min, chased for
the indicated times, and lysed with buffer A containing 10 mM
iodoacetamide, and the extracts were subjected to immunoprecipita-
tion (anti-N-term antibody, 1 ~l/tube), 8% gel electrophoresis without
sample reduction, and autoradiography as described under "Materials
and Methods."
most of the trimeric, but not the dimeric or monomeric forms
of both the type I and type II receptors. Thus, the reduction-
sensitive trimers were apparently artifacts of cell lysis.
Fig. 9 shows the kinetics of type I and type II scavenger
receptor processing examined using iodoacetamide-containing
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lysis buffer and nonreducing electrophoresis. The maturation
of the precursor forms was fairly slow, and the mature forms
were stable for the first 8 h of chase and were degraded by 24
h of chase. The dimeric degraded form of the type I receptor,
d-20, was detected by 2 h of chase, and its stability was
comparable to that of the full length mature form. The d-20
form was not recognized by the anti-SRCR domain antibody
(not shown), suggesting that both of the chains in this form
of the dimer had been proteolytically cleaved.
The results with iodoacetamide suggested that the extra-
cellular cysteine, Cys 3 , is probably the only cysteine in either
the type I or type II receptors which normally participates in
the interchain disulfide bond responsible for covalent dimer
formation. To directly test this, we generated expression
vectors for mutant type I and II receptors (Cys83 to Gly') and
isolated stable CHO transfectants, CHO[bSR-I(Gly")] and
CHO[bSR-II(Gly3)], which express the mutant receptors.
Analysis of the saturation kinetics for the degradation of 125I-
AcLDL by cells expressing the wild-type (Cys"8 ) and mutant
(Gly") type I and type II receptors showed that the mutations
did not alter the receptors' activities (Freeman et a., 1991,
and data not shown). The affinities of the wild-type and
mutant receptors for '25I-AcLDL were virtually identical. Fig.
8 shows the effects of the mutations and iodoacetamide on
the covalent oligomerization of the scavenger receptors. The
cells were pulse-labeled with [3 5S]methionine for 20 min and
chased for 2 h prior to cell lysis, immunoprecipitation, elec-
trophoresis, and autoradiography. All of the samples were
unreduced. For the GlyS mutants in the absence of iodoacet-
amide (lanes 3 and 7), monomeric and dimeric, but no tri-
meric, forms were observed. In the presence of iodoacetamide,
only monomeric Gly3 mutant receptors were observed (lanes
4 and 8). Thus, in intact cells, wild-type receptors were
comprised of monomers and covalent dimers linked by CysS3
disulfides. The covalent, reduction-sensitive trimers observed
in the transfected CHO cells after lysis without iodoacetamide
(lanes 1 and 5), and presumably the trimers that we isolated
from bovine tissue (Kodama et al., 1988), were artifacts of
oxidation during cell disruption and probably arise because of
disulfides formed by Cys'7.
Although these experiments show that the scavenger recep-
tors do not normally form covalent trimers, the presence of
the collagenous domain, the receptors' a,a'-dipyridyl-sensi-
tive post-translational processing, and the efficient formation
of covalent trimers when the cells were disrupted without a
sulfhydryl trap all indicate that the receptors are normally
noncovalent trimers. To independently confirm this, we pulse-
labeled CHO transfectants expressing the wild-type receptors
for either 20 or 120 min with [35S]methionine and examined
the effects of treating the labeled, intact cells with the lipid-
soluble chemical cross-linker DFDNB. The cells were subse-
quently lysed in the presence of iodoacetamide, and the oli-
gomerization state of immunoprecipitated receptors was ana-
lyzed by electrophoresis (Fig. 10). After a 20-min pulse, the
precursor forms of the type I and type II receptors were cross-
linked into reduction-resistant dimers and trimers (lanes 1, 2,
5, and 6). Without reduction (lanes 3, 4, 7, and 8), cross-
linking significantly increased the amounts of trimeric forms.
The electrophoretic mobilities of the reduction-resistant
cross-linked dimers and trimers were virtually identical with
the non-cross-linked reduction-sensitive dimers and trimers
(lanes 3 and 7, and results using iodoacetamide-free lysis
buffer, not shown). In the unreduced, cross-linked specimens
(lanes 4 and 8), the minor bands migrating with apparent
masses greater than those of the trimeric forms (e.g. those
highlighted by dots) have not been identified, but might
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FIG. 10. Effects of treating transfected cells with the cross-
linker difluorodinitrobenzene on wild-type scavenger recep-
tor electrophoresis. Cells expressing wild-type (Cys') type I and
type II scavenger receptors were plated in medium E, subsequently
pulse-labeled with 300 MCi/ml [35S]methionine for either 20 min or
120 min, and treated with or without 350 AM DFDNB as described
under "Materials and Methods." The cells were then lysed with buffer
A containing 10 mM iodoacetamide and 5 mM glycine, and the extracts
were subjected to immunoprecipitation (anti-N-term antibody, 1 p1/
tube), 3-10% gradient gel electrophoresis with or without sample
reduction, and autoradiography as described under "Materials and
Methods." The solid dots above the molecular mass markers indicate
the locations of high molecular weight bands in the cross-linked
material.
represent higher order receptor oligomers. The results of
cross-linking after a 120-min pulse showed that the oligomer-
ization of the mature forms of the receptors (lanes 9-16) was
similar to that of the precursors. Similar cross-linking results
were observed for the Gly' mutants (data not shown). Thus,
both wild-type and mutant type I and type II receptors form
noncovalently associated trimers.
DISCUSSION
We recently cloned type I and type II scavenger receptor
cDNAs from both bovine lung (Kodama et al., 1990; Rohrer
et al., 1990) and murine macrophages (Freeman et al., 1990).
The homologous human cDNAs have also been cloned (Mat-
sumoto et al., 1990). Both types of scavenger receptor se-
quences were predicted to encode transmembrane proteins
with multiple extracellular domains, including an a-helical
coiled-coil domain and a 72-amino acid domain comprising
24 Gly-X- Y triplets. Because of these triplet repeats and our
demonstration that a trimeric, but not dimeric or monomeric
form of the purified bovine receptor can bind ligands (Kodama
et al., 1988), we proposed that this domain oligomerizes into
a collagenous triple helix (Kodama et al., 1990). The type I
and II receptors differ only by the presence in the type I
receptor of an extracellular cysteine-rich C-terminal domain,
called the SRCR domain (Rohrer et al., 1990; Freeman et al.,
1990). In the current work, we generated polyclonal anti-
peptide antibodies which recognize bovine scavenger receptors
expressed in stable CHO cell transfectants (Freeman et al.,
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1991) and used these antibodies to study the processing and
structures of the receptors.
Both type I and type II scavenger receptors behaved as
typical cell surface membrane proteins. Precursor forms were
co-translationally modified with high mannose N-linked sug-
ars and oligomerized (see below) in the endoplasmic reticulum
and were transported to the Golgi apparatus, where the N-
linked chains were converted into Endo H-resistant complex-
type oligosaccharides. The mature forms of the receptors were
then expressed on the cell surface. The 15-17-kDa increases
in the apparent masses of the receptors on conversion from
the precursor to the mature forms were primarily due to
maturation of the N-linked oligosaccharides. The apparent
masses of the deglycosylated receptors were similar to those
predicted from the deduced amino acid sequences (50 kDa
and 38 kDa for the type I and type II receptors). Proteolytic
cleavage of the extracellular C terminus of the mature form
of the type I receptor lead to the formation of a relatively
stable truncated form of the molecule. Similar proteolytic
processing of the native LDL receptor has also been observed
(Kozarsky et al., 1986; Lehrman et al., 1985). The functional
significance of this proteolysis of the scavenger receptor re-
mains to be determined.
The efficiency of the post-translational processing and in-
tracellular transport of the type I and type II scavenger
receptors, as well as their electrophoretic mobilities, were
altered by treatment of the transfectants with a,a'-dipyridyl,
an inhibitor of the collagen-modifying enzymes prolyl hydrox-
ylase and lysyl hydroxylase (Hurych and Chvapil, 1965; Ki-
virikko and Myllyea, 1986). The effects of a,a'-dipyridyl were
similar to those previously observed with other proteins con-
taining collagenous domains, e.g. serum mannan binding pro-
tein (Colley and Baenziger, 1987a, 1987b) and the lung sur-
factant apoprotein (O'Reilly et al., 1988), and therefore pro-
vide strong experimental support for the proposal that the
Gly-X- Y repeat domain folds into a collagenous triple helix.
The relatively slow transport of the receptors from the endo-
plasmic reticulum to the Golgi (30-60 min) may, in part,
reflect the time required for the extensive post-translational
steps in collagen triple helix assembly (prolyl and lysyl hy-
droxylation, prolyl cis-trans isomerization, alignment, and
folding of the monomers into trimers, see Kivirikko and
Myllyla, 1986) in addition to the time required for the folding
and intermolecular association of the other portions of the
receptor (e.g., the a-helical coiled-coil domain).
The covalent and noncovalent association of the receptors'
polypeptide chains into oligomers was examined using the
sulfhydryl trapping agent iodoacetamide, the chemical cross-
linker DFDNB, and site-specific mutagenesis. Both type I
and type II scavenger receptors have cysteine residues at
positions 17 (cytoplasmic domain) and 83 (extracellular
spacer domain). The precursor and mature forms of both type
I and type II receptors can be found as monomers and Cys83 -
dependent, reduction-sensitive dimers. Disulfide-linked tri-
mers are not present in intact cells, but are formed when the
cells are lysed in the absence of a sulfhydryl trapping agent
because of oxidation of the side chain of Cys"7. The reducing
environment of the cytoplasm apparently prevents the partic-
ipation of Cys' 7 in disulfide bonding in intact cells. The type
I receptor has 6 cysteines in the SRCR domain which are not
present in the type II receptor. The similarity of the oligomeric
structures of the type I and type II receptors and the evolu-
tionary conservation of the cysteines in SRCR domains (Free-
man et aL, 1990) strongly suggests that the cysteines in the
SRCR domain are probably all involved in intramolecular
disulfide bonds. We previously reported that the scavenger
receptors purified from bovine lung membranes were com-
posed of reduction-sensitive dimers and trimers (Kodama et
al., 1988). Furthermore, ligand blotting experiments indicated
that only the trimeric form could bind the ligand AcLDL.
The current studies using transfected CHO cells suggest that
the disulfide-linked trimeric form of the purified bovine lung
receptor was also an oxidation artifact.
Although disulfide-linked trimers are experimental arti-
facts, our findings strongly suggest that both precursor and
mature type I and type II receptor chains normally associate
into noncovalent trimers. Reduction-resistant dimers and tri-
mers were observed after cross-linking receptor chains with
DFDNB in intact cells. The facile formation of disulfide-
linked trimers when the cells are lysed as well as the presence
of the collagenous domain and a,a'-dipyridyl sensitivity sup-
port the conclusion that the receptor chains associate as
trimers. Thus, the type I and type II scavenger receptors are
noncovalently associated trimers comprising disulfide-linked
dimers and monomers. While it seems likely that the collag-
enous domain contributes significantly to the trimerization of
receptor subunits, other domains, particularly the a-helical
coiled coil domain, may also play an important role in trimer-
ization. Clearly, the disulfide bond at Cys' is not required for
trimerization. Assessment of the relative contributions of the
different domains to receptor trimerization will require addi-
tional experiments.
The stoichiometry of the dimers and monomers in the
functional receptors has not yet been established. In the
simplest trimeric model, each dimer would associate with a
single monomer to form a functional "unit" trimer. An at-
tractive, alternative model for the structure of the scavenger
receptors is a higher order oligomerization model based on
the structures of complement factor Clq (Schumaker et al.,
1981; Reid et al., 1982), lung surfactant apoprotein (Voss et
al., 1988; Hass et al., 1991), and the serum mannose binding
protein (Thiel and Reid, 1989). These secreted proteins, which
also contain short collagenous domains, assemble into higher
order oligomers containing multiple collagenous triple helices.
They have a distinctive ultrastructure which resembles a
bouquet of tulips (collagenous stems with C-terminal globular
bulbs). In addition to the higher order oligomerization of
proteins containing collagenous domains, proteins with large
a-helical coiled-coil domains are also known to assemble into
higher order oligomers (Bourne, 1991). Our observation of
chemically cross-linked species with apparent masses greater
than those of the trimeric forms is consistent with possible
higher order oligomeric structures. Additional studies will be
required to characterize more precisely the oligomerization
states and structures of the functional type I and type II
scavenger receptors.
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Appendix B
The SRCR domains: an update
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This appendix provides an update to the review of the scavenger
receptor cysteine rich (SRCR) domain superfamily presented in chapter 5. In
particular, it presents information about the 5 new proteins which have joined
the superfamily since the publication of the review, and correctly aligns CD6
domain 1, which was improperly aligned in the published figure. It also reviews
the recent discovery of a ligand for CD6.
Two new members of the group A SRCR domains have been identified,
MARCO and Enterokinase. The distinguishing property of the group A SRCR
domains is the presence of 6 cysteines, and in particular the absence of Cys1
and Cys4 (see chapter 5). MARCO, or SR-AIII, is a glycoprotein which has an
extended collagenous region in addition to its single SRCR domain and is
expressed on the surface of a subset of macrophages. (Elomaa et al., 1995). It
has been suggested that MARCO's SRCR domain is involved in the interaction
of this receptor with bacteria; however this is highly questionable. Alignment of
the MARCO SRCR domain with the group A consensus sequence (Figure C.1)
reveals that it matches the consensus quite well - of the residues in the
consensus sequence, 78% are matched by MARCO.
Enterokinase is an intestinal membrane-associated protease that
cleaves and activates trypsinogen, and has been found to contain a single
SRCR domain (Kitamoto et al., 1994). It is a modular protein, and also includes
domains homologous to the LDL-receptor, meprin, Cl r/s, as well as a serine
protease domain. Alignment of the SRCR domain of the bovine sequence with
the group A consensus reveals that it is a relatively poor fit to the consensus(Figure C.1). While the N-terminal half of the domain fits the consensus fairly
well (55 % identity), the C-terminal portion is extremely difficult to align. One of
the cysteines (probably Cys s) is apparently missing. In the alignment reported
by Kitamoto and colleagues, it was proposed that Cys7 and Cys8 are missing,
and that the cysteine that I have aligned as 8 is not part of this domain. In any
case, it may well be that this domain is the remnant of an SRCR domain, and no
longer has the SRCR fold. On the other hand, perhaps it is stable without
formation of the canonical disulfide bonds.
Three additional members of the group B SRCR domain have been at
least partially cloned and sequenced. The major distinguishing feature of group
B is the presence of 8 characteristic cysteine residues (see chapter 5). The new
group B members include Ebnerin, PEMA, and a gall-bladder mucin, and they
contain a total of at least 11 additional SRCR domains. One additional group B
domain, human CD6 domain 1, has been added to the alignment (Figure C.1),
as it was improperly aligned in the published work (chapter 5). The reason for
this misalignment is fairly clear - there is a very large sequence inserted
between cysteines 5 and 6.
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The first of the new proteins, Ebnerin, is a multidomain glycoprotein
which contains 4 SRCR domains, 3 bone morphogenic protein-I domains, and a
region homologous to the zona pelucida domain (Li and Snyder, 1995). It is
expressed in the von Ebner's glands, which are salivary glands involved in
taste perception. The 4 SRCR domains from the rat protein are obviously a
fairly recent result of tandem duplication within the gene, as the domains are all
virtually identical to each other (Fig C.1). The domains all match the consensus
sequence extraordinarily well: for example domain 2 has 98% identity with the
consensus. In the published sequence, domain 1 is incomplete, starting well
within the SRCR domain. It seems quite likely that the authors failed to clone
the N-terminal sequence of the protein, a conclusion supported by the lack of a
signal peptide and by their own finding that the protein expressed in 293 cells
has a substantially greater mobility on SDS-PAGE gels than the native Ebnerin.
PEMA (Petromyzon marinus SRCR containing protein), a protein
consisting of 2 SRCR domains and 5 EGF-like repeats has recently been
identified (Mayer and Tichy, 1995). PEMA is a sea lamprey protein, and was
cloned from a larval intestinal tissue. It is in the Genbank database, but no
information concerning its function or expression has been published. PEMA's
two SRCR domains are fairly similar to each other, and match the consensus
sequence quite well (Figure C.1).
The gall-bladder mucin is a protein secreted by gall-bladder epithelial
cells which presumably plays a role in the protection of those cells. Partial
cDNA clones of the bovine gall-bladder mucin which contains 5 SRCR domains
in addition to multiple presumably O-glycosylated serine/threonine rich regions
have been identified (Nunes et al., 1995). One of these clones, pGBM7-1,
contains 4 SRCR domains, which are termed Ga711-Ga714 in Figure C.1.
These 4 SRCR domains are virtually identical to each other, and are
extraordinarily similar to those found in Ebnerin -- Ebnerin domain 2 and mucin
domain 1 have 80% sequence identity. The 4 mucin sequences are an
excellent match for the consensus sequence, as is the SRCR domain from the
other cDNA clone pGBM31-1 (called Ga311 in Figure C.1)
The use of the SRCR domains in such a broad variety of proteins argues
that it is a "tinker-toy" type module, able to function in numerous different
contexts. It seems likely that our observation in the review (Chapter 5) that the
mammalian SRCR domains are mainly associated with proteins which are
potentially involved in host defense is not particularly significant -- it seems
unlikely that the mucin or enterokinase has a role in host defense, although it is
a possibility. The functions of these newer SRCR domains are in no case
known. However since the publication of the review, studies of CD6 been
illuminating in this regard. Bowen, Aruffo and colleagues have cloned the
Activated Leukocyte-Cell Adhesion Molecule (ALCAM), a Ig domain containing
protein found on activated leukocytes which binds to CD6 (Bowen et al., 1995).
Studies with individual segments of CD6 demonstrated that SRCR domain 3
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expressed as a soluble independent module is capable of binding ALCAM,
proving that the SRCR domain is responsible for this interaction (Whitney et al.,
1995b). The discovery of other ligands for the SRCR domains should help
further our understanding of this domain.
-- page 181 --
Figure B.1. Comparison of the sequences of 13 new SRCR domains to
previously derived consensus sequences.
The sequences were manually aligned. Abbreviations used are as
follows: ConsA/B, consensus sequences for the group A and B SRCR domains(see chapter 5); Enter, bovine enterokinase; MARCO, mouse MARCO; PEMA,
sea lamprey PEMA; Ga71 and Ga3 11, bovine gall-bladder mucin clones
pGBM7-1 and pGBM31-1. Murine CD6 domain-1 is also presented, as it was
incorrectly aligned in the review presented in chapter 5. Where multiple
domains exist within the same protein, they are numbered starting at the amino
terminus. Consensus sites are indicated in the top row for both domain types as
described in chapter 5. These consensus residues have not been adjusted to
take the new sequences into account, and are denoted by a single amino acid(capital letter) or a single class of residue (a, aliphatic (A, I, L, V); x, aromatic (F,
W, Y); h, hydrophobic (a, x, M); +, positively charged (H, K, R); -, negatively
charged (D, E); ±, charged (-, +); o, S or T).
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Appendix C
Progress in the determination of the high resolution
structure of an SRCR domain
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Introduction
Generation of a high resolution structure of an SRCR domain would
provide a significant resource. Presumably all of the SRCR domains have the
same overall fold. Accordingly, structural information about a single SRCR
domain should provide data about all the members of this increasingly
widespread superfamily. There are two basic approaches one can take to
determine the structure of a domain this size (102 amino acids). The classical
approach used to determine such a structure is X-ray crystallography. X-ray
structure determination can be quite difficult, as conditions which promote the
nucleation and growth of crystals which diffract adequately are not always
readily discovered. X-ray crystallography typically requires significant
quantities of protein. Determination of a structure of a domain this large by
means of nuclear magnetic resonance (NMR) is also feasible (Wuthrich, 1990).
In order to facilitate this process, substitution of '5N-labeled amino acids is
highly desirable. Thus, expression in bacterial systems or perhaps yeast is the
most practical way to generate material for this approach. This appendix
describes efforts to express the SRCR domain of the type I bovine scavenger
receptor in both Pichia pastoris and E. coli. It also summarizes the progress
which has been made on the expression and refolding of the membrane
proximal domain of CD6 in E. coli.
I carried out most of the experiments described in this appendix. Gus
Leotta, an undergraduate (UROP) working with me, generated and sequenced
the Pichia pHIL-S1 [b-SRCR] construct, and made the Pichia HisMut÷
transformants. Michael Bowen and Alejandro Aruffo at the Bristol-Myers Squibb
Pharmaceutical Research Institute have generously provided reagents and
advice for the work on CD6 SRCR domain 3.
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Experimental procedures
Materials - pHIL-S1 and pPIC-9 were obtained from Invitrogen, Ni-NTA
agarose was from Qiagen, pET15b and E. coli BL21 (DE3)pLysS were from
Novagen. All basic molecular biological manipulations were carried out as
described in Sambrook et al., (1989).
Generation of Pichia pastoris bSRCR expression constructs -To attempt to
express the SRCR portion of the bovine SR-AI in Pichia pastoris, three different
expression constructs were generated. The first of these was generated using
PCR and two oligonucleotides, primer 1 (5' GCCGCCCTCGAGCTCACCACCA
TCACCATCATCACCACAGCGGCCGCAGAGCTAGCGTTTTAATTAAGACTAGT
ATGCAAAGACAATCTAAT 3') and primer 2 (5' - GCCGCCGGATCCGCGGAATT
CGAATGAAAATATGATGCA 3'). These oligonucleotides were used with
plasmid pXSR7 (Kodama et al., 1990) to generate a PCR product that contained
the entire SRCR domain. The PCR product was digested with Xho I and Bam
HI, and the digested product was ligated with pHIL-S1 which had been digested
with the same enzymes. The construct was then sequenced on both strands
using the dideoxy method (Sequenase, US Biochemical). The expressed
construct, pHIL-S1[His-bSRCR] would consist of an N-terminal PHO1 signal, 8
His residues for affinity purification, an in-frame Not I sequence (for insertion of
an epitope tag if desired), and a heart muscle kinase sequence for 3P labeling.
The final N-terminal amino acid sequence after signal sequence cleavage
would be predicted to be HHHHHHHHSGRRASVLIKTSM 34s-, where M345
corresponds to the beginning of homology with the bovine SRCR domain. M345
is the only methionine in the SRCR domain, and thus the N-terminal "utility
peptide" could be cleaved off with cyanogen bromide after use for purification.
The SRCR domain was then transferred into the pPIC9 vector, which has an a-
factor leader sequence instead of the PHO1 sequence found in pHIL-S1. In
order to do this, the insert was excised from the pHIL-S1 construct with Xho I
and EcoR-l, and then linkered with two oligonucleotides (5'-CAGGGCCCATG-3'
and 5'-CATGGGCCCTGAGCT-3') to blunt the Xho I site. This insert was then
ligated to pPIC9 digested with Sna BI and Eco RI, and the finished construct,
pPIC9[His-bSRCR] was sequenced as described above. It is possible that the
leader sequence could interfere with expression, so a construct without it was
also made. The leader was excised by digestion of pHIL-S [His-bSRCR] with
Xho I, partial blunting with Klenow and dGTP, dTTP, and dCTP, digestion with
Spe I, removal of 5' overhangs with mung bean nuclease, and ligation. The
excised region was sequenced as described above. The product of this, pHIL-
S1[b-SRCR], should produce protein product which, after signal sequence
cleavage, would begin with the sequence RSM s5.
Transfection and expression in Pichia pastoris - The three expression
constructs were linearized with Bgl II and transfected into the histidine
auxotrophic Pichia pastoris strain GS115 using the spheroplast method as
described in the manufacturer's instructions (Invitrogen, Pichia expression kit).
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Transfection was evaluated by ability of transfectants to grow in the absence of
histidine, and disruption of the AOX1 locus was verified by determination of the
loss of ability to grow on methanol as a sole carbon source (i.e. the yeast should
change from His-Mut to His÷Mut-). Alternatively, the vectors were digested with
Sal I prior to transfection. This should result in integration of the vector at the
His4 locus, resulting in a His÷Mut÷ transfectant. Presence of the insert in the
transfected yeast was verified by PCR using primers flanking the insert (AOX5'
and AOX3', Invitrogen). Expression of the transfected gene was carried out as
described (see Invitrogen manual for all solutions/details). Briefly, transfected
yeast were inoculated into BMGY (which contains glycerol as a carbon source)
in baffled flasks and grown in baffled flasks on a rotary shaker at 300C until they
reach an OD, of -1.0. They were then pelleted at 1500xg, and induced by
resuspending at an OD6 of 1.0 (His÷Mut ÷) or 10.0 (His÷Mut-) in BMMY (which
contains methanol as a carbon source). Methanol was added to 0.5% every
day to compensate for evaporation. After 5 days, the yeast were harvested by
centrifugation at 1500xg and the supernatant and the pellet were frozen at -
200C. Secreted proteins were visualized by SDS-PAGE and Coomassie or
silver staining (Kozarsky et al., 1986; Morrissey, 1981).
Generation of bSRCR DNA constructs for expression in E. coli - The bacterial
expression construct was generated as follows. The bSRCR insert was excised
from pHIL-SI[His-bSRCR] by digestion with Spe I, blunting with Klenow, and
Bam HI digestion. The gel purified insert was then ligated with pET-15b which
had been digested with Nde I, blunted with Klenow, and digested with Bam HI.
The resulting vector, pET-15b[bSRCR], was sequenced at the ligation joins.
Expression of this construct in bacteria should give a product with the N-
terminal sequence MGSSHHHHHHSSGLVPRGSHTSM345, which includes a
His tag for purification, and both a thrombin site and a unique methionine to
allow cleavage of this leader region from the SRCR domain. This plasmid was
then transfected into the expression host E. coli BL21 (DE3)pLysS.
Expression and purification of bSRCR from E. coli - Transfected bacteria were
inoculated into LB containing 100 pg/ml ampicillin and 34 gg/ml
chloramphenicol, and grown at 370C until reaching an OD6 of -0.6.
Expression was then induced by addition of isopropyl P~-D-
thiogalactopyranoside to 1 mM. Three hours after induction, the bacteria were
harvested by centrifugation for 15 minutes at 6000xg, and the resulting pellets
were frozen at 200C. Proteins were solubilized by sonicating the pellets for 1
min. on ice (setting 7, Model 185 Branson Sonifier) in 40 ml Buffer A (6 M
guanidine*HCI, 100 mM sodium phosphate, 100 mM Tris pH 8.0). The resulting
mixture was stirred for 1 hr at room temperature, and sonicated twice for 1 min.
The sample was then clarified by centrifugation for 2x15 min. at 9000xg. The
supernatant was mixed with an equal volume of a 1: 1 suspension of Ni-NTA
agarose in Buffer A, and incubated at room temperature on a rotator for 1 hr.
The mixture was poured into an column (1.5 cm internal diameter). The matrix
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was washed with 100 ml buffer A, and 50 ml Buffer B (Buffer A, pH 6.3). It was
then eluted with buffer C (Buffer A, pH 4.5). The eluate was monitored by OD280.
Fractions containing protein were pooled, and evaluated by SDS-PAGE and
Coomassie Blue staining as described above.
Refolding and analysis of bSRCR - Many refolding protocols were attempted,
however the most generally useful one was as follows. Purified bSRCR (10-20
mg/ml) was reduced by addition of dithiothreitol to 100 mM and immersion in a
boiling water bath for 20 minutes. The sample was then diluted to 1 mg/ml with
8 M GuHCI. Refolding reactions were typically done at a final protein
concentration of ~25gg/ml in 200 mM Tris pH 8.5 containing 1 mM EDTA.
Additives and variations attempted included the addition of 10% glycerol, 1-2 M
urea, 1-2.5 M guanidine HCI, 0.5 M arginine, Ham's F12 media, and complete
Dulbecco's phosphate buffered saline (Gibco). Redox reagents added were
typically 3 mM reduced glutathione and 0.3 mM oxidized glutathione, although
different ratios and quantities were attempted. Refolding reactions were tried at
40C, 250C, and 370C for 1 to 10 days at varying pH values. Refolding reactions
were analyzed using reversed phase HPLC. The reaction mixture was injected
over a Vydac C18 analytical column (218TP54). The column was eluted with
the following gradient (buffer D = acetonitrile/0.1% trifluoroacetic acid (TFA);
buffer E, H20/0.1% TFA): 5 minutes 0-23% buffer D (balance was buffer E), 20
minutes 23-43% D, and 2 minutes 43-100% D. Initial purified material (which
was oxidized) eluted at 20.4 min, while fully reduced material eluted at 23.7
min. Refolded material which looked promising was further analyzed by
proteolytic digestion. Refolded material (200 gg) was boiled in 8 M Urea for 20
minutes, cooled to room temperature, diluted with 50 mM Tris/1 mM CaCI2, pH
7.6 to a final urea concentration of 1 M, and digested with 4 gg modified trypsin
(Promega) for 16 hr at 370C. Digests were evaluated by reversed phase HPLC
as described above using a slightly different gradient (0-10 min, 0% D, 10-50
min, 0-40% D, 50-51 min, 40-100% D). Peaks were analyzed by amino acid
analysis (MIT Biopolymers Facility, Dept. of Biology).
Generation of murine CD6 domain 3 DNA expression constructs -Two different
mCD6-3 constructs were made. These were SmCD6, which contains residues
260-361, and LmCD6, which includes residues 260-394 (Whitney et al., 1995a).
The constructs were generated by PCR, using murine CD6-pCDM8 (provided
by Michael Bowen, Brystol-Myers Squibb) vector as a template, and two
oligonucleotides, Primer 1 (5'-GGGAATTCCATATGGAGCACCAGTCCTGGCG
C-3') and either Primer 2 (SmCD6-3) (5'-CGTTGAAGGGATCCTCAGCCTGAGC
AGACAACCCT-3') or Primer 3 (LmCD6-3) (5'-CGTTGAAGGGATCCTCATGAGT
CCTTATCCTTCAC-3'). The resulting PCR products were digested with Nde I
and Bam HI, and ligated with pET-15b which had been cut with the same
enzymes. The resulting constructs were then sequenced. SmCD6-3 had a
base change that resulted in the conversion of Arg324 to a Ser, and will be
reconstructed at a future time. LmCD6-3 had a single conservative base
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change. These constructs when expressed will encode proteins with the N-
terminal sequence MGSSHHHHHHSSGLVPRGSHME20, which includes a His
tag and a thrombin cleavage site. The short construct encodes a protein
product that ends at residue 361, the long at residue 394. These plasmids were
transfected into the expression host E. coli BL21 (DE3)pLysS.
Expression, purification, and refolding of mCD6-3 from E. coli - SmCD6-3 and
LmCD6-3 were expressed, purified, refolded, and subjected to HPLC analysis
exactly as described for the bSRCR protein product. ELISA analysis was
carried out using monoclonal antibody #38 (a conformation specific rat-anti-
mCD6 domain 3 antibody), and using COS cell expressed mCD6-3 as a
positive control (the antibody and mCD6-3 were generous gifts of Michael
Bowen). Briefly, samples to be analyzed were diluted in coating buffer (50 mM
sodium bicarbonate, pH 9.6), and incubated overnight in Immobilon-1 96 well
dishes (Fisher). Wells were washed 3 times with PBS containing 0.05%
Tween-20, and blocked for 1 hour with 100 gI EIA specimen diluent (Genetic
Systems). The wells were then washed twice with PBS/Tween-20, and
mAB#38 diluted to 1 gg/ml in specimen diluent was added. After a 1.5 hr
incubation at room temperature, the wells were washed 4 times with
PBS/Tween-20, and horse-radish peroxidase-anti-rat-IgG (Biosource
International) was added at a dilution of 1:5000 in specimen diluent. Following
a 1 hour incubation, the wells were washed 4 times with PBS/Tween-20, and
developed with EIA chromagen RG (Genetic Systems). The reaction was
stopped by addition of 1 N H2SO4, and wells were read at 450 nm.
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Results and discussion
As an initial approach to the high level expression of a SRCR domain,
expression of the bovine SR-Al's SRCR domain (bSRCR) in the methylotropic
yeast Pichia pastoris was chosen. This system was selected for several
reasons. It has been reported that Pichia is capable of producing correctly
folded secreted proteins with yields exceeding 1 gram per liter (Tschopp et al.,
1987). As Pichia is eukarytoic, it may be expected to correctly arrange disulfide
bonds in the proteins it secretes. Pichia can grow in defined media, and the
very high levels of expression make isotopic labeling for NMR feasible.
Constructs to express and secrete bSRCR with and without a His tag
leader sequence were generated and transfected into Pichia as described in
materials and methods. Secretion of the product into the media was evaluated
by SDS-PAGE and silver staining or Coomassie Blue staining, or by 32p
labeling of the heart muscle kinase site (His containing constructs only)
followed by SDS-PAGE and autoradiography. Despite several variations of
constructs, integration sites, and expression conditions, protein expression was
never detected. The different constructs used contained either a PHO1 or an a-
factor leader sequence. In the case of PHO1, constructs with and without the N-
terminal His tag and heart muscle kinase sites were tried. The Pichia constructs
were integrated into the Pichia genome at both the AOX1 site and the His 4
locus. Apparently, approximately 50% of the proteins that are attempted to be
expressed in Pichia express poorly or not at all (Jim Cregg, personal
communication). It would appear that the bovine SRCR domain is among this
50%.
An alternative approach to expression is to use E. coli. E. coli has
several advantage as an expression host. It can express many proteins at
moderately high levels (typically -50 mg/I), and isotopic substitution for NMR is
simple. However there are drawbacks. Disulfide containing molecules will
typically not be produced in the correctly folded form. Thus, the expressed
protein must be subjected to in vitro refolding reactions. The conditions which
enable a protein to fold successfully are highly variable, and may require
considerable effort to discover. This problem is exacerbated in the case of the
bSRCR domain, for which there are no known ligands. Thus, the only way to
assess whether a refolding reaction has been successful is to determine the
disulfide bond arrangement and compare the result to that found in the whole
receptor expressed in CHO cells (see chapter 6).
The bovine SR-Al SRCR domain was inserted into a vector placing the
cDNA under the control of a T7 promoter. Addition of IPTG to the growth media
resulted in massive induction of SRCR domains, which were found upon lysis of
the bacteria to be completely insoluble unless denaturants were added,
presumably in inclusion bodies. Yields of Ni2+-affinity purified protein were
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around 50 mg/I. The purified protein was assessed by SDS-PAGE and
reversed phase HPLC, and found to be fairly pure.
Efforts to refold the bSRCR domain were ultimately unsuccessful. The
material purified from the bacteria was oxidized. Upon reduction, its mobility by
reversed phase HPLC was substantially different. Many refolding conditions
caused the domain to refold to the initial fully oxidized form. Proteolytic
digestion and amino acid analysis of this form revealed that the cysteines were
forming nearest neighbor disulfides, i.e. Cys2-CysS, CysO-Cys6 , and by inference
Cys7-Cys8 , instead of the correct Cys2-Cys7 , CysS-Cys8 , CysS-Cys6 arrangement.
Occasionally different forms were observed, however they were not particularly
reproducible. The difficult of the assay as well as the strong propensity of the
protein to form vicinal disulfides was the eventual downfall of this approach.
Current efforts are focused on the refolding of bacterially expressed
murine CD6 SRCR domain #3 (mCD6-3). The issues and problems facing this
task are the same as those facing bSRCR, with one important difference:
mCD6-3 has a known ligand, ALCAM (Whitney et al., 1995b; see Appendix B
for details). This enables the refolding reaction to be monitored by means of a
simple ELISA assay, allowing numerous refolding conditions to be readily
screened in parallel. Furthermore, conformation specific monoclonal antibodies
have been isolated, providing an alternative assay.
Two expression constructs were produced. The first of these, SmCD6-3,
includes only the third SRCR domain. The second, LmCD6-3, encodes this
SRCR domain and an additional 34 amino acid stretch between this domain
and the membrane spanning region of the protein. This extension apparently
enhances ligand binding to some degree (Whitney et al., 1995b). Following
induction and Ni2+-affinity purification, yields were approximately 26 mg
SmCD6-3 and 43 mg LmCD6-3 per liter. HPLC analysis of the purified material
revealed that it was oxidized, with substantially different mobility than the
reduced material. Refolding reactions yielded products with still different
mobility. Analysis of these products is in progress. Conformation specific
monoclonal antibodies are capable of recognized several different forms of
refolded material, however no refolded form is as yet able to bind ALCAM.
Assuming that this material can be correctly refolded, NMR studies and X-ray
analysis should prove highly illuminating.
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Appendix D
Progress in the crystallization of the secreted type I
class A human scavenger receptor
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Introduction
Many of the predictions made concerning the structure of the type I and
type II class A scavenger receptors have been verified and extended in the
course of the work reported in this thesis. Support was provided for the receptor
being trimeric, and for the existence of the collagen and a-helical coiled-coil
domains, as well as the determination of the disulfide pattern of the SRCR
domain. Low resolution images of the receptor were obtained via electron
microscopy. Expression of the receptor at high levels (Chapter 6) allowed for
the possibility of obtaining higher resolution information via X-ray
crystallography. Possession of a high resolution structure of the receptor would
help us investigate the puzzling questions remaining concerning scavenger
receptor structure/function. Crystallization of a long, fibrous glycoprotein may
prove difficult, however initial results appear promising.
The crystallization trials described in this chapter were initiated by Gus
Leotta, am undergraduate (UROP) working with me. He did the initial factorial
screen. I've done the subsequent refinement of conditions and characterization
of crystals. Dr. Larry Stern has provided much advice and assistance in all
aspects of this project.
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Materials and methods
Expression and purification of s-hSR-Al - Secreted human type I receptor (s-
hSR-AI) was expressed and purified as described in chapter 6. The purified
material was buffer exchanged into 10 mM Tris, pH 7.4 using a Centricon 100
(Amicon) and subsequently concentrated to 10-20 mg/ml (Lowry et al., 1951).
Crystallization conditions - Crystallization trials were carried out using the
hanging drop method as previously described (Ducruix and Giege, 1992).
Briefly, 1 pl purified s-hSR-AI was mixed with 1 p.1 precipitant on a cover slip.
This cover slip was rapidly inverted and placed over a grease rimmed well of a
24 well dish (Linbro) containing 500 pIl of precipitant. The sealed drops are
incubated at room temperature to allow crystals to form. Initial selection of
precipitants was guided by a standard factorial screen of conditions which had
been successfully used to crystallize other proteins (Jancarik and Kim, 1991).
Conditions which led to precipitation were further investigated to find precipitant
concentrations in which crystals could nucleate and grow to larger sizes. The
composition which works best is currently 15% PEG-4K containing 100 mM
sodium cacadolite at pH 6.5.
X-ray diffraction studies - Crystals were harvested in 17% PEG-4K containing
100 mM sodium cacadolite at pH 6.5 and mounted in 0.5 mm Lindeman tubes
as previously described (Ducruix and Giege, 1992). Crystals were initially
characterized with 10 min still shots at 00 and 900 angles, as well as 6 hr shots
with 10 oscillation at the same angles. Studies were carried out using a Rigaku
RU200 X-ray set with a rotating copper anode and a 0.3 x 3 mm filament run at
50,000 volts, 100 mA. K, radiation was selected with a graphite
monochrometer, and diffraction data were collected using a R-axis-2 image
plate area detector.
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Results and Discussion
Initial attempts to crystallize s-hSR-AI gave promising results. The
factorial screen gave numerous conditions which precipitated the receptor.
Refinement of these conditions led to the identification of 15% polyethylene
glycol (4000 Da molecular weight) and pH 6.5 as conditions which could
promote crystal growth. These conditions resulted in the growth of crystals of
several different morphologies. The most prevalent form is apparently star
shaped (diagrammed in Figure D.1). These stars are actually composites of
diamond shape plates. The two forms drawn to the right of the star are
frequently observed. Mechanical disruption of the stars causes them to
separate into single diamond shaped plates. The dimensions of these
diamonds are typically 100 gpm long, 50 gpm wide, and about 5 gpm thick. Under
the same conditions, two other structures are occasionally observed. Needles
of approximately 160 plm by 20 gpm have been seen, as have amorphous
crystals with dimensions of 80 mm by 20 plm. It has not been established that
these crystals are in fact s-hSR-Al. The other drop constitutents, namely PEG,
sodium cacadolyte, and Tris, are highly unlikely to crystallize at these
concentrations. It is possible that protein or other contaminants in the
preparation could be crystallizing. Accordingly, an essential control experiment
at this point is to isolate several crystals and establish via SDS-PAGE that they
are in fact composed of scavenger receptor.
Initial attempts to characterize these crystals using X-ray diffraction have
been unsuccessful. Analysis of single diamond shaped and needle-like
crystals gave either no diffraction or very weak diffraction. There are several
possible reasons for this. Electron microscopy of single molecules has
revealed that the receptor is roughly 400 A long (see chapter 6). Assuming that
the long axis of the receptor lies in the short dimension of the crystal, this means
that a 5 pim thick crystal would have only ~125 molecules in this dimension.
This may well not be enough to diffract adequately. It may also be that the
crystals are simply disordered. Attempts to grow larger crystals are in progress,
as are attempts to crystallize the type II receptor. The most promising prospect
is to use the small crystal forms to seed different conditions which do not
inherently support nucleation, but might support further crystal growth. Efforts
are currently being hindered by batch-to-batch variation of crystallization
conditions, however this problem appears to have been overcome. Further
studies will be required to iron out this and other technical difficulties.
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Figure D.1 Crystal forms obtained using s-hSR-AI
Morphologies and sizes of observed crystals are shown. Crystals were
observed at 40x magnification with a dissecting microscope, and
measurements were estimated using an optical micrometer.
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Crystal forms obtained using s-hSR-Al
Stars
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Needles
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